id	sid	tid	token	lemma	pos
chd-210	1	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-210	1	2	e1	e1	NOUN
chd-210	1	3	cancer	cancer	NOUN
chd-210	1	4	health	health	NOUN
chd-210	1	5	disparities	disparity	NOUN
chd-210	1	6	research	research	VERB
chd-210	1	7	racial	racial	ADJ
chd-210	1	8	disparities	disparity	NOUN
chd-210	1	9	in	in	ADP
chd-210	1	10	the	the	DET
chd-210	1	11	genetic	genetic	ADJ
chd-210	1	12	landscape	landscape	NOUN
chd-210	1	13	of	of	ADP
chd-210	1	14	lung	lung	NOUN
chd-210	1	15	cancer	cancer	NOUN
chd-210	1	16	shashi	shashi	PROPN
chd-210	1	17	anand1,2	anand1,2	PROPN
chd-210	1	18	,	,	PUNCT
chd-210	1	19	kunwar	kunwar	NOUN
chd-210	1	20	somesh	somesh	PROPN
chd-210	1	21	vikramdeo1,2	vikramdeo1,2	PROPN
chd-210	1	22	,	,	PUNCT
chd-210	1	23	seema	seema	PROPN
chd-210	1	24	singh1,2,3	singh1,2,3	PROPN
chd-210	1	25	,	,	PUNCT
chd-210	1	26	ajay	ajay	PROPN
chd-210	1	27	pratap	pratap	PROPN
chd-210	1	28	singh1,2,3	singh1,2,3	PROPN
chd-210	1	29	,	,	PUNCT
chd-210	1	30	santanu	santanu	VERB
chd-210	1	31	dasgupta1,2,3	dasgupta1,2,3	ADJ
chd-210	1	32	*	*	PROPN
chd-210	1	33	1department	1department	NUM
chd-210	1	34	of	of	ADP
chd-210	1	35	pathology	pathology	NOUN
chd-210	1	36	,	,	PUNCT
chd-210	1	37	college	college	NOUN
chd-210	1	38	of	of	ADP
chd-210	1	39	medicine	medicine	NOUN
chd-210	1	40	,	,	PUNCT
chd-210	1	41	university	university	NOUN
chd-210	1	42	of	of	ADP
chd-210	1	43	south	south	PROPN
chd-210	1	44	alabama	alabama	PROPN
chd-210	1	45	,	,	PUNCT
chd-210	1	46	mobile	mobile	NOUN
chd-210	1	47	,	,	PUNCT
chd-210	1	48	al	al	PROPN
chd-210	1	49	36617	36617	NUM
chd-210	1	50	2cancer	2cancer	NUM
chd-210	1	51	biology	biology	NOUN
chd-210	1	52	program	program	NOUN
chd-210	1	53	,	,	PUNCT
chd-210	1	54	mitchell	mitchell	PROPN
chd-210	1	55	cancer	cancer	PROPN
chd-210	1	56	institute	institute	PROPN
chd-210	1	57	,	,	PUNCT
chd-210	1	58	university	university	PROPN
chd-210	1	59	of	of	ADP
chd-210	1	60	south	south	PROPN
chd-210	1	61	alabama	alabama	PROPN
chd-210	1	62	,	,	PUNCT
chd-210	1	63	mobile	mobile	NOUN
chd-210	1	64	,	,	PUNCT
chd-210	1	65	al	al	PROPN
chd-210	1	66	36604	36604	NUM
chd-210	2	1	3department	3department	NUM
chd-210	2	2	of	of	ADP
chd-210	2	3	biochemistry	biochemistry	NOUN
chd-210	2	4	and	and	CCONJ
chd-210	2	5	molecular	molecular	ADJ
chd-210	2	6	biology	biology	NOUN
chd-210	2	7	,	,	PUNCT
chd-210	2	8	university	university	NOUN
chd-210	2	9	of	of	ADP
chd-210	2	10	south	south	PROPN
chd-210	2	11	alabama	alabama	PROPN
chd-210	2	12	,	,	PUNCT
chd-210	2	13	mobile	mobile	PROPN
chd-210	2	14	,	,	PUNCT
chd-210	2	15	al	al	PROPN
chd-210	2	16	36688	36688	NUM
chd-210	2	17	.	.	PUNCT
chd-210	3	1	*	*	PUNCT
chd-210	3	2	corresponding	correspond	VERB
chd-210	3	3	author	author	NOUN
chd-210	3	4	:	:	PUNCT
chd-210	3	5	santanu	santanu	PROPN
chd-210	3	6	dasgupta	dasgupta	PROPN
chd-210	3	7	,	,	PUNCT
chd-210	3	8	phone	phone	NOUN
chd-210	3	9	:	:	PUNCT
chd-210	3	10	251	251	NUM
chd-210	3	11	-	-	SYM
chd-210	3	12	445	445	NUM
chd-210	3	13	-	-	PUNCT
chd-210	3	14	9805	9805	NUM
chd-210	3	15	,	,	PUNCT
chd-210	3	16	fax	fax	NOUN
chd-210	3	17	:	:	PUNCT
chd-210	3	18	251	251	NUM
chd-210	3	19	-	-	SYM
chd-210	3	20	460	460	NUM
chd-210	3	21	-	-	SYM
chd-210	3	22	6994	6994	NUM
chd-210	3	23	,	,	PUNCT
chd-210	3	24	email	email	NOUN
chd-210	3	25	:	:	PUNCT
chd-210	4	1	dasgupta@southalabama.edu	dasgupta@southalabama.edu	PROPN
chd-210	4	2	.	.	PUNCT
chd-210	5	1	abstract	abstract	ADJ
chd-210	5	2	lung	lung	NOUN
chd-210	5	3	cancer	cancer	NOUN
chd-210	5	4	has	have	VERB
chd-210	5	5	the	the	DET
chd-210	5	6	highest	high	ADJ
chd-210	5	7	cancer	cancer	NOUN
chd-210	5	8	-	-	PUNCT
chd-210	5	9	related	relate	VERB
chd-210	5	10	mortality	mortality	NOUN
chd-210	5	11	worldwide	worldwide	ADV
chd-210	5	12	and	and	CCONJ
chd-210	5	13	in	in	ADP
chd-210	5	14	the	the	DET
chd-210	5	15	united	united	PROPN
chd-210	5	16	states	states	PROPN
chd-210	5	17	.	.	PUNCT
chd-210	6	1	although	although	SCONJ
chd-210	6	2	reduced	reduce	VERB
chd-210	6	3	tobacco	tobacco	NOUN
chd-210	6	4	consumption	consumption	NOUN
chd-210	6	5	and	and	CCONJ
chd-210	6	6	advancement	advancement	NOUN
chd-210	6	7	in	in	ADP
chd-210	6	8	therapies	therapy	NOUN
chd-210	6	9	have	have	AUX
chd-210	6	10	led	lead	VERB
chd-210	6	11	to	to	ADP
chd-210	6	12	a	a	DET
chd-210	6	13	modest	modest	ADJ
chd-210	6	14	decline	decline	NOUN
chd-210	6	15	in	in	ADP
chd-210	6	16	lung	lung	NOUN
chd-210	6	17	cancer	cancer	NOUN
chd-210	6	18	death	death	NOUN
chd-210	6	19	rates	rate	NOUN
chd-210	6	20	over	over	ADP
chd-210	6	21	the	the	DET
chd-210	6	22	past	past	ADJ
chd-210	6	23	two	two	NUM
chd-210	6	24	decades	decade	NOUN
chd-210	6	25	;	;	PUNCT
chd-210	6	26	the	the	DET
chd-210	6	27	overall	overall	ADJ
chd-210	6	28	survival	survival	NOUN
chd-210	6	29	rate	rate	NOUN
chd-210	6	30	is	be	AUX
chd-210	6	31	still	still	ADV
chd-210	6	32	disappointing	disappointing	ADJ
chd-210	6	33	.	.	PUNCT
chd-210	7	1	moreover	moreover	ADV
chd-210	7	2	,	,	PUNCT
chd-210	7	3	raceassociated	raceassociate	VERB
chd-210	7	4	disparities	disparity	NOUN
chd-210	7	5	are	be	AUX
chd-210	7	6	also	also	ADV
chd-210	7	7	observed	observe	VERB
chd-210	7	8	,	,	PUNCT
chd-210	7	9	especially	especially	ADV
chd-210	7	10	in	in	ADP
chd-210	7	11	the	the	DET
chd-210	7	12	clinical	clinical	ADJ
chd-210	7	13	outcomes	outcome	NOUN
chd-210	7	14	.	.	PUNCT
chd-210	8	1	socioeconomic	socioeconomic	ADJ
chd-210	8	2	factors	factor	NOUN
chd-210	8	3	are	be	AUX
chd-210	8	4	considered	consider	VERB
chd-210	8	5	major	major	ADJ
chd-210	8	6	contributors	contributor	NOUN
chd-210	8	7	in	in	ADP
chd-210	8	8	cancer	cancer	NOUN
chd-210	8	9	health	health	NOUN
chd-210	8	10	disparities	disparity	NOUN
chd-210	8	11	,	,	PUNCT
chd-210	8	12	however	however	ADV
chd-210	8	13	,	,	PUNCT
chd-210	8	14	the	the	DET
chd-210	8	15	differences	difference	NOUN
chd-210	8	16	in	in	ADP
chd-210	8	17	the	the	DET
chd-210	8	18	genetic	genetic	ADJ
chd-210	8	19	landscape	landscape	NOUN
chd-210	8	20	of	of	ADP
chd-210	8	21	lung	lung	NOUN
chd-210	8	22	cancer	cancer	NOUN
chd-210	8	23	among	among	ADP
chd-210	8	24	different	different	ADJ
chd-210	8	25	racial	racial	ADJ
chd-210	8	26	groups	group	NOUN
chd-210	8	27	have	have	AUX
chd-210	8	28	also	also	ADV
chd-210	8	29	been	be	AUX
chd-210	8	30	reported	report	VERB
chd-210	8	31	.	.	PUNCT
chd-210	9	1	in	in	ADP
chd-210	9	2	this	this	DET
chd-210	9	3	review	review	NOUN
chd-210	9	4	,	,	PUNCT
chd-210	9	5	we	we	PRON
chd-210	9	6	shed	shed	VERB
chd-210	9	7	light	light	NOUN
chd-210	9	8	on	on	ADP
chd-210	9	9	the	the	DET
chd-210	9	10	genetic	genetic	ADJ
chd-210	9	11	heterogeneity	heterogeneity	NOUN
chd-210	9	12	of	of	ADP
chd-210	9	13	lung	lung	NOUN
chd-210	9	14	cancer	cancer	NOUN
chd-210	9	15	and	and	CCONJ
chd-210	9	16	race	race	NOUN
chd-210	9	17	-	-	PUNCT
chd-210	9	18	associated	associate	VERB
chd-210	9	19	differences	difference	NOUN
chd-210	9	20	in	in	ADP
chd-210	9	21	genetic	genetic	ADJ
chd-210	9	22	alterations	alteration	NOUN
chd-210	9	23	to	to	PART
chd-210	9	24	build	build	VERB
chd-210	9	25	a	a	DET
chd-210	9	26	framework	framework	NOUN
chd-210	9	27	for	for	ADP
chd-210	9	28	future	future	ADJ
chd-210	9	29	studies	study	NOUN
chd-210	9	30	to	to	PART
chd-210	9	31	understand	understand	VERB
chd-210	9	32	the	the	DET
chd-210	9	33	biological	biological	ADJ
chd-210	9	34	basis	basis	NOUN
chd-210	9	35	of	of	ADP
chd-210	9	36	lung	lung	NOUN
chd-210	9	37	cancer	cancer	NOUN
chd-210	9	38	disparities	disparity	NOUN
chd-210	9	39	.	.	PUNCT
chd-210	10	1	keywords	keyword	NOUN
chd-210	10	2	:	:	PUNCT
chd-210	10	3	lung	lung	NOUN
chd-210	10	4	cancer	cancer	NOUN
chd-210	10	5	,	,	PUNCT
chd-210	10	6	smoking	smoking	NOUN
chd-210	10	7	,	,	PUNCT
chd-210	10	8	racial	racial	ADJ
chd-210	10	9	disparity	disparity	NOUN
chd-210	10	10	,	,	PUNCT
chd-210	10	11	gene	gene	NOUN
chd-210	10	12	mutation	mutation	NOUN
chd-210	10	13	,	,	PUNCT
chd-210	10	14	mitochondria	mitochondria	PROPN
chd-210	10	15	.	.	PUNCT
chd-210	11	1	citation	citation	NOUN
chd-210	11	2	:	:	PUNCT
chd-210	11	3	anand	anand	PROPN
chd-210	11	4	s	s	PART
chd-210	11	5	et	et	PROPN
chd-210	11	6	al	al	PROPN
chd-210	11	7	(	(	PUNCT
chd-210	11	8	2022	2022	NUM
chd-210	11	9	)	)	PUNCT
chd-210	11	10	racial	racial	ADJ
chd-210	11	11	disparities	disparity	NOUN
chd-210	11	12	in	in	ADP
chd-210	11	13	the	the	DET
chd-210	11	14	genetic	genetic	ADJ
chd-210	11	15	landscape	landscape	NOUN
chd-210	11	16	of	of	ADP
chd-210	11	17	lung	lung	NOUN
chd-210	11	18	cancer	cancer	NOUN
chd-210	11	19	.	.	PUNCT
chd-210	12	1	cancer	cancer	NOUN
chd-210	12	2	health	health	NOUN
chd-210	12	3	disparities	disparity	NOUN
chd-210	12	4	6	6	NUM
chd-210	12	5	:	:	PUNCT
chd-210	12	6	e1	e1	NOUN
chd-210	12	7	-	-	PUNCT
chd-210	12	8	9	9	NUM
chd-210	12	9	.	.	PUNCT
chd-210	13	1	doi:10.9777	doi:10.9777	VERB
chd-210	13	2	/	/	SYM
chd-210	13	3	chd.2021.1006	chd.2021.1006	ADJ
chd-210	13	4	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-210	13	5	e2	e2	PROPN
chd-210	13	6	cancer	cancer	NOUN
chd-210	13	7	health	health	NOUN
chd-210	13	8	disparities	disparity	NOUN
chd-210	13	9	research	research	NOUN
chd-210	13	10	introduction	introduction	NOUN
chd-210	13	11	lung	lung	NOUN
chd-210	13	12	cancer	cancer	NOUN
chd-210	13	13	(	(	PUNCT
chd-210	13	14	lc	lc	NOUN
chd-210	13	15	)	)	PUNCT
chd-210	13	16	is	be	AUX
chd-210	13	17	a	a	DET
chd-210	13	18	lethal	lethal	ADJ
chd-210	13	19	disease	disease	NOUN
chd-210	13	20	that	that	PRON
chd-210	13	21	took	take	VERB
chd-210	13	22	1.8	1.8	NUM
chd-210	13	23	million	million	NUM
chd-210	13	24	lives	life	NOUN
chd-210	13	25	globally	globally	ADV
chd-210	13	26	in	in	ADP
chd-210	13	27	2020	2020	NUM
chd-210	13	28	[	[	X
chd-210	13	29	1	1	NUM
chd-210	13	30	]	]	PUNCT
chd-210	13	31	.	.	PUNCT
chd-210	14	1	this	this	DET
chd-210	14	2	year	year	NOUN
chd-210	14	3	,	,	PUNCT
chd-210	14	4	it	it	PRON
chd-210	14	5	is	be	AUX
chd-210	14	6	expected	expect	VERB
chd-210	14	7	to	to	PART
chd-210	14	8	kill	kill	VERB
chd-210	14	9	nearly	nearly	ADV
chd-210	14	10	131,880	131,880	NUM
chd-210	14	11	people	people	NOUN
chd-210	14	12	in	in	ADP
chd-210	14	13	the	the	DET
chd-210	14	14	united	united	PROPN
chd-210	14	15	states	states	PROPN
chd-210	14	16	alone	alone	ADV
chd-210	14	17	,	,	PUNCT
chd-210	14	18	with	with	ADP
chd-210	14	19	around	around	ADP
chd-210	14	20	235,760	235,760	NUM
chd-210	14	21	new	new	ADJ
chd-210	14	22	diagnoses	diagnosis	NOUN
chd-210	14	23	[	[	X
chd-210	14	24	1	1	NUM
chd-210	14	25	]	]	PUNCT
chd-210	14	26	.	.	PUNCT
chd-210	15	1	although	although	SCONJ
chd-210	15	2	with	with	ADP
chd-210	15	3	advances	advance	NOUN
chd-210	15	4	in	in	ADP
chd-210	15	5	therapy	therapy	NOUN
chd-210	15	6	,	,	PUNCT
chd-210	15	7	the	the	DET
chd-210	15	8	lc	lc	PROPN
chd-210	15	9	mortality	mortality	NOUN
chd-210	15	10	rate	rate	NOUN
chd-210	15	11	has	have	AUX
chd-210	15	12	been	be	AUX
chd-210	15	13	on	on	ADP
chd-210	15	14	a	a	DET
chd-210	15	15	mild	mild	ADJ
chd-210	15	16	decline	decline	NOUN
chd-210	15	17	over	over	ADP
chd-210	15	18	the	the	DET
chd-210	15	19	past	past	ADJ
chd-210	15	20	two	two	NUM
chd-210	15	21	decades	decade	NOUN
chd-210	15	22	,	,	PUNCT
chd-210	15	23	the	the	DET
chd-210	15	24	overall	overall	ADJ
chd-210	15	25	5	5	NUM
chd-210	15	26	-	-	PUNCT
chd-210	15	27	year	year	NOUN
chd-210	15	28	survival	survival	NOUN
chd-210	15	29	rate	rate	NOUN
chd-210	15	30	of	of	ADP
chd-210	15	31	lc	lc	NOUN
chd-210	15	32	patients	patient	NOUN
chd-210	15	33	is	be	AUX
chd-210	15	34	still	still	ADV
chd-210	15	35	at	at	ADP
chd-210	15	36	21.7	21.7	NUM
chd-210	15	37	%	%	NOUN
chd-210	15	38	[	[	X
chd-210	15	39	1,2	1,2	NUM
chd-210	15	40	]	]	PUNCT
chd-210	15	41	.	.	PUNCT
chd-210	16	1	another	another	DET
chd-210	16	2	upsetting	upsetting	ADJ
chd-210	16	3	fact	fact	NOUN
chd-210	16	4	is	be	AUX
chd-210	16	5	that	that	SCONJ
chd-210	16	6	in	in	ADP
chd-210	16	7	the	the	DET
chd-210	16	8	united	united	PROPN
chd-210	16	9	states	states	PROPN
chd-210	16	10	,	,	PUNCT
chd-210	16	11	lc	lc	PROPN
chd-210	16	12	disproportionately	disproportionately	ADV
chd-210	16	13	affects	affect	VERB
chd-210	16	14	people	people	NOUN
chd-210	16	15	of	of	ADP
chd-210	16	16	african	african	ADJ
chd-210	16	17	descend	descend	NOUN
chd-210	16	18	(	(	PUNCT
chd-210	16	19	aa	aa	INTJ
chd-210	16	20	,	,	PUNCT
chd-210	16	21	african	african	ADJ
chd-210	16	22	american	american	PROPN
chd-210	16	23	)	)	PUNCT
chd-210	16	24	compared	compare	VERB
chd-210	16	25	to	to	ADP
chd-210	16	26	those	those	PRON
chd-210	16	27	of	of	ADP
chd-210	16	28	european	european	ADJ
chd-210	16	29	origin	origin	NOUN
chd-210	16	30	(	(	PUNCT
chd-210	16	31	ca	ca	PROPN
chd-210	16	32	,	,	PUNCT
chd-210	16	33	caucasian	caucasian	PROPN
chd-210	16	34	american	american	PROPN
chd-210	16	35	)	)	PUNCT
chd-210	16	36	.	.	PUNCT
chd-210	17	1	the	the	DET
chd-210	17	2	incidence	incidence	NOUN
chd-210	17	3	of	of	ADP
chd-210	17	4	lc	lc	PROPN
chd-210	17	5	is	be	AUX
chd-210	17	6	1.15	1.15	NUM
chd-210	17	7	times	time	NOUN
chd-210	17	8	higher	high	ADJ
chd-210	17	9	among	among	ADP
chd-210	17	10	the	the	DET
chd-210	17	11	aa	aa	PROPN
chd-210	17	12	men	man	NOUN
chd-210	17	13	compared	compare	VERB
chd-210	17	14	to	to	ADP
chd-210	17	15	the	the	DET
chd-210	17	16	ca	ca	NOUN
chd-210	17	17	men	man	NOUN
chd-210	17	18	(	(	PUNCT
chd-210	17	19	85.4/100,000	85.4/100,000	NUM
chd-210	17	20	-	-	PUNCT
chd-210	17	21	aa	aa	NOUN
chd-210	17	22	vs.	vs.	ADP
chd-210	17	23	74.3/100,000	74.3/100,000	NUM
chd-210	17	24	-	-	PUNCT
chd-210	17	25	ca	ca	NOUN
chd-210	17	26	)	)	PUNCT
chd-210	17	27	,	,	PUNCT
chd-210	17	28	whereas	whereas	SCONJ
chd-210	17	29	it	it	PRON
chd-210	17	30	is	be	AUX
chd-210	17	31	0.86	0.86	NUM
chd-210	17	32	times	time	NOUN
chd-210	17	33	lower	low	ADJ
chd-210	17	34	among	among	ADP
chd-210	17	35	the	the	DET
chd-210	17	36	aa	aa	NOUN
chd-210	17	37	women	woman	NOUN
chd-210	17	38	compared	compare	VERB
chd-210	17	39	to	to	ADP
chd-210	17	40	the	the	DET
chd-210	17	41	ca	ca	NOUN
chd-210	17	42	women	woman	NOUN
chd-210	17	43	(	(	PUNCT
chd-210	17	44	49.2/100,000	49.2/100,000	NUM
chd-210	17	45	-	-	PUNCT
chd-210	17	46	aa	aa	NOUN
chd-210	17	47	vs.	vs.	ADP
chd-210	17	48	57.4/100,000	57.4/100,000	NUM
chd-210	17	49	-	-	PUNCT
chd-210	17	50	ca	ca	NOUN
chd-210	17	51	)	)	PUNCT
chd-210	18	1	[	[	X
chd-210	18	2	3	3	NUM
chd-210	18	3	]	]	PUNCT
chd-210	18	4	.	.	PUNCT
chd-210	19	1	similarly	similarly	ADV
chd-210	19	2	,	,	PUNCT
chd-210	19	3	the	the	DET
chd-210	19	4	lc	lc	PROPN
chd-210	19	5	mortality	mortality	NOUN
chd-210	19	6	is	be	AUX
chd-210	19	7	1.18	1.18	NUM
chd-210	19	8	times	time	NOUN
chd-210	19	9	higher	high	ADJ
chd-210	19	10	among	among	ADP
chd-210	19	11	the	the	DET
chd-210	19	12	aa	aa	NOUN
chd-210	19	13	men	man	NOUN
chd-210	19	14	than	than	ADP
chd-210	19	15	the	the	DET
chd-210	19	16	ca	ca	NOUN
chd-210	19	17	men	man	NOUN
chd-210	19	18	(	(	PUNCT
chd-210	19	19	63.9/100,000	63.9/100,000	NUM
chd-210	19	20	-	-	PUNCT
chd-210	19	21	aa	aa	NOUN
chd-210	19	22	vs.	vs.	ADP
chd-210	19	23	54.1/100,000	54.1/100,000	NUM
chd-210	19	24	-	-	PUNCT
chd-210	19	25	ca	ca	NOUN
chd-210	19	26	)	)	PUNCT
chd-210	19	27	and	and	CCONJ
chd-210	19	28	0.88	0.88	NUM
chd-210	19	29	times	time	NOUN
chd-210	19	30	lower	low	ADJ
chd-210	19	31	among	among	ADP
chd-210	19	32	the	the	DET
chd-210	19	33	aa	aa	NOUN
chd-210	19	34	women	woman	NOUN
chd-210	19	35	than	than	ADP
chd-210	19	36	ca	can	AUX
chd-210	19	37	women	woman	NOUN
chd-210	19	38	(	(	PUNCT
chd-210	19	39	33.9/100,000	33.9/100,000	NUM
chd-210	19	40	-	-	PUNCT
chd-210	19	41	aa	aa	NOUN
chd-210	19	42	vs.	vs.	ADP
chd-210	19	43	37.9/100,000	37.9/100,000	NUM
chd-210	19	44	-	-	PUNCT
chd-210	19	45	ca	ca	NOUN
chd-210	19	46	)	)	PUNCT
chd-210	19	47	.	.	PUNCT
chd-210	20	1	moreover	moreover	ADV
chd-210	20	2	,	,	PUNCT
chd-210	20	3	aa	aa	PROPN
chd-210	20	4	lc	lc	PROPN
chd-210	20	5	patients	patient	NOUN
chd-210	20	6	are	be	AUX
chd-210	20	7	16	16	NUM
chd-210	20	8	%	%	NOUN
chd-210	20	9	less	less	ADV
chd-210	20	10	likely	likely	ADJ
chd-210	20	11	to	to	PART
chd-210	20	12	have	have	VERB
chd-210	20	13	an	an	DET
chd-210	20	14	early	early	ADJ
chd-210	20	15	diagnosis	diagnosis	NOUN
chd-210	20	16	and	and	CCONJ
chd-210	20	17	are	be	AUX
chd-210	20	18	diagnosed	diagnose	VERB
chd-210	20	19	at	at	ADP
chd-210	20	20	advanced	advanced	ADJ
chd-210	20	21	stages	stage	NOUN
chd-210	20	22	[	[	X
chd-210	20	23	3	3	NUM
chd-210	20	24	]	]	PUNCT
chd-210	20	25	.	.	PUNCT
chd-210	21	1	the	the	DET
chd-210	21	2	5	5	NUM
chd-210	21	3	-	-	PUNCT
chd-210	21	4	year	year	NOUN
chd-210	21	5	overall	overall	ADJ
chd-210	21	6	survival	survival	NOUN
chd-210	21	7	rate	rate	NOUN
chd-210	21	8	among	among	ADP
chd-210	21	9	the	the	DET
chd-210	21	10	aa	aa	NOUN
chd-210	21	11	is	be	AUX
chd-210	21	12	also	also	ADV
chd-210	21	13	lower	low	ADJ
chd-210	21	14	(	(	PUNCT
chd-210	21	15	16	16	NUM
chd-210	21	16	%	%	NOUN
chd-210	21	17	)	)	PUNCT
chd-210	21	18	than	than	ADP
chd-210	21	19	that	that	PRON
chd-210	21	20	of	of	ADP
chd-210	21	21	the	the	DET
chd-210	21	22	ca	ca	NOUN
chd-210	21	23	group	group	NOUN
chd-210	21	24	(	(	PUNCT
chd-210	21	25	19	19	NUM
chd-210	21	26	%	%	NOUN
chd-210	21	27	)	)	PUNCT
chd-210	22	1	[	[	X
chd-210	22	2	3	3	NUM
chd-210	22	3	]	]	PUNCT
chd-210	22	4	,	,	PUNCT
chd-210	22	5	underscoring	underscore	VERB
chd-210	22	6	the	the	DET
chd-210	22	7	need	need	NOUN
chd-210	22	8	to	to	PART
chd-210	22	9	define	define	VERB
chd-210	22	10	the	the	DET
chd-210	22	11	factors	factor	NOUN
chd-210	22	12	underlying	underlie	VERB
chd-210	22	13	these	these	DET
chd-210	22	14	racial	racial	ADJ
chd-210	22	15	health	health	NOUN
chd-210	22	16	disparities	disparity	NOUN
chd-210	22	17	.	.	PUNCT
chd-210	23	1	potential	potential	ADJ
chd-210	23	2	contributing	contribute	VERB
chd-210	23	3	factors	factor	NOUN
chd-210	23	4	associated	associate	VERB
chd-210	23	5	with	with	ADP
chd-210	23	6	lung	lung	NOUN
chd-210	23	7	cancer	cancer	NOUN
chd-210	23	8	disparity	disparity	NOUN
chd-210	23	9	cigarette	cigarette	NOUN
chd-210	23	10	smoking	smoking	NOUN
chd-210	23	11	plays	play	VERB
chd-210	23	12	a	a	DET
chd-210	23	13	significant	significant	ADJ
chd-210	23	14	role	role	NOUN
chd-210	23	15	in	in	ADP
chd-210	23	16	lung	lung	NOUN
chd-210	23	17	tumorigenesis	tumorigenesis	NOUN
chd-210	24	1	[	[	X
chd-210	24	2	4–7	4–7	NOUN
chd-210	24	3	]	]	X
chd-210	24	4	.	.	PUNCT
chd-210	25	1	although	although	SCONJ
chd-210	25	2	the	the	DET
chd-210	25	3	overall	overall	ADJ
chd-210	25	4	cigarette	cigarette	NOUN
chd-210	25	5	smoking	smoking	NOUN
chd-210	25	6	prevalence	prevalence	NOUN
chd-210	25	7	is	be	AUX
chd-210	25	8	similar	similar	ADJ
chd-210	25	9	in	in	ADP
chd-210	25	10	both	both	CCONJ
chd-210	25	11	aa	aa	NOUN
chd-210	25	12	and	and	CCONJ
chd-210	25	13	ca	ca	NOUN
chd-210	25	14	populations	population	NOUN
chd-210	25	15	(	(	PUNCT
chd-210	25	16	15%-aa	15%-aa	NUM
chd-210	25	17	vs.	vs.	ADP
chd-210	25	18	16	16	NUM
chd-210	25	19	%	%	NOUN
chd-210	25	20	ca	ca	NOUN
chd-210	25	21	)	)	PUNCT
chd-210	25	22	,	,	PUNCT
chd-210	25	23	it	it	PRON
chd-210	25	24	appears	appear	VERB
chd-210	25	25	to	to	PART
chd-210	25	26	be	be	AUX
chd-210	25	27	higher	high	ADJ
chd-210	25	28	among	among	ADP
chd-210	25	29	ca	ca	NOUN
chd-210	25	30	women	woman	NOUN
chd-210	25	31	compared	compare	VERB
chd-210	25	32	to	to	ADP
chd-210	25	33	the	the	DET
chd-210	25	34	aa	aa	ADJ
chd-210	25	35	women	woman	NOUN
chd-210	25	36	(	(	PUNCT
chd-210	25	37	15	15	NUM
chd-210	25	38	%	%	NOUN
chd-210	25	39	vs.	vs.	ADP
chd-210	25	40	12	12	NUM
chd-210	25	41	%	%	NOUN
chd-210	25	42	)	)	PUNCT
chd-210	26	1	[	[	X
chd-210	26	2	2	2	NUM
chd-210	26	3	]	]	PUNCT
chd-210	26	4	.	.	PUNCT
chd-210	27	1	notably	notably	ADV
chd-210	27	2	,	,	PUNCT
chd-210	27	3	the	the	DET
chd-210	27	4	metabolic	metabolic	NOUN
chd-210	27	5	capability	capability	NOUN
chd-210	27	6	of	of	ADP
chd-210	27	7	cigarette	cigarette	NOUN
chd-210	27	8	smoke	smoke	NOUN
chd-210	27	9	-	-	PUNCT
chd-210	27	10	derived	derive	VERB
chd-210	27	11	carcinogens	carcinogen	NOUN
chd-210	27	12	may	may	AUX
chd-210	27	13	also	also	ADV
chd-210	27	14	vary	vary	VERB
chd-210	27	15	in	in	ADP
chd-210	27	16	different	different	ADJ
chd-210	27	17	racial	racial	ADJ
chd-210	27	18	populations	population	NOUN
chd-210	27	19	giving	give	VERB
chd-210	27	20	rise	rise	NOUN
chd-210	27	21	to	to	ADP
chd-210	27	22	an	an	DET
chd-210	27	23	increased	increase	VERB
chd-210	27	24	risk	risk	NOUN
chd-210	27	25	of	of	ADP
chd-210	27	26	lc	lc	PROPN
chd-210	27	27	.	.	PUNCT
chd-210	28	1	for	for	ADP
chd-210	28	2	example	example	NOUN
chd-210	28	3	,	,	PUNCT
chd-210	28	4	the	the	DET
chd-210	28	5	clearance	clearance	NOUN
chd-210	28	6	of	of	ADP
chd-210	28	7	cigarette	cigarette	NOUN
chd-210	28	8	smoke	smoke	NOUN
chd-210	28	9	-	-	PUNCT
chd-210	28	10	derived	derive	VERB
chd-210	28	11	nicotine	nicotine	NOUN
chd-210	28	12	in	in	ADP
chd-210	28	13	the	the	DET
chd-210	28	14	body	body	NOUN
chd-210	28	15	is	be	AUX
chd-210	28	16	regulated	regulate	VERB
chd-210	28	17	by	by	ADP
chd-210	28	18	the	the	DET
chd-210	28	19	cyp2a6	cyp2a6	PROPN
chd-210	28	20	gene	gene	NOUN
chd-210	28	21	,	,	PUNCT
chd-210	28	22	which	which	PRON
chd-210	28	23	converts	convert	VERB
chd-210	28	24	nicotine	nicotine	NOUN
chd-210	28	25	to	to	PART
chd-210	28	26	cotinine	cotinine	VERB
chd-210	28	27	[	[	X
chd-210	28	28	8	8	NUM
chd-210	28	29	]	]	PUNCT
chd-210	28	30	.	.	PUNCT
chd-210	29	1	different	different	ADJ
chd-210	29	2	genetic	genetic	ADJ
chd-210	29	3	variants	variant	NOUN
chd-210	29	4	of	of	ADP
chd-210	29	5	cyp2a6	cyp2a6	PROPN
chd-210	29	6	could	could	AUX
chd-210	29	7	potentially	potentially	ADV
chd-210	29	8	be	be	AUX
chd-210	29	9	associated	associate	VERB
chd-210	29	10	with	with	ADP
chd-210	29	11	increased	increase	VERB
chd-210	29	12	risk	risk	NOUN
chd-210	29	13	of	of	ADP
chd-210	29	14	lc	lc	NOUN
chd-210	29	15	in	in	ADP
chd-210	29	16	aa	aa	NOUN
chd-210	29	17	,	,	PUNCT
chd-210	29	18	as	as	SCONJ
chd-210	29	19	a	a	DET
chd-210	29	20	higher	high	ADJ
chd-210	29	21	level	level	NOUN
chd-210	29	22	of	of	ADP
chd-210	29	23	cotinine	cotinine	NOUN
chd-210	29	24	was	be	AUX
chd-210	29	25	detected	detect	VERB
chd-210	29	26	in	in	ADP
chd-210	29	27	the	the	DET
chd-210	29	28	blood	blood	NOUN
chd-210	29	29	of	of	ADP
chd-210	29	30	aa	aa	PROPN
chd-210	29	31	lc	lc	PROPN
chd-210	29	32	patients	patient	NOUN
chd-210	29	33	compared	compare	VERB
chd-210	29	34	to	to	ADP
chd-210	29	35	ca	ca	PROPN
chd-210	29	36	lc	lc	PROPN
chd-210	29	37	patients	patient	NOUN
chd-210	29	38	.	.	PUNCT
chd-210	30	1	however	however	ADV
chd-210	30	2	,	,	PUNCT
chd-210	30	3	a	a	DET
chd-210	30	4	clear	clear	ADJ
chd-210	30	5	link	link	NOUN
chd-210	30	6	associating	associate	VERB
chd-210	30	7	the	the	DET
chd-210	30	8	metabolism	metabolism	NOUN
chd-210	30	9	of	of	ADP
chd-210	30	10	nicotine	nicotine	NOUN
chd-210	30	11	and	and	CCONJ
chd-210	30	12	other	other	ADJ
chd-210	30	13	tobacco	tobacco	NOUN
chd-210	30	14	carcinogens	carcinogen	NOUN
chd-210	30	15	with	with	ADP
chd-210	30	16	lc	lc	NOUN
chd-210	30	17	disparity	disparity	NOUN
chd-210	30	18	has	have	AUX
chd-210	30	19	not	not	PART
chd-210	30	20	yet	yet	ADV
chd-210	30	21	been	be	AUX
chd-210	30	22	established	establish	VERB
chd-210	30	23	.	.	PUNCT
chd-210	31	1	the	the	DET
chd-210	31	2	geographical	geographical	ADJ
chd-210	31	3	location	location	NOUN
chd-210	31	4	and	and	CCONJ
chd-210	31	5	socioeconomic	socioeconomic	ADJ
chd-210	31	6	status	status	NOUN
chd-210	31	7	(	(	PUNCT
chd-210	31	8	ses	ses	PROPN
chd-210	31	9	)	)	PUNCT
chd-210	31	10	of	of	ADP
chd-210	31	11	the	the	DET
chd-210	31	12	patients	patient	NOUN
chd-210	31	13	also	also	ADV
chd-210	31	14	seem	seem	VERB
chd-210	31	15	to	to	PART
chd-210	31	16	be	be	AUX
chd-210	31	17	important	important	ADJ
chd-210	31	18	contributing	contribute	VERB
chd-210	31	19	factors	factor	NOUN
chd-210	31	20	in	in	ADP
chd-210	31	21	lc	lc	NOUN
chd-210	31	22	health	health	NOUN
chd-210	31	23	disparities	disparity	NOUN
chd-210	31	24	.	.	PUNCT
chd-210	32	1	people	people	NOUN
chd-210	32	2	from	from	ADP
chd-210	32	3	various	various	ADJ
chd-210	32	4	races	race	NOUN
chd-210	32	5	living	live	VERB
chd-210	32	6	in	in	ADP
chd-210	32	7	heavily	heavily	ADV
chd-210	32	8	industrialized	industrialize	VERB
chd-210	32	9	areas	area	NOUN
chd-210	32	10	and	and	CCONJ
chd-210	32	11	areas	area	NOUN
chd-210	32	12	with	with	ADP
chd-210	32	13	a	a	DET
chd-210	32	14	high	high	ADJ
chd-210	32	15	rate	rate	NOUN
chd-210	32	16	of	of	ADP
chd-210	32	17	air	air	NOUN
chd-210	32	18	pollution	pollution	NOUN
chd-210	32	19	may	may	AUX
chd-210	32	20	be	be	AUX
chd-210	32	21	associated	associate	VERB
chd-210	32	22	with	with	ADP
chd-210	32	23	an	an	DET
chd-210	32	24	increased	increase	VERB
chd-210	32	25	risk	risk	NOUN
chd-210	32	26	of	of	ADP
chd-210	32	27	lc	lc	PROPN
chd-210	32	28	development	development	NOUN
chd-210	32	29	[	[	X
chd-210	32	30	9	9	NUM
chd-210	32	31	]	]	PUNCT
chd-210	32	32	.	.	PUNCT
chd-210	33	1	in	in	ADP
chd-210	33	2	addition	addition	NOUN
chd-210	33	3	,	,	PUNCT
chd-210	33	4	body	body	NOUN
chd-210	33	5	mass	mass	PROPN
chd-210	33	6	index	index	NOUN
chd-210	33	7	,	,	PUNCT
chd-210	33	8	alcohol	alcohol	NOUN
chd-210	33	9	consumption	consumption	NOUN
chd-210	33	10	,	,	PUNCT
chd-210	33	11	radon	radon	NOUN
chd-210	33	12	,	,	PUNCT
chd-210	33	13	and	and	CCONJ
chd-210	33	14	alternative	alternative	ADJ
chd-210	33	15	or	or	CCONJ
chd-210	33	16	unidentified	unidentified	ADJ
chd-210	33	17	environmental	environmental	ADJ
chd-210	33	18	exposures	exposure	NOUN
chd-210	33	19	may	may	AUX
chd-210	33	20	also	also	ADV
chd-210	33	21	potentially	potentially	ADV
chd-210	33	22	contribute	contribute	VERB
chd-210	33	23	to	to	ADP
chd-210	33	24	lc	lc	NOUN
chd-210	33	25	health	health	NOUN
chd-210	33	26	disparities	disparity	NOUN
chd-210	33	27	[	[	X
chd-210	33	28	10	10	NUM
chd-210	33	29	]	]	PUNCT
chd-210	33	30	.	.	PUNCT
chd-210	34	1	on	on	ADP
chd-210	34	2	the	the	DET
chd-210	34	3	other	other	ADJ
chd-210	34	4	hand	hand	NOUN
chd-210	34	5	,	,	PUNCT
chd-210	34	6	the	the	DET
chd-210	34	7	lc	lc	NOUN
chd-210	34	8	risk	risk	NOUN
chd-210	34	9	may	may	AUX
chd-210	34	10	increase	increase	VERB
chd-210	34	11	in	in	ADP
chd-210	34	12	socioeconomically	socioeconomically	ADV
chd-210	34	13	disadvantaged	disadvantaged	ADJ
chd-210	34	14	racial	racial	ADJ
chd-210	34	15	groups	group	NOUN
chd-210	34	16	continuously	continuously	ADV
chd-210	34	17	exposed	expose	VERB
chd-210	34	18	to	to	ADP
chd-210	34	19	low	low	ADJ
chd-210	34	20	ses	se	NOUN
chd-210	34	21	-	-	PUNCT
chd-210	34	22	derived	derive	VERB
chd-210	34	23	stressors	stressor	NOUN
chd-210	34	24	accompanied	accompany	VERB
chd-210	34	25	by	by	ADP
chd-210	34	26	a	a	DET
chd-210	34	27	high	high	ADJ
chd-210	34	28	prevalence	prevalence	NOUN
chd-210	34	29	of	of	ADP
chd-210	34	30	smoking	smoking	NOUN
chd-210	34	31	and	and	CCONJ
chd-210	34	32	other	other	ADJ
chd-210	34	33	unhealthy	unhealthy	ADJ
chd-210	34	34	behavior	behavior	NOUN
chd-210	34	35	.	.	PUNCT
chd-210	35	1	genetic	genetic	ADJ
chd-210	35	2	heterogeneity	heterogeneity	NOUN
chd-210	35	3	in	in	ADP
chd-210	35	4	lung	lung	NOUN
chd-210	35	5	cancer	cancer	NOUN
chd-210	35	6	and	and	CCONJ
chd-210	35	7	its	its	PRON
chd-210	35	8	association	association	NOUN
chd-210	35	9	with	with	ADP
chd-210	35	10	racial	racial	ADJ
chd-210	35	11	health	health	NOUN
chd-210	35	12	disparity	disparity	NOUN
chd-210	35	13	through	through	ADP
chd-210	35	14	comprehensive	comprehensive	ADJ
chd-210	35	15	next	next	ADJ
chd-210	35	16	-	-	PUNCT
chd-210	35	17	generation	generation	NOUN
chd-210	35	18	deep	deep	ADJ
chd-210	35	19	sequencing	sequencing	NOUN
chd-210	35	20	,	,	PUNCT
chd-210	35	21	numerous	numerous	ADJ
chd-210	35	22	genetic	genetic	ADJ
chd-210	35	23	anomalies	anomaly	NOUN
chd-210	35	24	have	have	AUX
chd-210	35	25	been	be	AUX
chd-210	35	26	cataloged	catalog	VERB
chd-210	35	27	in	in	ADP
chd-210	35	28	lc	lc	PROPN
chd-210	35	29	.	.	PUNCT
chd-210	36	1	to	to	ADP
chd-210	36	2	date	date	NOUN
chd-210	36	3	,	,	PUNCT
chd-210	36	4	a	a	DET
chd-210	36	5	panel	panel	NOUN
chd-210	36	6	of	of	ADP
chd-210	36	7	twenty	twenty	NUM
chd-210	36	8	genes	gene	NOUN
chd-210	36	9	with	with	ADP
chd-210	36	10	the	the	DET
chd-210	36	11	highest	high	ADJ
chd-210	36	12	frequency	frequency	NOUN
chd-210	36	13	of	of	ADP
chd-210	36	14	mutations	mutation	NOUN
chd-210	36	15	have	have	AUX
chd-210	36	16	been	be	AUX
chd-210	36	17	identified	identify	VERB
chd-210	36	18	in	in	ADP
chd-210	36	19	lc	lc	PROPN
chd-210	36	20	(	(	PUNCT
chd-210	36	21	figure	figure	NOUN
chd-210	36	22	1	1	NUM
chd-210	36	23	)	)	PUNCT
chd-210	36	24	.	.	PUNCT
chd-210	37	1	in	in	ADP
chd-210	37	2	addition	addition	NOUN
chd-210	37	3	,	,	PUNCT
chd-210	37	4	several	several	ADJ
chd-210	37	5	different	different	ADJ
chd-210	37	6	types	type	NOUN
chd-210	37	7	of	of	ADP
chd-210	37	8	genetic	genetic	ADJ
chd-210	37	9	mutations	mutation	NOUN
chd-210	37	10	have	have	AUX
chd-210	37	11	been	be	AUX
chd-210	37	12	reported	report	VERB
chd-210	37	13	,	,	PUNCT
chd-210	37	14	including	include	VERB
chd-210	37	15	nonsense	nonsense	NOUN
chd-210	37	16	substitution	substitution	NOUN
chd-210	37	17	,	,	PUNCT
chd-210	37	18	missense	missense	NOUN
chd-210	37	19	substitution	substitution	NOUN
chd-210	37	20	,	,	PUNCT
chd-210	37	21	synonymous	synonymous	ADJ
chd-210	37	22	substitution	substitution	NOUN
chd-210	37	23	,	,	PUNCT
chd-210	37	24	inframe	inframe	ADJ
chd-210	37	25	insertion	insertion	NOUN
chd-210	37	26	,	,	PUNCT
chd-210	37	27	frameshift	frameshift	ADJ
chd-210	37	28	insertion	insertion	NOUN
chd-210	37	29	or	or	CCONJ
chd-210	37	30	deletion	deletion	NOUN
chd-210	37	31	mutations	mutation	NOUN
chd-210	37	32	(	(	PUNCT
chd-210	37	33	figure	figure	NOUN
chd-210	37	34	2	2	NUM
chd-210	37	35	)	)	PUNCT
chd-210	37	36	.	.	PUNCT
chd-210	38	1	among	among	ADP
chd-210	38	2	these	these	DET
chd-210	38	3	genes	gene	NOUN
chd-210	38	4	,	,	PUNCT
chd-210	38	5	egfr	egfr	NOUN
chd-210	38	6	and	and	CCONJ
chd-210	38	7	kras	kras	PROPN
chd-210	38	8	appear	appear	VERB
chd-210	38	9	to	to	PART
chd-210	38	10	be	be	AUX
chd-210	38	11	the	the	DET
chd-210	38	12	most	most	ADV
chd-210	38	13	frequently	frequently	ADV
chd-210	38	14	mutated	mutate	VERB
chd-210	38	15	ones	one	NOUN
chd-210	38	16	in	in	ADP
chd-210	38	17	lc	lc	PROPN
chd-210	38	18	.	.	PROPN
chd-210	38	19	egfr	egfr	PROPN
chd-210	38	20	gene	gene	NOUN
chd-210	38	21	mutations	mutation	NOUN
chd-210	38	22	predominantly	predominantly	ADV
chd-210	38	23	occur	occur	VERB
chd-210	38	24	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-210	38	25	e3	e3	NOUN
chd-210	38	26	cancer	cancer	NOUN
chd-210	38	27	health	health	NOUN
chd-210	38	28	disparities	disparity	NOUN
chd-210	38	29	research	research	VERB
chd-210	38	30	among	among	ADP
chd-210	38	31	non	non	ADJ
chd-210	38	32	-	-	ADJ
chd-210	38	33	smoker	smoker	ADJ
chd-210	38	34	patients	patient	NOUN
chd-210	38	35	with	with	ADP
chd-210	38	36	adenocarcinoma	adenocarcinoma	NOUN
chd-210	38	37	histology	histology	NOUN
chd-210	38	38	,	,	PUNCT
chd-210	38	39	whereas	whereas	SCONJ
chd-210	38	40	kras	kra	NOUN
chd-210	38	41	mutations	mutation	NOUN
chd-210	38	42	are	be	AUX
chd-210	38	43	common	common	ADJ
chd-210	38	44	among	among	ADP
chd-210	38	45	smokers	smoker	NOUN
chd-210	38	46	with	with	ADP
chd-210	38	47	squamous	squamous	ADJ
chd-210	38	48	cell	cell	NOUN
chd-210	38	49	carcinoma	carcinoma	NOUN
chd-210	38	50	histology	histology	NOUN
chd-210	39	1	[	[	X
chd-210	39	2	11	11	NUM
chd-210	39	3	]	]	PUNCT
chd-210	39	4	.	.	PUNCT
chd-210	40	1	in	in	ADP
chd-210	40	2	an	an	DET
chd-210	40	3	earlier	early	ADJ
chd-210	40	4	study	study	NOUN
chd-210	40	5	by	by	ADP
chd-210	40	6	liedner	liedner	NOUN
chd-210	40	7	et	et	PROPN
chd-210	40	8	al	al	PROPN
chd-210	40	9	.	.	PROPN
chd-210	40	10	,	,	PUNCT
chd-210	40	11	aa	aa	PROPN
chd-210	40	12	lc	lc	PROPN
chd-210	40	13	patients	patient	NOUN
chd-210	40	14	were	be	AUX
chd-210	40	15	found	find	VERB
chd-210	40	16	to	to	PART
chd-210	40	17	harbor	harbor	VERB
chd-210	40	18	a	a	DET
chd-210	40	19	significantly	significantly	ADV
chd-210	40	20	lower	low	ADJ
chd-210	40	21	number	number	NOUN
chd-210	40	22	of	of	ADP
chd-210	40	23	egfr	egfr	ADJ
chd-210	40	24	mutations	mutation	NOUN
chd-210	40	25	compared	compare	VERB
chd-210	40	26	to	to	ADP
chd-210	40	27	their	their	PRON
chd-210	40	28	ca	ca	NOUN
chd-210	40	29	counterparts	counterpart	NOUN
chd-210	40	30	,	,	PUNCT
chd-210	40	31	thereby	thereby	ADV
chd-210	40	32	predicting	predict	VERB
chd-210	40	33	a	a	DET
chd-210	40	34	poorer	poorer	ADV
chd-210	40	35	therapeutic	therapeutic	ADJ
chd-210	40	36	response	response	NOUN
chd-210	40	37	from	from	ADP
chd-210	40	38	treatment	treatment	NOUN
chd-210	40	39	with	with	ADP
chd-210	40	40	the	the	DET
chd-210	40	41	tyrosine	tyrosine	NOUN
chd-210	40	42	kinase	kinase	PROPN
chd-210	40	43	inhibitors	inhibitor	NOUN
chd-210	40	44	[	[	X
chd-210	40	45	12	12	NUM
chd-210	40	46	]	]	PUNCT
chd-210	40	47	.	.	PUNCT
chd-210	41	1	a	a	DET
chd-210	41	2	subsequent	subsequent	ADJ
chd-210	41	3	study	study	NOUN
chd-210	41	4	by	by	ADP
chd-210	41	5	harada	harada	PROPN
chd-210	41	6	et	et	PROPN
chd-210	41	7	el	el	PROPN
chd-210	41	8	.	.	PROPN
chd-210	41	9	reported	report	VERB
chd-210	41	10	a	a	DET
chd-210	41	11	novel	novel	NOUN
chd-210	41	12	egfr	egfr	NOUN
chd-210	41	13	exon-20	exon-20	PROPN
chd-210	41	14	mutation	mutation	NOUN
chd-210	41	15	in	in	ADP
chd-210	41	16	aa	aa	PROPN
chd-210	41	17	subjects	subject	NOUN
chd-210	41	18	[	[	X
chd-210	41	19	13	13	NUM
chd-210	41	20	]	]	PUNCT
chd-210	41	21	.	.	PUNCT
chd-210	42	1	in	in	ADP
chd-210	42	2	addition	addition	NOUN
chd-210	42	3	,	,	PUNCT
chd-210	42	4	they	they	PRON
chd-210	42	5	also	also	ADV
chd-210	42	6	identified	identify	VERB
chd-210	42	7	five	five	NUM
chd-210	42	8	egfr	egfr	ADV
chd-210	42	9	-	-	PUNCT
chd-210	42	10	activating	activate	VERB
chd-210	42	11	mutations	mutation	NOUN
chd-210	42	12	in	in	ADP
chd-210	42	13	eight	eight	NUM
chd-210	42	14	aa	aa	NOUN
chd-210	42	15	cases	case	NOUN
chd-210	42	16	who	who	PRON
chd-210	42	17	were	be	AUX
chd-210	42	18	either	either	PRON
chd-210	42	19	never	never	ADV
chd-210	42	20	or	or	CCONJ
chd-210	42	21	light	light	NOUN
chd-210	42	22	smokes	smoke	NOUN
chd-210	42	23	,	,	PUNCT
chd-210	42	24	whereas	whereas	SCONJ
chd-210	42	25	no	no	DET
chd-210	42	26	egfr	egfr	ADJ
chd-210	42	27	mutation	mutation	NOUN
chd-210	42	28	was	be	AUX
chd-210	42	29	detected	detect	VERB
chd-210	42	30	among	among	ADP
chd-210	42	31	the	the	DET
chd-210	42	32	heavy	heavy	ADJ
chd-210	42	33	smokers	smoker	NOUN
chd-210	42	34	.	.	PUNCT
chd-210	43	1	interestingly	interestingly	ADV
chd-210	43	2	,	,	PUNCT
chd-210	43	3	a	a	DET
chd-210	43	4	couple	couple	NOUN
chd-210	43	5	of	of	ADP
chd-210	43	6	insertional	insertional	ADJ
chd-210	43	7	egfr	egfr	ADJ
chd-210	43	8	gene	gene	NOUN
chd-210	43	9	mutations	mutation	NOUN
chd-210	43	10	encompassing	encompass	VERB
chd-210	43	11	exon	exon	NOUN
chd-210	43	12	20	20	NUM
chd-210	43	13	such	such	ADJ
chd-210	43	14	as	as	ADP
chd-210	43	15	n771gy	n771gy	NOUN
chd-210	43	16	and	and	CCONJ
chd-210	43	17	a767	a767	PROPN
chd-210	43	18	-	-	PUNCT
chd-210	43	19	v769dup	v769dup	PROPN
chd-210	43	20	were	be	AUX
chd-210	43	21	identified	identify	VERB
chd-210	43	22	exclusively	exclusively	ADV
chd-210	43	23	in	in	ADP
chd-210	43	24	the	the	DET
chd-210	43	25	aa	aa	PROPN
chd-210	43	26	lc	lc	PROPN
chd-210	43	27	patients	patient	NOUN
chd-210	43	28	.	.	PUNCT
chd-210	44	1	other	other	ADJ
chd-210	44	2	than	than	ADP
chd-210	44	3	egfr	egfr	ADJ
chd-210	44	4	,	,	PUNCT
chd-210	44	5	n375s	n375s	PROPN
chd-210	44	6	-	-	PUNCT
chd-210	44	7	met	meet	VERB
chd-210	44	8	gene	gene	NOUN
chd-210	44	9	mutation	mutation	NOUN
chd-210	44	10	was	be	AUX
chd-210	44	11	detected	detect	VERB
chd-210	44	12	in	in	ADP
chd-210	44	13	around	around	ADP
chd-210	44	14	13	13	NUM
chd-210	44	15	%	%	NOUN
chd-210	44	16	of	of	ADP
chd-210	44	17	east	east	PROPN
chd-210	44	18	asian	asian	PROPN
chd-210	44	19	lc	lc	PROPN
chd-210	44	20	patients	patient	NOUN
chd-210	44	21	and	and	CCONJ
chd-210	44	22	2.6	2.6	NUM
chd-210	44	23	%	%	NOUN
chd-210	44	24	ca	ca	AUX
chd-210	44	25	lc	lc	VERB
chd-210	44	26	patients	patient	NOUN
chd-210	44	27	but	but	CCONJ
chd-210	44	28	not	not	PART
chd-210	44	29	in	in	ADP
chd-210	44	30	the	the	DET
chd-210	44	31	aa	aa	PROPN
chd-210	44	32	lc	lc	PROPN
chd-210	44	33	patients	patient	NOUN
chd-210	45	1	[	[	X
chd-210	45	2	14	14	NUM
chd-210	45	3	]	]	PUNCT
chd-210	45	4	.	.	PUNCT
chd-210	46	1	inactivation	inactivation	NOUN
chd-210	46	2	of	of	ADP
chd-210	46	3	stk11	stk11	ADJ
chd-210	46	4	gene	gene	NOUN
chd-210	46	5	,	,	PUNCT
chd-210	46	6	also	also	ADV
chd-210	46	7	known	know	VERB
chd-210	46	8	as	as	ADP
chd-210	46	9	lkb1	lkb1	PROPN
chd-210	46	10	,	,	PUNCT
chd-210	46	11	either	either	CCONJ
chd-210	46	12	due	due	ADP
chd-210	46	13	to	to	ADP
chd-210	46	14	deletion	deletion	NOUN
chd-210	46	15	or	or	CCONJ
chd-210	46	16	insertions	insertion	NOUN
chd-210	46	17	,	,	PUNCT
chd-210	46	18	have	have	AUX
chd-210	46	19	been	be	AUX
chd-210	46	20	reported	report	VERB
chd-210	46	21	to	to	PART
chd-210	46	22	be	be	AUX
chd-210	46	23	more	more	ADV
chd-210	46	24	frequent	frequent	ADJ
chd-210	46	25	in	in	ADP
chd-210	46	26	caucasian	caucasian	ADJ
chd-210	46	27	americans	americans	PROPN
chd-210	46	28	compared	compare	VERB
chd-210	46	29	to	to	ADP
chd-210	46	30	african	african	ADJ
chd-210	46	31	american	american	ADJ
chd-210	46	32	and	and	CCONJ
chd-210	46	33	asian	asian	ADJ
chd-210	46	34	nslc	nslc	NOUN
chd-210	46	35	patients	patient	NOUN
chd-210	46	36	[	[	X
chd-210	46	37	15,16	15,16	NUM
chd-210	46	38	]	]	PUNCT
chd-210	46	39	.	.	PUNCT
chd-210	47	1	a	a	DET
chd-210	47	2	more	more	ADV
chd-210	47	3	recent	recent	ADJ
chd-210	47	4	study	study	NOUN
chd-210	47	5	by	by	ADP
chd-210	47	6	lusk	lusk	PROPN
chd-210	47	7	et	et	PROPN
chd-210	47	8	al	al	PROPN
chd-210	47	9	.	.	PROPN
chd-210	47	10	sequenced	sequence	VERB
chd-210	47	11	193	193	NUM
chd-210	47	12	aa	aa	NOUN
chd-210	47	13	lc	lc	PROPN
chd-210	47	14	cases	case	NOUN
chd-210	47	15	for	for	ADP
chd-210	47	16	determining	determine	VERB
chd-210	47	17	the	the	DET
chd-210	47	18	mutational	mutational	ADJ
chd-210	47	19	landscape	landscape	NOUN
chd-210	47	20	and	and	CCONJ
chd-210	47	21	identified	identify	VERB
chd-210	47	22	a	a	DET
chd-210	47	23	panel	panel	NOUN
chd-210	47	24	of	of	ADP
chd-210	47	25	88	88	NUM
chd-210	47	26	distinctly	distinctly	ADV
chd-210	47	27	mutated	mutate	VERB
chd-210	47	28	genes	gene	NOUN
chd-210	47	29	in	in	ADP
chd-210	47	30	addition	addition	NOUN
chd-210	47	31	to	to	ADP
chd-210	47	32	the	the	DET
chd-210	47	33	commonly	commonly	ADV
chd-210	47	34	found	find	VERB
chd-210	47	35	lc	lc	NOUN
chd-210	47	36	-	-	PUNCT
chd-210	47	37	associated	associate	VERB
chd-210	47	38	driver	driver	NOUN
chd-210	47	39	mutations	mutation	NOUN
chd-210	47	40	[	[	X
chd-210	47	41	17	17	NUM
chd-210	47	42	]	]	PUNCT
chd-210	47	43	.	.	PUNCT
chd-210	48	1	novel	novel	ADJ
chd-210	48	2	mutations	mutation	NOUN
chd-210	48	3	in	in	ADP
chd-210	48	4	pabpc1	pabpc1	PROPN
chd-210	48	5	,	,	PUNCT
chd-210	48	6	pms2	pms2	PROPN
chd-210	48	7	,	,	PUNCT
chd-210	48	8	cdc27	cdc27	PROPN
chd-210	48	9	,	,	PUNCT
chd-210	48	10	oxct2	oxct2	NOUN
chd-210	48	11	,	,	PUNCT
chd-210	48	12	gstm1	gstm1	PROPN
chd-210	48	13	,	,	PUNCT
chd-210	48	14	rhpn2	rhpn2	PROPN
chd-210	48	15	,	,	PUNCT
chd-210	48	16	zc3hc1	zc3hc1	PROPN
chd-210	48	17	and	and	CCONJ
chd-210	48	18	mll3	mll3	NOUN
chd-210	48	19	genes	gene	NOUN
chd-210	48	20	were	be	AUX
chd-210	48	21	noted	note	VERB
chd-210	48	22	exclusively	exclusively	ADV
chd-210	48	23	in	in	ADP
chd-210	48	24	the	the	DET
chd-210	48	25	aa	aa	PROPN
chd-210	48	26	subjects	subject	NOUN
chd-210	48	27	.	.	PUNCT
chd-210	49	1	figure	figure	NOUN
chd-210	49	2	1	1	NUM
chd-210	49	3	.	.	PUNCT
chd-210	50	1	the	the	DET
chd-210	50	2	landscape	landscape	NOUN
chd-210	50	3	of	of	ADP
chd-210	50	4	gene	gene	NOUN
chd-210	50	5	mutations	mutation	NOUN
chd-210	50	6	in	in	ADP
chd-210	50	7	lung	lung	NOUN
chd-210	50	8	cancer	cancer	NOUN
chd-210	50	9	.	.	PUNCT
chd-210	51	1	top	top	ADJ
chd-210	51	2	20	20	NUM
chd-210	51	3	gene	gene	NOUN
chd-210	51	4	mutations	mutation	NOUN
chd-210	51	5	identified	identify	VERB
chd-210	51	6	in	in	ADP
chd-210	51	7	lung	lung	NOUN
chd-210	51	8	cancer	cancer	NOUN
chd-210	51	9	patients	patient	NOUN
chd-210	51	10	.	.	PUNCT
chd-210	52	1	data	datum	NOUN
chd-210	52	2	assembled	assemble	VERB
chd-210	52	3	with	with	ADP
chd-210	52	4	permission	permission	NOUN
chd-210	52	5	from	from	ADP
chd-210	52	6	the	the	DET
chd-210	52	7	cosmic	cosmic	ADJ
chd-210	52	8	database	database	NOUN
chd-210	52	9	(	(	PUNCT
chd-210	52	10	https://cancer.sanger.ac.uk/cosmic	https://cancer.sanger.ac.uk/cosmic	NOUN
chd-210	52	11	)	)	PUNCT
chd-210	52	12	.	.	PUNCT
chd-210	53	1	asterisks	asterisk	NOUN
chd-210	53	2	indicate	indicate	VERB
chd-210	53	3	the	the	DET
chd-210	53	4	genes	gene	NOUN
chd-210	53	5	,	,	PUNCT
chd-210	53	6	the	the	DET
chd-210	53	7	mutation	mutation	NOUN
chd-210	53	8	spectrum	spectrum	NOUN
chd-210	53	9	of	of	ADP
chd-210	53	10	which	which	PRON
chd-210	53	11	have	have	AUX
chd-210	53	12	been	be	AUX
chd-210	53	13	examined	examine	VERB
chd-210	53	14	in	in	ADP
chd-210	53	15	various	various	ADJ
chd-210	53	16	racial	racial	ADJ
chd-210	53	17	population	population	NOUN
chd-210	53	18	.	.	PUNCT
chd-210	54	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-210	54	2	e4	e4	PROPN
chd-210	54	3	cancer	cancer	NOUN
chd-210	54	4	health	health	NOUN
chd-210	54	5	disparities	disparity	NOUN
chd-210	54	6	research	research	NOUN
chd-210	54	7	figure	figure	NOUN
chd-210	54	8	2	2	NUM
chd-210	54	9	.	.	NOUN
chd-210	54	10	nature	nature	NOUN
chd-210	54	11	of	of	ADP
chd-210	54	12	somatic	somatic	ADJ
chd-210	54	13	gene	gene	NOUN
chd-210	54	14	mutation	mutation	NOUN
chd-210	54	15	observed	observe	VERB
chd-210	54	16	in	in	ADP
chd-210	54	17	a	a	DET
chd-210	54	18	large	large	ADJ
chd-210	54	19	number	number	NOUN
chd-210	54	20	of	of	ADP
chd-210	54	21	lung	lung	NOUN
chd-210	54	22	cancer	cancer	NOUN
chd-210	54	23	sample	sample	NOUN
chd-210	54	24	pools	pool	NOUN
chd-210	54	25	as	as	SCONJ
chd-210	54	26	analyzed	analyze	VERB
chd-210	54	27	from	from	ADP
chd-210	54	28	the	the	DET
chd-210	54	29	cosmic	cosmic	ADJ
chd-210	54	30	database	database	NOUN
chd-210	54	31	(	(	PUNCT
chd-210	54	32	https://cancer.sanger.ac.uk/cosmic	https://cancer.sanger.ac.uk/cosmic	NOUN
chd-210	54	33	)	)	PUNCT
chd-210	54	34	.	.	PUNCT
chd-210	55	1	in	in	ADP
chd-210	55	2	a	a	DET
chd-210	55	3	recent	recent	ADJ
chd-210	55	4	meta	meta	ADJ
chd-210	55	5	-	-	PUNCT
chd-210	55	6	analysis	analysis	NOUN
chd-210	55	7	involving	involve	VERB
chd-210	55	8	a	a	DET
chd-210	55	9	total	total	NOUN
chd-210	55	10	of	of	ADP
chd-210	55	11	11,867	11,867	NUM
chd-210	55	12	aa	aa	NOUN
chd-210	55	13	,	,	PUNCT
chd-210	55	14	ca	can	AUX
chd-210	55	15	,	,	PUNCT
chd-210	55	16	hispanic	hispanic	ADJ
chd-210	55	17	/	/	SYM
chd-210	55	18	latina	latina	ADJ
chd-210	55	19	(	(	PUNCT
chd-210	55	20	his	his	PRON
chd-210	55	21	)	)	PUNCT
chd-210	55	22	and	and	CCONJ
chd-210	55	23	asian	asian	ADJ
chd-210	55	24	patients	patient	NOUN
chd-210	55	25	,	,	PUNCT
chd-210	55	26	costa	costa	PROPN
chd-210	55	27	et	et	PROPN
chd-210	55	28	al	al	PROPN
chd-210	55	29	.	.	PROPN
chd-210	55	30	performed	perform	VERB
chd-210	55	31	a	a	DET
chd-210	55	32	comparative	comparative	ADJ
chd-210	55	33	analysis	analysis	NOUN
chd-210	55	34	of	of	ADP
chd-210	55	35	lc	lc	PROPN
chd-210	55	36	associated	associated	ADJ
chd-210	55	37	mutations	mutation	NOUN
chd-210	55	38	in	in	ADP
chd-210	55	39	key	key	ADJ
chd-210	55	40	genes	gene	NOUN
chd-210	55	41	,	,	PUNCT
chd-210	55	42	including	include	VERB
chd-210	55	43	egfr	egfr	NOUN
chd-210	55	44	,	,	PUNCT
chd-210	55	45	alk	alk	PROPN
chd-210	55	46	,	,	PUNCT
chd-210	55	47	ros-1	ros-1	VERB
chd-210	55	48	and	and	CCONJ
chd-210	55	49	braf	braf	NOUN
chd-210	55	50	[	[	X
chd-210	55	51	18	18	NUM
chd-210	55	52	]	]	PUNCT
chd-210	55	53	.	.	PUNCT
chd-210	56	1	the	the	DET
chd-210	56	2	most	most	ADV
chd-210	56	3	frequently	frequently	ADV
chd-210	56	4	occurring	occur	VERB
chd-210	56	5	mutations	mutation	NOUN
chd-210	56	6	in	in	ADP
chd-210	56	7	the	the	DET
chd-210	56	8	aa	aa	NOUN
chd-210	56	9	subjects	subject	NOUN
chd-210	56	10	involved	involve	VERB
chd-210	56	11	egfr	egfr	NOUN
chd-210	56	12	(	(	PUNCT
chd-210	56	13	6	6	NUM
chd-210	56	14	%	%	NOUN
chd-210	56	15	)	)	PUNCT
chd-210	56	16	,	,	PUNCT
chd-210	56	17	braf	braf	NOUN
chd-210	56	18	(	(	PUNCT
chd-210	56	19	1	1	NUM
chd-210	56	20	%	%	NOUN
chd-210	56	21	)	)	PUNCT
chd-210	56	22	,	,	PUNCT
chd-210	56	23	and	and	CCONJ
chd-210	56	24	alk	alk	VERB
chd-210	56	25	(	(	PUNCT
chd-210	56	26	1	1	NUM
chd-210	56	27	%	%	NOUN
chd-210	56	28	)	)	PUNCT
chd-210	56	29	.	.	PUNCT
chd-210	57	1	however	however	ADV
chd-210	57	2	,	,	PUNCT
chd-210	57	3	the	the	DET
chd-210	57	4	incidence	incidence	NOUN
chd-210	57	5	of	of	ADP
chd-210	57	6	egfr	egfr	NOUN
chd-210	57	7	and	and	CCONJ
chd-210	57	8	braf	braf	NOUN
chd-210	57	9	mutations	mutation	NOUN
chd-210	57	10	was	be	AUX
chd-210	57	11	lower	low	ADJ
chd-210	57	12	in	in	ADP
chd-210	57	13	the	the	DET
chd-210	57	14	aa	aa	NOUN
chd-210	57	15	subjects	subject	NOUN
chd-210	57	16	compared	compare	VERB
chd-210	57	17	to	to	ADP
chd-210	57	18	the	the	DET
chd-210	57	19	ca	ca	NOUN
chd-210	57	20	subjects	subject	NOUN
chd-210	57	21	.	.	PUNCT
chd-210	58	1	another	another	DET
chd-210	58	2	study	study	NOUN
chd-210	58	3	in	in	ADP
chd-210	58	4	116	116	NUM
chd-210	58	5	lc	lc	NOUN
chd-210	58	6	cases	case	NOUN
chd-210	58	7	by	by	ADP
chd-210	58	8	hunt	hunt	NOUN
chd-210	58	9	et	et	PROPN
chd-210	58	10	al	al	PROPN
chd-210	58	11	.	.	PROPN
chd-210	58	12	reported	report	VERB
chd-210	58	13	a	a	DET
chd-210	58	14	higher	high	ADJ
chd-210	58	15	prevalence	prevalence	NOUN
chd-210	58	16	of	of	ADP
chd-210	58	17	kras	kras	PROPN
chd-210	58	18	mutations	mutation	NOUN
chd-210	58	19	in	in	ADP
chd-210	58	20	the	the	DET
chd-210	58	21	aa	aa	PROPN
chd-210	58	22	lc	lc	PROPN
chd-210	58	23	subjects	subject	NOUN
chd-210	58	24	compared	compare	VERB
chd-210	58	25	to	to	ADP
chd-210	58	26	the	the	DET
chd-210	58	27	ca	ca	NOUN
chd-210	58	28	lc	lc	PROPN
chd-210	58	29	subjects	subject	NOUN
chd-210	58	30	[	[	X
chd-210	58	31	19	19	NUM
chd-210	58	32	]	]	PUNCT
chd-210	58	33	.	.	PUNCT
chd-210	59	1	on	on	ADP
chd-210	59	2	the	the	DET
chd-210	59	3	contrary	contrary	NOUN
chd-210	59	4	,	,	PUNCT
chd-210	59	5	analyses	analysis	NOUN
chd-210	59	6	of	of	ADP
chd-210	59	7	121	121	NUM
chd-210	59	8	lc	lc	NOUN
chd-210	59	9	cases	case	NOUN
chd-210	59	10	by	by	ADP
chd-210	59	11	reinersman	reinersman	NOUN
chd-210	59	12	et	et	PROPN
chd-210	59	13	al	al	PROPN
chd-210	59	14	.	.	PROPN
chd-210	59	15	reported	report	VERB
chd-210	59	16	a	a	DET
chd-210	59	17	higher	high	ADJ
chd-210	59	18	abundance	abundance	NOUN
chd-210	59	19	of	of	ADP
chd-210	59	20	kras	kras	PROPN
chd-210	59	21	mutations	mutation	NOUN
chd-210	59	22	among	among	ADP
chd-210	59	23	the	the	DET
chd-210	59	24	ca	ca	NOUN
chd-210	59	25	lc	lc	PROPN
chd-210	59	26	subjects	subject	NOUN
chd-210	59	27	,	,	PUNCT
chd-210	59	28	compared	compare	VERB
chd-210	59	29	to	to	ADP
chd-210	59	30	the	the	DET
chd-210	59	31	aa	aa	PROPN
chd-210	59	32	lc	lc	PROPN
chd-210	59	33	subjects	subject	NOUN
chd-210	59	34	(	(	PUNCT
chd-210	59	35	26	26	NUM
chd-210	59	36	%	%	NOUN
chd-210	59	37	vs.	vs.	ADP
chd-210	59	38	17	17	NUM
chd-210	59	39	%	%	NOUN
chd-210	59	40	)	)	PUNCT
chd-210	59	41	.	.	PUNCT
chd-210	60	1	of	of	ADP
chd-210	60	2	note	note	NOUN
chd-210	60	3	,	,	PUNCT
chd-210	60	4	this	this	DET
chd-210	60	5	study	study	NOUN
chd-210	60	6	also	also	ADV
chd-210	60	7	reported	report	VERB
chd-210	60	8	higher	high	ADJ
chd-210	60	9	rate	rate	NOUN
chd-210	60	10	of	of	ADP
chd-210	60	11	egfr	egfr	ADJ
chd-210	60	12	gene	gene	NOUN
chd-210	60	13	mutations	mutation	NOUN
chd-210	60	14	in	in	ADP
chd-210	60	15	the	the	DET
chd-210	60	16	aa	aa	PROPN
chd-210	60	17	lc	lc	PROPN
chd-210	60	18	compared	compare	VERB
chd-210	60	19	to	to	ADP
chd-210	60	20	the	the	DET
chd-210	60	21	ca	ca	NOUN
chd-210	60	22	lc	lc	PROPN
chd-210	60	23	subjects	subject	NOUN
chd-210	60	24	(	(	PUNCT
chd-210	60	25	19	19	NUM
chd-210	60	26	%	%	NOUN
chd-210	60	27	vs.	vs.	ADP
chd-210	60	28	13	13	NUM
chd-210	60	29	%	%	NOUN
chd-210	60	30	)	)	PUNCT
chd-210	61	1	[	[	X
chd-210	61	2	20	20	NUM
chd-210	61	3	]	]	PUNCT
chd-210	61	4	.	.	PUNCT
chd-210	62	1	more	more	ADJ
chd-210	62	2	information	information	NOUN
chd-210	62	3	about	about	ADP
chd-210	62	4	genetic	genetic	ADJ
chd-210	62	5	mutations	mutation	NOUN
chd-210	62	6	between	between	ADP
chd-210	62	7	ca	ca	NOUN
chd-210	62	8	and	and	CCONJ
chd-210	62	9	aa	aa	PROPN
chd-210	62	10	lung	lung	NOUN
chd-210	62	11	cancer	cancer	NOUN
chd-210	62	12	patients	patient	NOUN
chd-210	62	13	is	be	AUX
chd-210	62	14	provided	provide	VERB
chd-210	62	15	in	in	ADP
chd-210	62	16	table	table	NOUN
chd-210	62	17	1	1	NUM
chd-210	62	18	.	.	PUNCT
chd-210	63	1	the	the	DET
chd-210	63	2	tp53	tp53	PROPN
chd-210	63	3	gene	gene	NOUN
chd-210	63	4	is	be	AUX
chd-210	63	5	well	well	ADV
chd-210	63	6	regarded	regard	VERB
chd-210	63	7	as	as	ADP
chd-210	63	8	the	the	DET
chd-210	63	9	key	key	ADJ
chd-210	63	10	regulator	regulator	NOUN
chd-210	63	11	of	of	ADP
chd-210	63	12	genomic	genomic	ADJ
chd-210	63	13	stability	stability	NOUN
chd-210	63	14	and	and	CCONJ
chd-210	63	15	the	the	DET
chd-210	63	16	most	most	ADV
chd-210	63	17	frequently	frequently	ADV
chd-210	63	18	altered	alter	VERB
chd-210	63	19	molecule	molecule	NOUN
chd-210	63	20	in	in	ADP
chd-210	63	21	human	human	ADJ
chd-210	63	22	cancers	cancer	NOUN
chd-210	63	23	[	[	X
chd-210	63	24	21	21	NUM
chd-210	63	25	]	]	PUNCT
chd-210	63	26	.	.	PUNCT
chd-210	64	1	in	in	ADP
chd-210	64	2	a	a	DET
chd-210	64	3	comprehensive	comprehensive	ADJ
chd-210	64	4	analysis	analysis	NOUN
chd-210	64	5	of	of	ADP
chd-210	64	6	431	431	NUM
chd-210	64	7	subjects	subject	NOUN
chd-210	64	8	,	,	PUNCT
chd-210	64	9	kytola	kytola	PROPN
chd-210	64	10	et	et	PROPN
chd-210	64	11	al	al	PROPN
chd-210	64	12	.	.	PROPN
chd-210	64	13	have	have	AUX
chd-210	64	14	reported	report	VERB
chd-210	64	15	a	a	DET
chd-210	64	16	significantly	significantly	ADV
chd-210	64	17	higher	high	ADJ
chd-210	64	18	frequency	frequency	NOUN
chd-210	64	19	of	of	ADP
chd-210	64	20	p53	p53	NOUN
chd-210	64	21	gene	gene	NOUN
chd-210	64	22	mutation	mutation	NOUN
chd-210	64	23	in	in	ADP
chd-210	64	24	aa	aa	PROPN
chd-210	64	25	lc	lc	PROPN
chd-210	64	26	patients	patient	NOUN
chd-210	64	27	compared	compare	VERB
chd-210	64	28	to	to	ADP
chd-210	64	29	the	the	DET
chd-210	64	30	ca	ca	NOUN
chd-210	64	31	lc	lc	PROPN
chd-210	64	32	patients	patient	NOUN
chd-210	65	1	[	[	X
chd-210	65	2	22	22	NUM
chd-210	65	3	]	]	PUNCT
chd-210	65	4	.	.	PUNCT
chd-210	66	1	moreover	moreover	ADV
chd-210	66	2	,	,	PUNCT
chd-210	66	3	significantly	significantly	ADV
chd-210	66	4	higher	high	ADJ
chd-210	66	5	level	level	NOUN
chd-210	66	6	of	of	ADP
chd-210	66	7	amplification	amplification	NOUN
chd-210	66	8	of	of	ADP
chd-210	66	9	a	a	DET
chd-210	66	10	5	5	NUM
chd-210	66	11	-	-	PUNCT
chd-210	66	12	gene	gene	NOUN
chd-210	66	13	signature	signature	NOUN
chd-210	66	14	,	,	PUNCT
chd-210	66	15	including	include	VERB
chd-210	66	16	mcl1	mcl1	PROPN
chd-210	66	17	,	,	PUNCT
chd-210	66	18	runx1t1	runx1t1	NUM
chd-210	66	19	,	,	PUNCT
chd-210	66	20	cdk8	cdk8	NOUN
chd-210	66	21	,	,	PUNCT
chd-210	66	22	cat6a	cat6a	PROPN
chd-210	66	23	,	,	PUNCT
chd-210	66	24	and	and	CCONJ
chd-210	66	25	rad21	rad21	NOUN
chd-210	66	26	,	,	PUNCT
chd-210	66	27	was	be	AUX
chd-210	66	28	noted	note	VERB
chd-210	66	29	in	in	ADP
chd-210	66	30	the	the	DET
chd-210	66	31	aa	aa	PROPN
chd-210	66	32	lc	lc	PROPN
chd-210	66	33	cases	case	NOUN
chd-210	66	34	,	,	PUNCT
chd-210	66	35	compared	compare	VERB
chd-210	66	36	to	to	ADP
chd-210	66	37	the	the	DET
chd-210	66	38	ca	ca	NOUN
chd-210	66	39	lc	lc	PROPN
chd-210	66	40	subjects	subject	NOUN
chd-210	66	41	.	.	PUNCT
chd-210	67	1	in	in	ADP
chd-210	67	2	another	another	DET
chd-210	67	3	study	study	NOUN
chd-210	67	4	,	,	PUNCT
chd-210	67	5	mitchell	mitchell	PROPN
chd-210	67	6	et	et	PROPN
chd-210	67	7	al	al	PROPN
chd-210	67	8	.	.	PROPN
chd-210	67	9	reported	report	VERB
chd-210	67	10	a	a	DET
chd-210	67	11	higher	high	ADJ
chd-210	67	12	frequency	frequency	NOUN
chd-210	67	13	of	of	ADP
chd-210	67	14	mutations	mutation	NOUN
chd-210	67	15	in	in	ADP
chd-210	67	16	ptprt	ptprt	NOUN
chd-210	67	17	and	and	CCONJ
chd-210	67	18	jak2	jak2	PROPN
chd-210	67	19	in	in	ADP
chd-210	67	20	aas	aas	PROPN
chd-210	67	21	than	than	ADP
chd-210	67	22	cas	cas	PROPN
chd-210	68	1	[	[	X
chd-210	68	2	23	23	NUM
chd-210	68	3	]	]	PUNCT
chd-210	68	4	.	.	PUNCT
chd-210	69	1	they	they	PRON
chd-210	69	2	detected	detect	VERB
chd-210	69	3	ptprt	ptprt	NOUN
chd-210	69	4	and	and	CCONJ
chd-210	69	5	jak2	jak2	PROPN
chd-210	69	6	gene	gene	NOUN
chd-210	69	7	mutations	mutation	NOUN
chd-210	69	8	in	in	ADP
chd-210	69	9	24	24	NUM
chd-210	69	10	%	%	NOUN
chd-210	69	11	(	(	PUNCT
chd-210	69	12	13/54	13/54	NUM
chd-210	69	13	)	)	PUNCT
chd-210	69	14	and	and	CCONJ
chd-210	69	15	7.4	7.4	NUM
chd-210	69	16	%	%	NOUN
chd-210	69	17	(	(	PUNCT
chd-210	69	18	4/54	4/54	NUM
chd-210	69	19	)	)	PUNCT
chd-210	69	20	aa	aa	PROPN
chd-210	69	21	lc	lc	PROPN
chd-210	69	22	cases	case	NOUN
chd-210	69	23	,	,	PUNCT
chd-210	69	24	respectively	respectively	ADV
chd-210	69	25	,	,	PUNCT
chd-210	69	26	compared	compare	VERB
chd-210	69	27	to	to	ADP
chd-210	69	28	8	8	NUM
chd-210	69	29	%	%	NOUN
chd-210	69	30	(	(	PUNCT
chd-210	69	31	30/381	30/381	NUM
chd-210	69	32	)	)	PUNCT
chd-210	69	33	and	and	CCONJ
chd-210	69	34	2	2	NUM
chd-210	69	35	%	%	NOUN
chd-210	69	36	(	(	PUNCT
chd-210	69	37	7/381	7/381	NUM
chd-210	69	38	)	)	PUNCT
chd-210	69	39	in	in	ADP
chd-210	69	40	cas	cas	PROPN
chd-210	69	41	,	,	PUNCT
chd-210	69	42	respectively	respectively	ADV
chd-210	69	43	.	.	PUNCT
chd-210	70	1	changes	change	NOUN
chd-210	70	2	in	in	ADP
chd-210	70	3	copy	copy	NOUN
chd-210	70	4	number	number	NOUN
chd-210	70	5	have	have	AUX
chd-210	70	6	also	also	ADV
chd-210	70	7	been	be	AUX
chd-210	70	8	examined	examine	VERB
chd-210	70	9	in	in	ADP
chd-210	70	10	lc	lc	NOUN
chd-210	70	11	using	use	VERB
chd-210	70	12	high	high	ADJ
chd-210	70	13	-	-	PUNCT
chd-210	70	14	resolution	resolution	NOUN
chd-210	70	15	singlenucleotide	singlenucleotide	NOUN
chd-210	70	16	polymorphism	polymorphism	NOUN
chd-210	70	17	arrays	array	VERB
chd-210	70	18	to	to	ADP
chd-210	70	19	decipher	decipher	NOUN
chd-210	70	20	molecular	molecular	ADJ
chd-210	70	21	alterations	alteration	NOUN
chd-210	70	22	accumulated	accumulate	VERB
chd-210	70	23	during	during	ADP
chd-210	70	24	lung	lung	NOUN
chd-210	70	25	tumorigenesis	tumorigenesis	NOUN
chd-210	70	26	.	.	PUNCT
chd-210	71	1	considerably	considerably	ADV
chd-210	71	2	higher	high	ADJ
chd-210	71	3	frequency	frequency	NOUN
chd-210	71	4	of	of	ADP
chd-210	71	5	copy	copy	NOUN
chd-210	71	6	number	number	NOUN
chd-210	71	7	gain	gain	NOUN
chd-210	71	8	on	on	ADP
chd-210	71	9	16p13.13	16p13.13	NUM
chd-210	71	10	and	and	CCONJ
chd-210	71	11	16p13.11	16p13.11	NUM
chd-210	71	12	was	be	AUX
chd-210	71	13	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-210	71	14	e5	e5	PROPN
chd-210	71	15	cancer	cancer	NOUN
chd-210	71	16	health	health	NOUN
chd-210	71	17	disparities	disparity	NOUN
chd-210	71	18	research	research	NOUN
chd-210	71	19	noted	note	VERB
chd-210	71	20	among	among	ADP
chd-210	71	21	the	the	DET
chd-210	71	22	east	east	ADJ
chd-210	71	23	asian	asian	PROPN
chd-210	71	24	lc	lc	PROPN
chd-210	71	25	patients	patient	NOUN
chd-210	71	26	[	[	X
chd-210	71	27	14	14	NUM
chd-210	71	28	]	]	PUNCT
chd-210	71	29	.	.	PUNCT
chd-210	72	1	on	on	ADP
chd-210	72	2	the	the	DET
chd-210	72	3	contrary	contrary	NOUN
chd-210	72	4	,	,	PUNCT
chd-210	72	5	genomic	genomic	ADJ
chd-210	72	6	loss	loss	NOUN
chd-210	72	7	in	in	ADP
chd-210	72	8	19p13.3	19p13.3	NUM
chd-210	72	9	and	and	CCONJ
chd-210	72	10	19p13.11	19p13.11	NUM
chd-210	72	11	regions	region	NOUN
chd-210	72	12	was	be	AUX
chd-210	72	13	noted	note	VERB
chd-210	72	14	to	to	PART
chd-210	72	15	be	be	AUX
chd-210	72	16	higher	high	ADJ
chd-210	72	17	in	in	ADP
chd-210	72	18	ca	ca	NOUN
chd-210	72	19	lc	lc	PROPN
chd-210	72	20	patients	patient	NOUN
chd-210	72	21	.	.	PUNCT
chd-210	73	1	besides	besides	SCONJ
chd-210	73	2	lung	lung	NOUN
chd-210	73	3	cancer	cancer	NOUN
chd-210	73	4	,	,	PUNCT
chd-210	73	5	race	race	NOUN
chd-210	73	6	-	-	PUNCT
chd-210	73	7	specific	specific	ADJ
chd-210	73	8	genetic	genetic	ADJ
chd-210	73	9	heterogeneity	heterogeneity	NOUN
chd-210	73	10	is	be	AUX
chd-210	73	11	noted	note	VERB
chd-210	73	12	in	in	ADP
chd-210	73	13	other	other	ADJ
chd-210	73	14	human	human	ADJ
chd-210	73	15	malignanies	malignanie	NOUN
chd-210	73	16	as	as	ADV
chd-210	73	17	well	well	ADV
chd-210	73	18	.	.	PUNCT
chd-210	74	1	mutation	mutation	NOUN
chd-210	74	2	frequency	frequency	NOUN
chd-210	74	3	was	be	AUX
chd-210	74	4	found	find	VERB
chd-210	74	5	to	to	PART
chd-210	74	6	be	be	AUX
chd-210	74	7	appreciably	appreciably	ADV
chd-210	74	8	different	different	ADJ
chd-210	74	9	in	in	ADP
chd-210	74	10	aa	aa	NOUN
chd-210	74	11	and	and	CCONJ
chd-210	74	12	ca	can	AUX
chd-210	74	13	colorectal	colorectal	ADJ
chd-210	74	14	cancer	cancer	NOUN
chd-210	74	15	patients	patient	NOUN
chd-210	74	16	for	for	ADP
chd-210	74	17	kras	kras	PROPN
chd-210	74	18	(	(	PUNCT
chd-210	74	19	aa:23	aa:23	PROPN
chd-210	74	20	-	-	PUNCT
chd-210	74	21	44	44	NUM
chd-210	74	22	%	%	NOUN
chd-210	74	23	;	;	PUNCT
chd-210	74	24	ca:15	ca:15	PROPN
chd-210	74	25	-	-	PUNCT
chd-210	74	26	45	45	NUM
chd-210	74	27	%	%	NOUN
chd-210	74	28	)	)	PUNCT
chd-210	74	29	and	and	CCONJ
chd-210	74	30	braf	braf	NOUN
chd-210	74	31	(	(	PUNCT
chd-210	74	32	aa:4	aa:4	PROPN
chd-210	74	33	-	-	PUNCT
chd-210	74	34	6	6	NUM
chd-210	74	35	%	%	NOUN
chd-210	74	36	;	;	PUNCT
chd-210	74	37	ca:7	ca:7	PROPN
chd-210	74	38	-	-	SYM
chd-210	74	39	14	14	NUM
chd-210	74	40	%	%	NOUN
chd-210	74	41	)	)	PUNCT
chd-210	74	42	.	.	PUNCT
chd-210	75	1	similarly	similarly	ADV
chd-210	75	2	,	,	PUNCT
chd-210	75	3	mutation	mutation	NOUN
chd-210	75	4	frequency	frequency	NOUN
chd-210	75	5	of	of	ADP
chd-210	75	6	braf	braf	NOUN
chd-210	75	7	was	be	AUX
chd-210	75	8	75	75	NUM
chd-210	75	9	-	-	SYM
chd-210	75	10	80	80	NUM
chd-210	75	11	%	%	NOUN
chd-210	75	12	in	in	ADP
chd-210	75	13	ca	ca	PROPN
chd-210	75	14	papillary	papillary	ADJ
chd-210	75	15	thyroid	thyroid	NOUN
chd-210	75	16	carcinoma	carcinoma	NOUN
chd-210	75	17	patients	patient	NOUN
chd-210	75	18	as	as	SCONJ
chd-210	75	19	compared	compare	VERB
chd-210	75	20	to	to	ADP
chd-210	75	21	48	48	NUM
chd-210	75	22	%	%	NOUN
chd-210	75	23	in	in	ADP
chd-210	75	24	aa	aa	NOUN
chd-210	75	25	patients	patient	NOUN
chd-210	75	26	.	.	PUNCT
chd-210	76	1	in	in	ADP
chd-210	76	2	melanoma	melanoma	NOUN
chd-210	76	3	,	,	PUNCT
chd-210	76	4	mutation	mutation	NOUN
chd-210	76	5	frequency	frequency	NOUN
chd-210	76	6	of	of	ADP
chd-210	76	7	braf	braf	NOUN
chd-210	76	8	was	be	AUX
chd-210	76	9	8	8	NUM
chd-210	76	10	%	%	NOUN
chd-210	76	11	in	in	ADP
chd-210	76	12	aa	aa	NOUN
chd-210	76	13	relative	relative	ADJ
chd-210	76	14	to	to	ADP
chd-210	76	15	21	21	NUM
chd-210	76	16	%	%	NOUN
chd-210	76	17	in	in	ADP
chd-210	76	18	ca	ca	NOUN
chd-210	76	19	patients	patient	NOUN
chd-210	76	20	.	.	PUNCT
chd-210	77	1	such	such	ADJ
chd-210	77	2	striking	striking	ADJ
chd-210	77	3	differences	difference	NOUN
chd-210	77	4	are	be	AUX
chd-210	77	5	also	also	ADV
chd-210	77	6	noted	note	VERB
chd-210	77	7	for	for	ADP
chd-210	77	8	p53	p53	NOUN
chd-210	77	9	in	in	ADP
chd-210	77	10	breast	breast	NOUN
chd-210	77	11	cancer	cancer	NOUN
chd-210	77	12	patients	patient	NOUN
chd-210	77	13	with	with	ADP
chd-210	77	14	43	43	NUM
chd-210	77	15	%	%	NOUN
chd-210	77	16	mutation	mutation	NOUN
chd-210	77	17	rate	rate	NOUN
chd-210	77	18	in	in	ADP
chd-210	77	19	aa	aa	NOUN
chd-210	77	20	compared	compare	VERB
chd-210	77	21	to	to	ADP
chd-210	77	22	26.7	26.7	NUM
chd-210	77	23	%	%	NOUN
chd-210	77	24	in	in	ADP
chd-210	77	25	ca	ca	NOUN
chd-210	77	26	women	woman	NOUN
chd-210	77	27	[	[	X
chd-210	77	28	24	24	NUM
chd-210	77	29	]	]	PUNCT
chd-210	77	30	.	.	PUNCT
chd-210	78	1	table	table	NOUN
chd-210	78	2	1	1	NUM
chd-210	78	3	.	.	PUNCT
chd-210	79	1	the	the	DET
chd-210	79	2	spectrum	spectrum	NOUN
chd-210	79	3	of	of	ADP
chd-210	79	4	genetic	genetic	ADJ
chd-210	79	5	mutations	mutation	NOUN
chd-210	79	6	in	in	ADP
chd-210	79	7	caucasian	caucasian	ADJ
chd-210	79	8	and	and	CCONJ
chd-210	79	9	african	african	ADJ
chd-210	79	10	american	american	ADJ
chd-210	79	11	lung	lung	NOUN
chd-210	79	12	cancer	cancer	NOUN
chd-210	79	13	patients	patient	NOUN
chd-210	79	14	.	.	PUNCT
chd-210	80	1	gene	gene	NOUN
chd-210	80	2	name	name	NOUN
chd-210	80	3	variant	variant	NOUN
chd-210	80	4	frequency	frequency	NOUN
chd-210	80	5	in	in	ADP
chd-210	80	6	patients	patient	NOUN
chd-210	80	7	reference	reference	VERB
chd-210	80	8	caucasian	caucasian	ADJ
chd-210	80	9	african	african	ADJ
chd-210	80	10	american	american	PROPN
chd-210	80	11	egfr	egfr	PROPN
chd-210	80	12	kras	kras	PROPN
chd-210	81	1	g2303a	g2303a	PROPN
chd-210	81	2	or	or	CCONJ
chd-210	81	3	s768n	s768n	PROPN
chd-210	81	4	codons	codon	NOUN
chd-210	81	5	12	12	NUM
chd-210	81	6	and	and	CCONJ
chd-210	81	7	13	13	NUM
chd-210	81	8	of	of	ADP
chd-210	81	9	exon	exon	NOUN
chd-210	81	10	12	12	NUM
chd-210	81	11	(	(	PUNCT
chd-210	81	12	n1=102	n1=102	NOUN
chd-210	81	13	)	)	PUNCT
chd-210	81	14	17	17	NUM
chd-210	81	15	%	%	NOUN
chd-210	81	16	21	21	NUM
chd-210	81	17	%	%	NOUN
chd-210	81	18	(	(	PUNCT
chd-210	81	19	n=53	n=53	ADV
chd-210	81	20	)	)	PUNCT
chd-210	81	21	2	2	NUM
chd-210	81	22	%	%	NOUN
chd-210	81	23	23	23	NUM
chd-210	81	24	%	%	NOUN
chd-210	82	1	[	[	X
chd-210	82	2	12	12	NUM
chd-210	82	3	]	]	X
chd-210	82	4	egfr	egfr	PROPN
chd-210	82	5	kras	kras	PROPN
chd-210	82	6	braf	braf	PROPN
chd-210	82	7	pik3ca	pik3ca	PROPN
chd-210	82	8	(	(	PUNCT
chd-210	82	9	n=264	n=264	NOUN
chd-210	82	10	)	)	PUNCT
chd-210	82	11	5.68	5.68	NUM
chd-210	82	12	%	%	NOUN
chd-210	82	13	13.87	13.87	NUM
chd-210	82	14	%	%	NOUN
chd-210	82	15	3.03	3.03	NUM
chd-210	82	16	%	%	NOUN
chd-210	82	17	0.75	0.75	NUM
chd-210	82	18	%	%	NOUN
chd-210	82	19	(	(	PUNCT
chd-210	82	20	n=245	n=245	NUM
chd-210	82	21	)	)	PUNCT
chd-210	82	22	4.89	4.89	NUM
chd-210	82	23	%	%	NOUN
chd-210	82	24	12.87	12.87	NUM
chd-210	82	25	%	%	NOUN
chd-210	82	26	2.44	2.44	NUM
chd-210	82	27	%	%	NOUN
chd-210	82	28	0.81	0.81	NUM
chd-210	82	29	%	%	NOUN
chd-210	82	30	[	[	X
chd-210	82	31	25	25	NUM
chd-210	82	32	]	]	PUNCT
chd-210	82	33	egfrkras	egfrkras	NOUN
chd-210	82	34	exon	exon	VERB
chd-210	82	35	19	19	NUM
chd-210	82	36	deletions	deletion	NOUN
chd-210	82	37	and	and	CCONJ
chd-210	82	38	t2573	t2573	NOUN
chd-210	82	39	g	g	PROPN
chd-210	82	40	or	or	CCONJ
chd-210	82	41	l858r	l858r	PROPN
chd-210	82	42	c.34	c.34	NOUN
chd-210	82	43	g	g	NOUN
chd-210	82	44	,	,	PUNCT
chd-210	82	45	c.35	c.35	NOUN
chd-210	82	46	g	g	NOUN
chd-210	82	47	and	and	CCONJ
chd-210	82	48	c.38	c.38	PROPN
chd-210	82	49	g	g	NOUN
chd-210	82	50	in	in	ADP
chd-210	82	51	codons	codon	NOUN
chd-210	82	52	12	12	NUM
chd-210	82	53	and	and	CCONJ
chd-210	82	54	13	13	NUM
chd-210	82	55	of	of	ADP
chd-210	82	56	kras	kras	PROPN
chd-210	82	57	(	(	PUNCT
chd-210	82	58	n=399	n=399	NOUN
chd-210	82	59	)	)	PUNCT
chd-210	82	60	13.7	13.7	NUM
chd-210	82	61	%	%	NOUN
chd-210	82	62	25	25	NUM
chd-210	82	63	%	%	NOUN
chd-210	82	64	(	(	PUNCT
chd-210	82	65	n=67	n=67	PROPN
chd-210	82	66	)	)	PUNCT
chd-210	82	67	4.8	4.8	NUM
chd-210	82	68	%	%	NOUN
chd-210	82	69	30.6	30.6	NUM
chd-210	82	70	%	%	NOUN
chd-210	82	71	[	[	X
chd-210	82	72	26	26	NUM
chd-210	82	73	]	]	X
chd-210	82	74	egfr	egfr	NOUN
chd-210	82	75	exon	exon	PROPN
chd-210	82	76	19	19	NUM
chd-210	82	77	deletions	deletion	NOUN
chd-210	82	78	(	(	PUNCT
chd-210	82	79	n=335	n=335	NOUN
chd-210	82	80	)	)	PUNCT
chd-210	82	81	2	2	NUM
chd-210	82	82	%	%	NOUN
chd-210	82	83	(	(	PUNCT
chd-210	82	84	n=137	n=137	NUM
chd-210	82	85	)	)	PUNCT
chd-210	82	86	7	7	NUM
chd-210	82	87	%	%	NOUN
chd-210	82	88	[	[	X
chd-210	82	89	27	27	NUM
chd-210	82	90	]	]	SYM
chd-210	82	91	braf	braf	NOUN
chd-210	82	92	point	point	NOUN
chd-210	82	93	mutations	mutation	NOUN
chd-210	82	94	in	in	ADP
chd-210	82	95	exon	exon	NOUN
chd-210	82	96	11	11	NUM
chd-210	82	97	or	or	CCONJ
chd-210	82	98	exon	exon	NOUN
chd-210	82	99	15	15	NUM
chd-210	82	100	(	(	PUNCT
chd-210	82	101	n=108	n=108	PROPN
chd-210	82	102	)	)	PUNCT
chd-210	82	103	13.72	13.72	NUM
chd-210	82	104	%	%	NOUN
chd-210	82	105	(	(	PUNCT
chd-210	82	106	n=51	n=51	NOUN
chd-210	82	107	)	)	PUNCT
chd-210	82	108	3.7	3.7	NUM
chd-210	82	109	%	%	NOUN
chd-210	82	110	[	[	X
chd-210	82	111	28	28	NUM
chd-210	82	112	]	]	X
chd-210	82	113	egfr	egfr	ADJ
chd-210	82	114	braf	braf	NOUN
chd-210	82	115	ros-1	ros-1	ADV
chd-210	82	116	alk	alk	VERB
chd-210	82	117	activating	activate	VERB
chd-210	82	118	mutations	mutation	NOUN
chd-210	82	119	(	(	PUNCT
chd-210	82	120	n=9507	n=9507	NOUN
chd-210	82	121	)	)	PUNCT
chd-210	82	122	12	12	NUM
chd-210	82	123	%	%	NOUN
chd-210	82	124	3	3	NUM
chd-210	82	125	%	%	NOUN
chd-210	82	126	1	1	NUM
chd-210	82	127	%	%	NOUN
chd-210	82	128	2	2	NUM
chd-210	82	129	%	%	NOUN
chd-210	82	130	(	(	PUNCT
chd-210	82	131	n=3363	n=3363	NOUN
chd-210	82	132	)	)	PUNCT
chd-210	82	133	6	6	NUM
chd-210	82	134	%	%	NOUN
chd-210	82	135	1	1	NUM
chd-210	82	136	%	%	NOUN
chd-210	82	137	0	0	NUM
chd-210	82	138	%	%	NOUN
chd-210	82	139	1	1	NUM
chd-210	82	140	%	%	NOUN
chd-210	82	141	[	[	X
chd-210	82	142	18	18	NUM
chd-210	82	143	]	]	X
chd-210	82	144	egfr	egfr	PROPN
chd-210	82	145	kras	kras	PROPN
chd-210	82	146	exon	exon	PROPN
chd-210	82	147	19	19	NUM
chd-210	82	148	deletions	deletion	NOUN
chd-210	82	149	and	and	CCONJ
chd-210	82	150	exon	exon	NOUN
chd-210	82	151	21	21	NUM
chd-210	82	152	(	(	PUNCT
chd-210	82	153	l858r	l858r	NOUN
chd-210	82	154	)	)	PUNCT
chd-210	82	155	mutation	mutation	NOUN
chd-210	82	156	in	in	ADP
chd-210	82	157	codon	codon	PROPN
chd-210	82	158	12	12	NUM
chd-210	82	159	and	and	CCONJ
chd-210	82	160	13	13	NUM
chd-210	82	161	(	(	PUNCT
chd-210	82	162	n=476	n=476	NUM
chd-210	82	163	)	)	PUNCT
chd-210	82	164	13	13	NUM
chd-210	82	165	%	%	NOUN
chd-210	82	166	26	26	NUM
chd-210	82	167	%	%	NOUN
chd-210	82	168	(	(	PUNCT
chd-210	82	169	n=121	n=121	NUM
chd-210	82	170	)	)	PUNCT
chd-210	82	171	19	19	NUM
chd-210	82	172	%	%	NOUN
chd-210	82	173	17	17	NUM
chd-210	82	174	%	%	NOUN
chd-210	83	1	[	[	X
chd-210	83	2	20	20	NUM
chd-210	83	3	]	]	SYM
chd-210	83	4	kras	kras	PROPN
chd-210	83	5	g→t	g→t	PROPN
chd-210	83	6	transversion	transversion	NOUN
chd-210	83	7	in	in	ADP
chd-210	83	8	codon	codon	PROPN
chd-210	83	9	12	12	NUM
chd-210	83	10	(	(	PUNCT
chd-210	83	11	n=51	n=51	NOUN
chd-210	83	12	)	)	PUNCT
chd-210	83	13	20	20	NUM
chd-210	83	14	%	%	NOUN
chd-210	83	15	(	(	PUNCT
chd-210	83	16	n=60	n=60	NOUN
chd-210	83	17	)	)	PUNCT
chd-210	83	18	37	37	NUM
chd-210	83	19	%	%	NOUN
chd-210	84	1	[	[	X
chd-210	84	2	19	19	NUM
chd-210	84	3	]	]	X
chd-210	84	4	(	(	PUNCT
chd-210	84	5	n=381	n=381	NOUN
chd-210	84	6	)	)	PUNCT
chd-210	84	7	(	(	PUNCT
chd-210	84	8	n=52	n=52	NOUN
chd-210	84	9	)	)	PUNCT
chd-210	84	10	[	[	X
chd-210	84	11	23	23	NUM
chd-210	84	12	]	]	PUNCT
chd-210	84	13	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-210	84	14	e6	e6	NOUN
chd-210	84	15	cancer	cancer	NOUN
chd-210	84	16	health	health	NOUN
chd-210	84	17	disparities	disparity	NOUN
chd-210	84	18	research	research	VERB
chd-210	84	19	tp53	tp53	PROPN
chd-210	84	20	stk11	stk11	VERB
chd-210	84	21	rb1	rb1	PROPN
chd-210	84	22	kras	kra	NOUN
chd-210	84	23	egfr	egfr	ADJ
chd-210	84	24	smad4	smad4	PROPN
chd-210	84	25	pik3ca	pik3ca	NOUN
chd-210	84	26	49	49	NUM
chd-210	84	27	%	%	NOUN
chd-210	84	28	13	13	NUM
chd-210	84	29	%	%	NOUN
chd-210	84	30	4	4	NUM
chd-210	84	31	%	%	NOUN
chd-210	84	32	29	29	NUM
chd-210	84	33	%	%	NOUN
chd-210	84	34	13	13	NUM
chd-210	84	35	%	%	NOUN
chd-210	84	36	4	4	NUM
chd-210	84	37	%	%	NOUN
chd-210	84	38	5	5	NUM
chd-210	84	39	%	%	NOUN
chd-210	84	40	65	65	NUM
chd-210	84	41	%	%	NOUN
chd-210	84	42	21	21	NUM
chd-210	84	43	%	%	NOUN
chd-210	84	44	13	13	NUM
chd-210	84	45	%	%	NOUN
chd-210	84	46	27	27	NUM
chd-210	84	47	%	%	NOUN
chd-210	84	48	1	1	NUM
chd-210	84	49	%	%	NOUN
chd-210	84	50	8	8	NUM
chd-210	84	51	%	%	NOUN
chd-210	84	52	8	8	NUM
chd-210	84	53	%	%	NOUN
chd-210	84	54	1number	1number	NUM
chd-210	84	55	of	of	ADP
chd-210	84	56	patients	patient	NOUN
chd-210	84	57	.	.	PUNCT
chd-210	85	1	in	in	ADP
chd-210	85	2	addition	addition	NOUN
chd-210	85	3	to	to	ADP
chd-210	85	4	the	the	DET
chd-210	85	5	nuclear	nuclear	ADJ
chd-210	85	6	genetic	genetic	ADJ
chd-210	85	7	alterations	alteration	NOUN
chd-210	85	8	,	,	PUNCT
chd-210	85	9	changes	change	NOUN
chd-210	85	10	in	in	ADP
chd-210	85	11	the	the	DET
chd-210	85	12	mitochondrial	mitochondrial	ADJ
chd-210	85	13	genome	genome	NOUN
chd-210	85	14	and	and	CCONJ
chd-210	85	15	dysregulation	dysregulation	NOUN
chd-210	85	16	of	of	ADP
chd-210	85	17	various	various	ADJ
chd-210	85	18	mitochondrial	mitochondrial	ADJ
chd-210	85	19	functions	function	NOUN
chd-210	85	20	also	also	ADV
chd-210	85	21	play	play	VERB
chd-210	85	22	a	a	DET
chd-210	85	23	pivotal	pivotal	ADJ
chd-210	85	24	role	role	NOUN
chd-210	85	25	in	in	ADP
chd-210	85	26	human	human	ADJ
chd-210	85	27	tumorigenesis	tumorigenesis	NOUN
chd-210	85	28	[	[	X
chd-210	85	29	29	29	NUM
chd-210	85	30	–	–	PUNCT
chd-210	85	31	32	32	NUM
chd-210	85	32	]	]	PUNCT
chd-210	85	33	.	.	PUNCT
chd-210	86	1	mitochondria	mitochondria	PROPN
chd-210	86	2	are	be	AUX
chd-210	86	3	regarded	regard	VERB
chd-210	86	4	as	as	ADP
chd-210	86	5	the	the	DET
chd-210	86	6	powerhouse	powerhouse	NOUN
chd-210	86	7	of	of	ADP
chd-210	86	8	the	the	DET
chd-210	86	9	cells	cell	NOUN
chd-210	86	10	and	and	CCONJ
chd-210	86	11	generate	generate	VERB
chd-210	86	12	cellular	cellular	ADJ
chd-210	86	13	energy	energy	NOUN
chd-210	86	14	in	in	ADP
chd-210	86	15	the	the	DET
chd-210	86	16	form	form	NOUN
chd-210	86	17	of	of	ADP
chd-210	86	18	atp	atp	PROPN
chd-210	87	1	[	[	X
chd-210	87	2	33	33	NUM
chd-210	87	3	]	]	PUNCT
chd-210	87	4	.	.	PUNCT
chd-210	88	1	in	in	ADP
chd-210	88	2	humans	human	NOUN
chd-210	88	3	,	,	PUNCT
chd-210	88	4	mitochondria	mitochondria	PROPN
chd-210	88	5	are	be	AUX
chd-210	88	6	maternally	maternally	ADV
chd-210	88	7	inherited	inherit	VERB
chd-210	88	8	and	and	CCONJ
chd-210	88	9	harbor	harbor	VERB
chd-210	88	10	their	their	PRON
chd-210	88	11	own	own	ADJ
chd-210	88	12	dna	dna	NOUN
chd-210	88	13	(	(	PUNCT
chd-210	88	14	mtdna	mtdna	NOUN
chd-210	88	15	)	)	PUNCT
chd-210	88	16	.	.	PUNCT
chd-210	89	1	the	the	DET
chd-210	89	2	human	human	PROPN
chd-210	89	3	mtdna	mtdna	PROPN
chd-210	89	4	is	be	AUX
chd-210	89	5	a	a	DET
chd-210	89	6	16.5	16.5	NUM
chd-210	89	7	-	-	PUNCT
chd-210	89	8	kb	kb	PROPN
chd-210	89	9	doublestranded	doublestrande	VERB
chd-210	89	10	closed	close	VERB
chd-210	89	11	circular	circular	ADJ
chd-210	89	12	molecule	molecule	NOUN
chd-210	89	13	having	have	VERB
chd-210	89	14	37	37	NUM
chd-210	89	15	genes	gene	NOUN
chd-210	89	16	,	,	PUNCT
chd-210	89	17	which	which	PRON
chd-210	89	18	encode	encode	VERB
chd-210	89	19	for	for	ADP
chd-210	89	20	12s	12	NOUN
chd-210	89	21	and	and	CCONJ
chd-210	89	22	16s	16	NOUN
chd-210	89	23	rrnas	rrna	NOUN
chd-210	89	24	,	,	PUNCT
chd-210	89	25	22	22	NUM
chd-210	89	26	trnas	trnas	NOUN
chd-210	89	27	,	,	PUNCT
chd-210	89	28	and	and	CCONJ
chd-210	89	29	13	13	NUM
chd-210	89	30	respiratory	respiratory	ADJ
chd-210	89	31	complex	complex	ADJ
chd-210	89	32	proteins	protein	NOUN
chd-210	89	33	(	(	PUNCT
chd-210	89	34	i	i	PROPN
chd-210	89	35	,	,	PUNCT
chd-210	89	36	iii	iii	PROPN
chd-210	89	37	,	,	PUNCT
chd-210	89	38	iv	iv	NOUN
chd-210	89	39	,	,	PUNCT
chd-210	89	40	and	and	CCONJ
chd-210	89	41	v	v	NOUN
chd-210	89	42	)	)	PUNCT
chd-210	89	43	essential	essential	ADJ
chd-210	89	44	for	for	ADP
chd-210	89	45	the	the	DET
chd-210	89	46	oxidative	oxidative	ADJ
chd-210	89	47	phosphorylation	phosphorylation	NOUN
chd-210	89	48	system	system	NOUN
chd-210	89	49	(	(	PUNCT
chd-210	89	50	oxphos	oxphos	NOUN
chd-210	89	51	)	)	PUNCT
chd-210	89	52	function	function	NOUN
chd-210	89	53	[	[	X
chd-210	89	54	33–36	33–36	NUM
chd-210	89	55	]	]	X
chd-210	89	56	.	.	PUNCT
chd-210	90	1	because	because	SCONJ
chd-210	90	2	of	of	ADP
chd-210	90	3	the	the	DET
chd-210	90	4	high	high	ADJ
chd-210	90	5	copy	copy	NOUN
chd-210	90	6	number	number	NOUN
chd-210	90	7	,	,	PUNCT
chd-210	90	8	mtdna	mtdna	NOUN
chd-210	90	9	mutation	mutation	NOUN
chd-210	90	10	detection	detection	NOUN
chd-210	90	11	is	be	AUX
chd-210	90	12	easier	easy	ADJ
chd-210	90	13	in	in	ADP
chd-210	90	14	cells	cell	NOUN
chd-210	90	15	compared	compare	VERB
chd-210	90	16	to	to	ADP
chd-210	90	17	nuclear	nuclear	ADJ
chd-210	90	18	dna	dna	NOUN
chd-210	90	19	.	.	PUNCT
chd-210	91	1	only	only	ADV
chd-210	91	2	a	a	DET
chd-210	91	3	handful	handful	ADJ
chd-210	91	4	number	number	NOUN
chd-210	91	5	of	of	ADP
chd-210	91	6	studies	study	NOUN
chd-210	91	7	have	have	AUX
chd-210	91	8	reported	report	VERB
chd-210	91	9	mtdna	mtdna	NOUN
chd-210	91	10	mutations	mutation	NOUN
chd-210	91	11	in	in	ADP
chd-210	91	12	lc	lc	PROPN
chd-210	91	13	,	,	PUNCT
chd-210	91	14	including	include	VERB
chd-210	91	15	our	our	PRON
chd-210	91	16	laboratory	laboratory	NOUN
chd-210	91	17	[	[	X
chd-210	91	18	37,38	37,38	NOUN
chd-210	91	19	]	]	PUNCT
chd-210	91	20	.	.	PUNCT
chd-210	92	1	the	the	DET
chd-210	92	2	frequency	frequency	NOUN
chd-210	92	3	of	of	ADP
chd-210	92	4	mtdna	mtdna	NOUN
chd-210	92	5	mutations	mutation	NOUN
chd-210	92	6	and	and	CCONJ
chd-210	92	7	copy	copy	NOUN
chd-210	92	8	number	number	NOUN
chd-210	92	9	is	be	AUX
chd-210	92	10	higher	high	ADJ
chd-210	92	11	in	in	ADP
chd-210	92	12	asian	asian	ADJ
chd-210	92	13	patients	patient	NOUN
chd-210	92	14	than	than	ADP
chd-210	92	15	in	in	ADP
chd-210	92	16	ca	ca	NOUN
chd-210	92	17	patients	patient	NOUN
chd-210	92	18	and	and	CCONJ
chd-210	92	19	associated	associate	VERB
chd-210	92	20	with	with	ADP
chd-210	92	21	egfr	egfr	ADJ
chd-210	92	22	gene	gene	NOUN
chd-210	92	23	mutation	mutation	NOUN
chd-210	92	24	[	[	X
chd-210	92	25	38	38	NUM
chd-210	92	26	]	]	PUNCT
chd-210	92	27	.	.	PUNCT
chd-210	93	1	another	another	DET
chd-210	93	2	study	study	NOUN
chd-210	93	3	also	also	ADV
chd-210	93	4	reported	report	VERB
chd-210	93	5	alterations	alteration	NOUN
chd-210	93	6	in	in	ADP
chd-210	93	7	mtdna	mtdna	NOUN
chd-210	93	8	copy	copy	NOUN
chd-210	93	9	number	number	NOUN
chd-210	93	10	in	in	ADP
chd-210	93	11	lung	lung	NOUN
chd-210	93	12	cancer	cancer	NOUN
chd-210	93	13	[	[	X
chd-210	93	14	39	39	NUM
chd-210	93	15	]	]	PUNCT
chd-210	93	16	,	,	PUNCT
chd-210	93	17	however	however	ADV
chd-210	93	18	,	,	PUNCT
chd-210	93	19	a	a	DET
chd-210	93	20	comparative	comparative	ADJ
chd-210	93	21	analysis	analysis	NOUN
chd-210	93	22	of	of	ADP
chd-210	93	23	mtdna	mtdna	NOUN
chd-210	93	24	copy	copy	NOUN
chd-210	93	25	number	number	NOUN
chd-210	93	26	in	in	ADP
chd-210	93	27	ca	ca	PROPN
chd-210	93	28	lc	lc	PROPN
chd-210	93	29	and	and	CCONJ
chd-210	93	30	aa	aa	PROPN
chd-210	93	31	lc	lc	PROPN
chd-210	93	32	patients	patient	NOUN
chd-210	93	33	,	,	PUNCT
chd-210	93	34	particularly	particularly	ADV
chd-210	93	35	linking	link	VERB
chd-210	93	36	smoking	smoking	NOUN
chd-210	93	37	habits	habit	NOUN
chd-210	93	38	remain	remain	VERB
chd-210	93	39	to	to	PART
chd-210	93	40	be	be	AUX
chd-210	93	41	determined	determine	VERB
chd-210	93	42	.	.	PUNCT
chd-210	94	1	moreover	moreover	ADV
chd-210	94	2	,	,	PUNCT
chd-210	94	3	the	the	DET
chd-210	94	4	disparities	disparity	NOUN
chd-210	94	5	in	in	ADP
chd-210	94	6	the	the	DET
chd-210	94	7	alteration	alteration	NOUN
chd-210	94	8	in	in	ADP
chd-210	94	9	the	the	DET
chd-210	94	10	nuclear	nuclear	ADJ
chd-210	94	11	genes	gene	NOUN
chd-210	94	12	associated	associate	VERB
chd-210	94	13	with	with	ADP
chd-210	94	14	oxphos	oxphos	NOUN
chd-210	94	15	function	function	NOUN
chd-210	94	16	are	be	AUX
chd-210	94	17	also	also	ADV
chd-210	94	18	less	less	ADV
chd-210	94	19	well	well	ADV
chd-210	94	20	defined	define	VERB
chd-210	94	21	between	between	ADP
chd-210	94	22	aa	aa	PROPN
chd-210	94	23	lc	lc	PROPN
chd-210	94	24	and	and	CCONJ
chd-210	94	25	ca	ca	AUX
chd-210	94	26	lc	lc	PROPN
chd-210	94	27	subjects	subject	NOUN
chd-210	94	28	.	.	PUNCT
chd-210	95	1	in	in	ADP
chd-210	95	2	an	an	DET
chd-210	95	3	interesting	interesting	ADJ
chd-210	95	4	recent	recent	ADJ
chd-210	95	5	study	study	NOUN
chd-210	95	6	,	,	PUNCT
chd-210	95	7	which	which	PRON
chd-210	95	8	utilized	utilize	VERB
chd-210	95	9	tcga	tcga	NOUN
chd-210	95	10	datasets	dataset	NOUN
chd-210	95	11	,	,	PUNCT
chd-210	95	12	nuclear	nuclear	ADJ
chd-210	95	13	dna	dna	NOUN
chd-210	95	14	encoded	encode	VERB
chd-210	95	15	mitochondrial	mitochondrial	ADJ
chd-210	95	16	oxphos	oxphos	NOUN
chd-210	95	17	pathway	pathway	NOUN
chd-210	95	18	-	-	PUNCT
chd-210	95	19	associated	associate	VERB
chd-210	95	20	genes	gene	NOUN
chd-210	95	21	were	be	AUX
chd-210	95	22	found	find	VERB
chd-210	95	23	to	to	PART
chd-210	95	24	be	be	AUX
chd-210	95	25	upregulated	upregulate	VERB
chd-210	95	26	in	in	ADP
chd-210	95	27	both	both	PRON
chd-210	95	28	lung	lung	NOUN
chd-210	95	29	adenocarcinoma	adenocarcinoma	NOUN
chd-210	95	30	and	and	CCONJ
chd-210	95	31	squamous	squamous	ADJ
chd-210	95	32	cell	cell	NOUN
chd-210	95	33	carcinoma	carcinoma	NOUN
chd-210	95	34	of	of	ADP
chd-210	95	35	aa	aa	PROPN
chd-210	95	36	patients	patient	NOUN
chd-210	95	37	compared	compare	VERB
chd-210	95	38	to	to	ADP
chd-210	95	39	the	the	DET
chd-210	95	40	subjects	subject	NOUN
chd-210	95	41	of	of	ADP
chd-210	95	42	european	european	ADJ
chd-210	95	43	origin	origin	NOUN
chd-210	96	1	[	[	X
chd-210	96	2	40	40	NUM
chd-210	96	3	]	]	PUNCT
chd-210	96	4	.	.	PUNCT
chd-210	97	1	this	this	DET
chd-210	97	2	study	study	NOUN
chd-210	97	3	also	also	ADV
chd-210	97	4	identified	identify	VERB
chd-210	97	5	a	a	DET
chd-210	97	6	predominance	predominance	NOUN
chd-210	97	7	of	of	ADP
chd-210	97	8	err1	err1	NOUN
chd-210	97	9	-	-	PUNCT
chd-210	97	10	pgc1α	pgc1α	PROPN
chd-210	97	11	–	–	PUNCT
chd-210	97	12	mediated	mediate	VERB
chd-210	97	13	transcriptional	transcriptional	ADJ
chd-210	97	14	program	program	NOUN
chd-210	97	15	enrichment	enrichment	NOUN
chd-210	97	16	,	,	PUNCT
chd-210	97	17	a	a	DET
chd-210	97	18	key	key	ADJ
chd-210	97	19	regulator	regulator	NOUN
chd-210	97	20	of	of	ADP
chd-210	97	21	mitochondrial	mitochondrial	ADJ
chd-210	97	22	biogenesis	biogenesis	NOUN
chd-210	97	23	in	in	ADP
chd-210	97	24	the	the	DET
chd-210	97	25	aa	aa	PROPN
chd-210	97	26	lc	lc	PROPN
chd-210	97	27	subjects	subject	NOUN
chd-210	97	28	compared	compare	VERB
chd-210	97	29	to	to	ADP
chd-210	97	30	the	the	DET
chd-210	97	31	european	european	ADJ
chd-210	97	32	american	american	ADJ
chd-210	97	33	subjects	subject	NOUN
chd-210	97	34	.	.	PUNCT
chd-210	98	1	in	in	ADP
chd-210	98	2	addition	addition	NOUN
chd-210	98	3	to	to	ADP
chd-210	98	4	energy	energy	NOUN
chd-210	98	5	generation	generation	NOUN
chd-210	98	6	,	,	PUNCT
chd-210	98	7	mitochondria	mitochondria	PROPN
chd-210	98	8	are	be	AUX
chd-210	98	9	involved	involve	VERB
chd-210	98	10	in	in	ADP
chd-210	98	11	various	various	ADJ
chd-210	98	12	critical	critical	ADJ
chd-210	98	13	cellular	cellular	ADJ
chd-210	98	14	functions	function	NOUN
chd-210	98	15	,	,	PUNCT
chd-210	98	16	including	include	VERB
chd-210	98	17	apoptosis	apoptosis	NOUN
chd-210	98	18	,	,	PUNCT
chd-210	98	19	inflammation	inflammation	NOUN
chd-210	98	20	,	,	PUNCT
chd-210	98	21	innate	innate	ADJ
chd-210	98	22	and	and	CCONJ
chd-210	98	23	adaptive	adaptive	ADJ
chd-210	98	24	immune	immune	ADJ
chd-210	98	25	system	system	NOUN
chd-210	98	26	,	,	PUNCT
chd-210	98	27	t	t	PROPN
chd-210	98	28	cell	cell	NOUN
chd-210	98	29	function	function	NOUN
chd-210	98	30	,	,	PUNCT
chd-210	98	31	macrophage	macrophage	ADJ
chd-210	98	32	polarization	polarization	NOUN
chd-210	98	33	,	,	PUNCT
chd-210	98	34	mitophagy	mitophagy	NOUN
chd-210	98	35	,	,	PUNCT
chd-210	98	36	calcium	calcium	NOUN
chd-210	98	37	,	,	PUNCT
chd-210	98	38	and	and	CCONJ
chd-210	98	39	damage	damage	NOUN
chd-210	98	40	-	-	PUNCT
chd-210	98	41	associated	associate	VERB
chd-210	98	42	molecular	molecular	ADJ
chd-210	98	43	pattern	pattern	NOUN
chd-210	98	44	(	(	PUNCT
chd-210	98	45	damp	damp	NOUN
chd-210	98	46	)	)	PUNCT
chd-210	98	47	signaling	signal	VERB
chd-210	98	48	[	[	X
chd-210	98	49	29	29	NUM
chd-210	98	50	]	]	PUNCT
chd-210	98	51	.	.	PUNCT
chd-210	99	1	as	as	ADP
chd-210	99	2	a	a	DET
chd-210	99	3	reason	reason	NOUN
chd-210	99	4	,	,	PUNCT
chd-210	99	5	alterations	alteration	NOUN
chd-210	99	6	in	in	ADP
chd-210	99	7	mitochondrial	mitochondrial	ADJ
chd-210	99	8	metabolism	metabolism	NOUN
chd-210	99	9	and	and	CCONJ
chd-210	99	10	functions	function	NOUN
chd-210	99	11	are	be	AUX
chd-210	99	12	regarded	regard	VERB
chd-210	99	13	as	as	ADP
chd-210	99	14	cancer	cancer	NOUN
chd-210	99	15	hallmarks	hallmark	NOUN
chd-210	99	16	.	.	PUNCT
chd-210	100	1	however	however	ADV
chd-210	100	2	,	,	PUNCT
chd-210	100	3	the	the	DET
chd-210	100	4	differential	differential	ADJ
chd-210	100	5	molecular	molecular	ADJ
chd-210	100	6	alteration	alteration	NOUN
chd-210	100	7	pattern	pattern	NOUN
chd-210	100	8	of	of	ADP
chd-210	100	9	these	these	DET
chd-210	100	10	critical	critical	ADJ
chd-210	100	11	pathways	pathway	NOUN
chd-210	100	12	remains	remain	VERB
chd-210	100	13	to	to	PART
chd-210	100	14	be	be	AUX
chd-210	100	15	determined	determine	VERB
chd-210	100	16	in	in	ADP
chd-210	100	17	lc	lc	NOUN
chd-210	100	18	patients	patient	NOUN
chd-210	100	19	with	with	ADP
chd-210	100	20	different	different	ADJ
chd-210	100	21	racial	racial	ADJ
chd-210	100	22	backgrounds	background	NOUN
chd-210	100	23	.	.	PUNCT
chd-210	101	1	conclusion	conclusion	NOUN
chd-210	101	2	and	and	CCONJ
chd-210	101	3	future	future	ADJ
chd-210	101	4	perspective	perspective	NOUN
chd-210	101	5	although	although	SCONJ
chd-210	101	6	genetic	genetic	ADJ
chd-210	101	7	differences	difference	NOUN
chd-210	101	8	have	have	AUX
chd-210	101	9	been	be	AUX
chd-210	101	10	reported	report	VERB
chd-210	101	11	among	among	ADP
chd-210	101	12	racially	racially	ADV
chd-210	101	13	disparate	disparate	ADJ
chd-210	101	14	populations	population	NOUN
chd-210	101	15	,	,	PUNCT
chd-210	101	16	they	they	PRON
chd-210	101	17	have	have	AUX
chd-210	101	18	not	not	PART
chd-210	101	19	been	be	AUX
chd-210	101	20	mechanistically	mechanistically	ADV
chd-210	101	21	linked	link	VERB
chd-210	101	22	to	to	ADP
chd-210	101	23	the	the	DET
chd-210	101	24	observed	observed	ADJ
chd-210	101	25	disproportionate	disproportionate	ADJ
chd-210	101	26	outcomes	outcome	NOUN
chd-210	101	27	.	.	PUNCT
chd-210	102	1	with	with	ADP
chd-210	102	2	the	the	DET
chd-210	102	3	power	power	NOUN
chd-210	102	4	of	of	ADP
chd-210	102	5	next	next	ADJ
chd-210	102	6	-	-	PUNCT
chd-210	102	7	generation	generation	NOUN
chd-210	102	8	deep	deep	ADJ
chd-210	102	9	sequencing	sequencing	NOUN
chd-210	102	10	of	of	ADP
chd-210	102	11	thousands	thousand	NOUN
chd-210	102	12	of	of	ADP
chd-210	102	13	tissue	tissue	NOUN
chd-210	102	14	samples	sample	NOUN
chd-210	102	15	,	,	PUNCT
chd-210	102	16	critical	critical	ADJ
chd-210	102	17	molecular	molecular	ADJ
chd-210	102	18	pathways	pathway	NOUN
chd-210	102	19	associated	associate	VERB
chd-210	102	20	with	with	ADP
chd-210	102	21	lung	lung	NOUN
chd-210	102	22	cancer	cancer	NOUN
chd-210	102	23	pathogenesis	pathogenesis	NOUN
chd-210	102	24	have	have	AUX
chd-210	102	25	been	be	AUX
chd-210	102	26	identified	identify	VERB
chd-210	102	27	,	,	PUNCT
chd-210	102	28	and	and	CCONJ
chd-210	102	29	based	base	VERB
chd-210	102	30	on	on	ADP
chd-210	102	31	that	that	DET
chd-210	102	32	knowledge	knowledge	NOUN
chd-210	102	33	,	,	PUNCT
chd-210	102	34	several	several	ADJ
chd-210	102	35	new	new	ADJ
chd-210	102	36	lines	line	NOUN
chd-210	102	37	of	of	ADP
chd-210	102	38	targeted	target	VERB
chd-210	102	39	therapeutics	therapeutic	NOUN
chd-210	102	40	are	be	AUX
chd-210	102	41	in	in	ADP
chd-210	102	42	place	place	NOUN
chd-210	102	43	,	,	PUNCT
chd-210	102	44	and	and	CCONJ
chd-210	102	45	many	many	ADJ
chd-210	102	46	are	be	AUX
chd-210	102	47	currently	currently	ADV
chd-210	102	48	under	under	ADP
chd-210	102	49	clinical	clinical	ADJ
chd-210	102	50	trials	trial	NOUN
chd-210	102	51	.	.	PUNCT
chd-210	103	1	of	of	ADP
chd-210	103	2	note	note	NOUN
chd-210	103	3	,	,	PUNCT
chd-210	103	4	these	these	DET
chd-210	103	5	cataloged	catalog	VERB
chd-210	103	6	molecular	molecular	ADJ
chd-210	103	7	changes	change	NOUN
chd-210	103	8	can	can	AUX
chd-210	103	9	also	also	ADV
chd-210	103	10	be	be	AUX
chd-210	103	11	helpful	helpful	ADJ
chd-210	103	12	to	to	PART
chd-210	103	13	develop	develop	VERB
chd-210	103	14	race	race	NOUN
chd-210	103	15	-	-	PUNCT
chd-210	103	16	specific	specific	ADJ
chd-210	103	17	biomarkers	biomarker	NOUN
chd-210	103	18	for	for	ADP
chd-210	103	19	diagnosis	diagnosis	NOUN
chd-210	103	20	,	,	PUNCT
chd-210	103	21	prognosis	prognosis	NOUN
chd-210	103	22	,	,	PUNCT
chd-210	103	23	and	and	CCONJ
chd-210	103	24	therapeutic	therapeutic	ADJ
chd-210	103	25	guidance	guidance	NOUN
chd-210	103	26	.	.	PUNCT
chd-210	104	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-210	104	2	e7	e7	PROPN
chd-210	104	3	cancer	cancer	NOUN
chd-210	104	4	health	health	NOUN
chd-210	104	5	disparities	disparity	NOUN
chd-210	104	6	research	research	VERB
chd-210	104	7	however	however	ADV
chd-210	104	8	,	,	PUNCT
chd-210	104	9	the	the	DET
chd-210	104	10	alteration	alteration	NOUN
chd-210	104	11	pattern	pattern	NOUN
chd-210	104	12	of	of	ADP
chd-210	104	13	the	the	DET
chd-210	104	14	majority	majority	NOUN
chd-210	104	15	of	of	ADP
chd-210	104	16	these	these	DET
chd-210	104	17	molecules	molecule	NOUN
chd-210	104	18	remains	remain	VERB
chd-210	104	19	largely	largely	ADV
chd-210	104	20	unknown	unknown	ADJ
chd-210	104	21	in	in	ADP
chd-210	104	22	racially	racially	ADV
chd-210	104	23	disparate	disparate	ADJ
chd-210	104	24	populations	population	NOUN
chd-210	104	25	.	.	PUNCT
chd-210	105	1	moreover	moreover	ADV
chd-210	105	2	,	,	PUNCT
chd-210	105	3	there	there	PRON
chd-210	105	4	are	be	VERB
chd-210	105	5	some	some	DET
chd-210	105	6	discrepancies	discrepancy	NOUN
chd-210	105	7	in	in	ADP
chd-210	105	8	the	the	DET
chd-210	105	9	outcome	outcome	NOUN
chd-210	105	10	of	of	ADP
chd-210	105	11	the	the	DET
chd-210	105	12	mutational	mutational	ADJ
chd-210	105	13	frequency	frequency	NOUN
chd-210	105	14	of	of	ADP
chd-210	105	15	crucial	crucial	ADJ
chd-210	105	16	lung	lung	NOUN
chd-210	105	17	cancer	cancer	NOUN
chd-210	105	18	-	-	PUNCT
chd-210	105	19	associated	associate	VERB
chd-210	105	20	genes	gene	NOUN
chd-210	105	21	among	among	ADP
chd-210	105	22	various	various	ADJ
chd-210	105	23	racial	racial	ADJ
chd-210	105	24	groups	group	NOUN
chd-210	105	25	in	in	ADP
chd-210	105	26	some	some	DET
chd-210	105	27	studies	study	NOUN
chd-210	105	28	,	,	PUNCT
chd-210	105	29	which	which	PRON
chd-210	105	30	could	could	AUX
chd-210	105	31	be	be	AUX
chd-210	105	32	due	due	ADJ
chd-210	105	33	to	to	ADP
chd-210	105	34	significant	significant	ADJ
chd-210	105	35	differences	difference	NOUN
chd-210	105	36	in	in	ADP
chd-210	105	37	sample	sample	NOUN
chd-210	105	38	size	size	NOUN
chd-210	105	39	,	,	PUNCT
chd-210	105	40	methods	method	NOUN
chd-210	105	41	used	use	VERB
chd-210	105	42	,	,	PUNCT
chd-210	105	43	and/or	and/or	CCONJ
chd-210	105	44	the	the	DET
chd-210	105	45	specificity	specificity	NOUN
chd-210	105	46	of	of	ADP
chd-210	105	47	the	the	DET
chd-210	105	48	type	type	NOUN
chd-210	105	49	of	of	ADP
chd-210	105	50	mutations	mutation	NOUN
chd-210	105	51	analyzed	analyze	VERB
chd-210	105	52	.	.	PUNCT
chd-210	106	1	notably	notably	ADV
chd-210	106	2	,	,	PUNCT
chd-210	106	3	an	an	DET
chd-210	106	4	in	in	ADP
chd-210	106	5	-	-	PUNCT
chd-210	106	6	depth	depth	NOUN
chd-210	106	7	analysis	analysis	NOUN
chd-210	106	8	of	of	ADP
chd-210	106	9	a	a	DET
chd-210	106	10	panel	panel	NOUN
chd-210	106	11	of	of	ADP
chd-210	106	12	potential	potential	ADJ
chd-210	106	13	molecular	molecular	ADJ
chd-210	106	14	targets	target	NOUN
chd-210	106	15	other	other	ADJ
chd-210	106	16	than	than	ADP
chd-210	106	17	egfr	egfr	NOUN
chd-210	106	18	and	and	CCONJ
chd-210	106	19	kras	kras	PROPN
chd-210	106	20	,	,	PUNCT
chd-210	106	21	remains	remain	VERB
chd-210	106	22	to	to	PART
chd-210	106	23	be	be	AUX
chd-210	106	24	carried	carry	VERB
chd-210	106	25	out	out	ADP
chd-210	106	26	in	in	ADP
chd-210	106	27	diverse	diverse	ADJ
chd-210	106	28	racial	racial	ADJ
chd-210	106	29	populations	population	NOUN
chd-210	106	30	.	.	PUNCT
chd-210	107	1	moreover	moreover	ADV
chd-210	107	2	,	,	PUNCT
chd-210	107	3	in	in	ADP
chd-210	107	4	addition	addition	NOUN
chd-210	107	5	to	to	ADP
chd-210	107	6	the	the	DET
chd-210	107	7	mutational	mutational	ADJ
chd-210	107	8	landscape	landscape	NOUN
chd-210	107	9	,	,	PUNCT
chd-210	107	10	analysis	analysis	NOUN
chd-210	107	11	of	of	ADP
chd-210	107	12	genome	genome	NOUN
chd-210	107	13	-	-	PUNCT
chd-210	107	14	wide	wide	ADJ
chd-210	107	15	polymorphisms	polymorphism	NOUN
chd-210	107	16	and	and	CCONJ
chd-210	107	17	profiling	profiling	NOUN
chd-210	107	18	of	of	ADP
chd-210	107	19	genes	gene	NOUN
chd-210	107	20	that	that	PRON
chd-210	107	21	are	be	AUX
chd-210	107	22	differentially	differentially	ADV
chd-210	107	23	amplified	amplify	VERB
chd-210	107	24	or	or	CCONJ
chd-210	107	25	lost	lose	VERB
chd-210	107	26	during	during	ADP
chd-210	107	27	lung	lung	NOUN
chd-210	107	28	tumorigenesis	tumorigenesis	NOUN
chd-210	107	29	in	in	ADP
chd-210	107	30	various	various	ADJ
chd-210	107	31	racial	racial	ADJ
chd-210	107	32	groups	group	NOUN
chd-210	107	33	will	will	AUX
chd-210	107	34	also	also	ADV
chd-210	107	35	help	help	VERB
chd-210	107	36	further	far	ADV
chd-210	107	37	our	our	PRON
chd-210	107	38	understanding	understanding	NOUN
chd-210	107	39	of	of	ADP
chd-210	107	40	the	the	DET
chd-210	107	41	genetic	genetic	ADJ
chd-210	107	42	basis	basis	NOUN
chd-210	107	43	of	of	ADP
chd-210	107	44	lung	lung	NOUN
chd-210	107	45	cancer	cancer	NOUN
chd-210	107	46	health	health	NOUN
chd-210	107	47	disparity	disparity	NOUN
chd-210	107	48	.	.	PUNCT
chd-210	108	1	on	on	ADP
chd-210	108	2	the	the	DET
chd-210	108	3	other	other	ADJ
chd-210	108	4	hand	hand	NOUN
chd-210	108	5	,	,	PUNCT
chd-210	108	6	despite	despite	SCONJ
chd-210	108	7	increasing	increase	VERB
chd-210	108	8	and	and	CCONJ
chd-210	108	9	emerging	emerge	VERB
chd-210	108	10	evidence	evidence	NOUN
chd-210	108	11	of	of	ADP
chd-210	108	12	alterations	alteration	NOUN
chd-210	108	13	in	in	ADP
chd-210	108	14	mitochondrial	mitochondrial	ADJ
chd-210	108	15	dna	dna	NOUN
chd-210	108	16	and	and	CCONJ
chd-210	108	17	nuclear	nuclear	ADJ
chd-210	108	18	genes	gene	NOUN
chd-210	108	19	targeting	target	VERB
chd-210	108	20	mitochondrial	mitochondrial	ADJ
chd-210	108	21	pathways	pathway	NOUN
chd-210	108	22	in	in	ADP
chd-210	108	23	various	various	ADJ
chd-210	108	24	human	human	ADJ
chd-210	108	25	malignancies	malignancy	NOUN
chd-210	108	26	,	,	PUNCT
chd-210	108	27	their	their	PRON
chd-210	108	28	association	association	NOUN
chd-210	108	29	with	with	ADP
chd-210	108	30	lung	lung	NOUN
chd-210	108	31	cancer	cancer	NOUN
chd-210	108	32	health	health	NOUN
chd-210	108	33	disparity	disparity	NOUN
chd-210	108	34	has	have	AUX
chd-210	108	35	remained	remain	VERB
chd-210	108	36	largely	largely	ADV
chd-210	108	37	undefined	undefined	ADJ
chd-210	108	38	.	.	PUNCT
chd-210	109	1	in	in	ADP
chd-210	109	2	the	the	DET
chd-210	109	3	coming	come	VERB
chd-210	109	4	decades	decade	NOUN
chd-210	109	5	,	,	PUNCT
chd-210	109	6	with	with	ADP
chd-210	109	7	the	the	DET
chd-210	109	8	advent	advent	NOUN
chd-210	109	9	and	and	CCONJ
chd-210	109	10	power	power	NOUN
chd-210	109	11	of	of	ADP
chd-210	109	12	multi	multi	ADJ
chd-210	109	13	-	-	ADJ
chd-210	109	14	omics	omics	ADJ
chd-210	109	15	technology	technology	NOUN
chd-210	109	16	,	,	PUNCT
chd-210	109	17	including	include	VERB
chd-210	109	18	single	single	ADJ
chd-210	109	19	-	-	PUNCT
chd-210	109	20	cell	cell	NOUN
chd-210	109	21	genomics	genomic	NOUN
chd-210	109	22	and	and	CCONJ
chd-210	109	23	proteogenomics	proteogenomic	NOUN
chd-210	109	24	,	,	PUNCT
chd-210	109	25	we	we	PRON
chd-210	109	26	hope	hope	VERB
chd-210	109	27	to	to	PART
chd-210	109	28	achieve	achieve	VERB
chd-210	109	29	appreciable	appreciable	ADJ
chd-210	109	30	success	success	NOUN
chd-210	109	31	in	in	ADP
chd-210	109	32	characterizing	characterize	VERB
chd-210	109	33	the	the	DET
chd-210	109	34	specific	specific	ADJ
chd-210	109	35	factors	factor	NOUN
chd-210	109	36	and	and	CCONJ
chd-210	109	37	molecular	molecular	ADJ
chd-210	109	38	pathways	pathway	NOUN
chd-210	109	39	contributing	contribute	VERB
chd-210	109	40	to	to	ADP
chd-210	109	41	the	the	DET
chd-210	109	42	lung	lung	NOUN
chd-210	109	43	health	health	NOUN
chd-210	109	44	disparity	disparity	NOUN
chd-210	109	45	to	to	PART
chd-210	109	46	ultimately	ultimately	ADV
chd-210	109	47	reduce	reduce	VERB
chd-210	109	48	the	the	DET
chd-210	109	49	disparity	disparity	NOUN
chd-210	109	50	gaps	gap	NOUN
chd-210	109	51	.	.	PUNCT
chd-210	110	1	acknowledgements	acknowledgement	NOUN
chd-210	110	2	this	this	DET
chd-210	110	3	work	work	NOUN
chd-210	110	4	is	be	AUX
chd-210	110	5	supported	support	VERB
chd-210	110	6	by	by	ADP
chd-210	110	7	funding	funding	NOUN
chd-210	110	8	from	from	ADP
chd-210	110	9	nih	nih	PROPN
chd-210	110	10	/	/	SYM
chd-210	110	11	nci	nci	PROPN
chd-210	111	1	[	[	X
chd-210	111	2	r01ca231925	r01ca231925	X
chd-210	111	3	(	(	PUNCT
chd-210	111	4	ss	ss	NOUN
chd-210	111	5	)	)	PUNCT
chd-210	111	6	,	,	PUNCT
chd-210	111	7	and	and	CCONJ
chd-210	111	8	mitchell	mitchell	PROPN
chd-210	111	9	cancer	cancer	PROPN
chd-210	111	10	institute	institute	PROPN
chd-210	111	11	,	,	PUNCT
chd-210	111	12	university	university	PROPN
chd-210	111	13	of	of	ADP
chd-210	111	14	south	south	PROPN
chd-210	111	15	alabama	alabama	PROPN
chd-210	111	16	(	(	PUNCT
chd-210	111	17	ap	ap	PROPN
chd-210	111	18	,	,	PUNCT
chd-210	111	19	ss	ss	NOUN
chd-210	111	20	and	and	CCONJ
chd-210	111	21	sd	sd	NOUN
chd-210	111	22	)	)	PUNCT
chd-210	111	23	.	.	PUNCT
chd-210	112	1	conflict	conflict	NOUN
chd-210	112	2	of	of	ADP
chd-210	112	3	interest	interest	NOUN
chd-210	112	4	the	the	DET
chd-210	112	5	authors	author	NOUN
chd-210	112	6	declare	declare	VERB
chd-210	112	7	that	that	SCONJ
chd-210	112	8	they	they	PRON
chd-210	112	9	have	have	VERB
chd-210	112	10	no	no	DET
chd-210	112	11	conflicts	conflict	NOUN
chd-210	112	12	of	of	ADP
chd-210	112	13	interests	interest	NOUN
chd-210	112	14	.	.	PUNCT
chd-210	113	1	authors	author	NOUN
chd-210	113	2	’	’	PART
chd-210	113	3	contribution	contribution	NOUN
chd-210	113	4	study	study	NOUN
chd-210	113	5	design	design	NOUN
chd-210	113	6	and	and	CCONJ
chd-210	113	7	oversight	oversight	NOUN
chd-210	113	8	:	:	PUNCT
chd-210	113	9	sd	sd	NOUN
chd-210	113	10	,	,	PUNCT
chd-210	113	11	data	datum	NOUN
chd-210	113	12	acquisition	acquisition	NOUN
chd-210	113	13	:	:	PUNCT
chd-210	113	14	sd	sd	PROPN
chd-210	113	15	,	,	PUNCT
chd-210	113	16	sa	sa	PROPN
chd-210	113	17	,	,	PUNCT
chd-210	113	18	ksv	ksv	PROPN
chd-210	113	19	,	,	PUNCT
chd-210	113	20	aps	aps	PROPN
chd-210	113	21	,	,	PUNCT
chd-210	113	22	ss	ss	PROPN
chd-210	113	23	,	,	PUNCT
chd-210	113	24	writing	writing	NOUN
chd-210	113	25	and	and	CCONJ
chd-210	113	26	review	review	NOUN
chd-210	113	27	:	:	PUNCT
chd-210	113	28	sd	sd	X
chd-210	113	29	,	,	PUNCT
chd-210	113	30	sa	sa	PROPN
chd-210	113	31	,	,	PUNCT
chd-210	113	32	ksv	ksv	PROPN
chd-210	113	33	,	,	PUNCT
chd-210	113	34	aps	aps	PROPN
chd-210	113	35	,	,	PUNCT
chd-210	113	36	ss	ss	PROPN
chd-210	113	37	.	.	PROPN
chd-210	113	38	references	reference	NOUN
chd-210	113	39	1	1	NUM
chd-210	113	40	sung	sung	ADJ
chd-210	113	41	h	h	NOUN
chd-210	113	42	,	,	PUNCT
chd-210	113	43	ferlay	ferlay	PROPN
chd-210	113	44	j	j	PROPN
chd-210	113	45	,	,	PUNCT
chd-210	113	46	siegel	siegel	PROPN
chd-210	113	47	rl	rl	PROPN
chd-210	113	48	,	,	PUNCT
chd-210	113	49	laversanne	laversanne	NOUN
chd-210	113	50	m	m	PROPN
chd-210	113	51	,	,	PUNCT
chd-210	113	52	soerjomataram	soerjomataram	PROPN
chd-210	113	53	i	i	PROPN
chd-210	113	54	,	,	PUNCT
chd-210	113	55	jemal	jemal	PROPN
chd-210	113	56	a	a	X
chd-210	113	57	,	,	PUNCT
chd-210	113	58	et	et	PROPN
chd-210	113	59	al	al	PROPN
chd-210	113	60	.	.	PUNCT
chd-210	114	1	global	global	ADJ
chd-210	114	2	cancer	cancer	NOUN
chd-210	114	3	statistics	statistic	NOUN
chd-210	114	4	2020	2020	NUM
chd-210	114	5	:	:	PUNCT
chd-210	114	6	globocan	globocan	PROPN
chd-210	114	7	estimates	estimate	NOUN
chd-210	114	8	of	of	ADP
chd-210	114	9	incidence	incidence	NOUN
chd-210	114	10	and	and	CCONJ
chd-210	114	11	mortality	mortality	NOUN
chd-210	114	12	worldwide	worldwide	ADV
chd-210	114	13	for	for	ADP
chd-210	114	14	36	36	NUM
chd-210	114	15	cancers	cancer	NOUN
chd-210	114	16	in	in	ADP
chd-210	114	17	185	185	NUM
chd-210	114	18	countries	country	NOUN
chd-210	114	19	.	.	PUNCT
chd-210	115	1	ca	can	AUX
chd-210	115	2	cancer	cancer	PROPN
chd-210	115	3	j	j	PROPN
chd-210	115	4	clin	clin	PROPN
chd-210	115	5	.	.	PUNCT
chd-210	116	1	2021	2021	NUM
chd-210	116	2	doi	doi	NOUN
chd-210	116	3	:	:	PUNCT
chd-210	116	4	10.3322	10.3322	NUM
chd-210	116	5	/	/	SYM
chd-210	116	6	caac.21660	caac.21660	PROPN
chd-210	116	7	2	2	NUM
chd-210	116	8	american	american	ADJ
chd-210	116	9	cancer	cancer	NOUN
chd-210	116	10	society	society	NOUN
chd-210	116	11	.	.	PUNCT
chd-210	117	1	american	american	ADJ
chd-210	117	2	cancer	cancer	NOUN
chd-210	117	3	society	society	NOUN
chd-210	117	4	:	:	PUNCT
chd-210	117	5	cancer	cancer	NOUN
chd-210	117	6	facts	fact	NOUN
chd-210	117	7	and	and	CCONJ
chd-210	117	8	figures	figure	NOUN
chd-210	117	9	2021	2021	NUM
chd-210	117	10	.	.	PUNCT
chd-210	118	1	atlanta	atlanta	PROPN
chd-210	118	2	,	,	PUNCT
chd-210	118	3	ga	ga	PROPN
chd-210	118	4	am	be	AUX
chd-210	118	5	cancer	cancer	NOUN
chd-210	118	6	soc	soc	NOUN
chd-210	118	7	.	.	PUNCT
chd-210	119	1	2021	2021	NUM
chd-210	119	2	3	3	NUM
chd-210	119	3	desantis	desantis	PROPN
chd-210	119	4	ce	ce	PROPN
chd-210	119	5	,	,	PUNCT
chd-210	119	6	miller	miller	PROPN
chd-210	119	7	kd	kd	PROPN
chd-210	119	8	,	,	PUNCT
chd-210	119	9	goding	gode	VERB
chd-210	119	10	sauer	sauer	PROPN
chd-210	119	11	a	a	PRON
chd-210	119	12	,	,	PUNCT
chd-210	119	13	jemal	jemal	PROPN
chd-210	119	14	a	a	X
chd-210	119	15	,	,	PUNCT
chd-210	119	16	siegel	siegel	PROPN
chd-210	119	17	rl	rl	PROPN
chd-210	119	18	.	.	PUNCT
chd-210	119	19	cancer	cancer	NOUN
chd-210	119	20	statistics	statistic	NOUN
chd-210	119	21	for	for	ADP
chd-210	119	22	african	african	ADJ
chd-210	119	23	americans	americans	PROPN
chd-210	119	24	,	,	PUNCT
chd-210	119	25	2019	2019	NUM
chd-210	119	26	.	.	PUNCT
chd-210	120	1	ca	can	AUX
chd-210	120	2	cancer	cancer	PROPN
chd-210	120	3	j	j	PROPN
chd-210	120	4	clin	clin	PROPN
chd-210	120	5	.	.	PUNCT
chd-210	121	1	2019	2019	NUM
chd-210	121	2	doi	doi	NOUN
chd-210	121	3	:	:	PUNCT
chd-210	121	4	10.3322	10.3322	NUM
chd-210	121	5	/	/	SYM
chd-210	121	6	caac.21555	caac.21555	PROPN
chd-210	121	7	4	4	NUM
chd-210	121	8	tyagi	tyagi	PROPN
chd-210	121	9	a	a	PROPN
chd-210	121	10	,	,	PUNCT
chd-210	121	11	sharma	sharma	PROPN
chd-210	121	12	s	s	PROPN
chd-210	121	13	,	,	PUNCT
chd-210	121	14	wu	wu	PROPN
chd-210	121	15	k	k	PROPN
chd-210	121	16	,	,	PUNCT
chd-210	121	17	wu	wu	PROPN
chd-210	121	18	sy	sy	PROPN
chd-210	121	19	,	,	PUNCT
chd-210	121	20	xing	xing	PROPN
chd-210	121	21	f	f	PROPN
chd-210	121	22	,	,	PUNCT
chd-210	121	23	liu	liu	PROPN
chd-210	121	24	y	y	PROPN
chd-210	121	25	,	,	PUNCT
chd-210	121	26	et	et	PROPN
chd-210	121	27	al	al	PROPN
chd-210	121	28	.	.	PROPN
chd-210	121	29	nicotine	nicotine	PROPN
chd-210	121	30	promotes	promote	VERB
chd-210	121	31	breast	breast	NOUN
chd-210	121	32	cancer	cancer	NOUN
chd-210	121	33	metastasis	metastasis	NOUN
chd-210	121	34	by	by	ADP
chd-210	121	35	stimulating	stimulate	VERB
chd-210	121	36	n2	n2	ADJ
chd-210	121	37	neutrophils	neutrophil	NOUN
chd-210	121	38	and	and	CCONJ
chd-210	121	39	generating	generate	VERB
chd-210	121	40	pre	pre	ADJ
chd-210	121	41	-	-	ADJ
chd-210	121	42	metastatic	metastatic	ADJ
chd-210	121	43	niche	niche	NOUN
chd-210	121	44	in	in	ADP
chd-210	121	45	lung	lung	NOUN
chd-210	121	46	.	.	PUNCT
chd-210	122	1	nat	nat	PROPN
chd-210	122	2	commun	commun	PROPN
chd-210	122	3	.	.	PUNCT
chd-210	123	1	2021	2021	NUM
chd-210	123	2	doi	doi	NOUN
chd-210	123	3	:	:	PUNCT
chd-210	123	4	10.1038	10.1038	NUM
chd-210	123	5	/	/	SYM
chd-210	123	6	s41467	s41467	NOUN
chd-210	123	7	-	-	PUNCT
chd-210	123	8	020	020	NUM
chd-210	123	9	-	-	PUNCT
chd-210	123	10	207339	207339	NUM
chd-210	123	11	5	5	NUM
chd-210	123	12	vu	vu	SYM
chd-210	123	13	t	t	PROPN
chd-210	123	14	,	,	PUNCT
chd-210	123	15	jin	jin	PROPN
chd-210	123	16	l	l	PROPN
chd-210	123	17	,	,	PUNCT
chd-210	123	18	datta	datta	PROPN
chd-210	123	19	pk	pk	PROPN
chd-210	123	20	.	.	PROPN
chd-210	123	21	effect	effect	NOUN
chd-210	123	22	of	of	ADP
chd-210	123	23	cigarette	cigarette	NOUN
chd-210	123	24	smoking	smoking	NOUN
chd-210	123	25	on	on	ADP
chd-210	123	26	epithelial	epithelial	ADJ
chd-210	123	27	to	to	ADP
chd-210	123	28	mesenchymal	mesenchymal	ADJ
chd-210	123	29	transition	transition	NOUN
chd-210	123	30	(	(	PUNCT
chd-210	123	31	emt	emt	PROPN
chd-210	123	32	)	)	PUNCT
chd-210	123	33	in	in	ADP
chd-210	123	34	lung	lung	NOUN
chd-210	123	35	cancer	cancer	NOUN
chd-210	123	36	.	.	PUNCT
chd-210	124	1	j	j	PROPN
chd-210	124	2	clin	clin	PROPN
chd-210	124	3	med	med	PROPN
chd-210	124	4	.	.	PUNCT
chd-210	125	1	2016	2016	NUM
chd-210	125	2	doi	doi	NOUN
chd-210	125	3	:	:	PUNCT
chd-210	125	4	10.3390	10.3390	NUM
chd-210	125	5	/	/	SYM
chd-210	125	6	jcm5040044	jcm5040044	NOUN
chd-210	125	7	6	6	NUM
chd-210	125	8	zhao	zhao	PROPN
chd-210	125	9	y	y	PROPN
chd-210	125	10	,	,	PUNCT
chd-210	125	11	xu	xu	PROPN
chd-210	125	12	y	y	PROPN
chd-210	125	13	,	,	PUNCT
chd-210	125	14	li	li	PROPN
chd-210	125	15	y	y	PROPN
chd-210	125	16	,	,	PUNCT
chd-210	125	17	xu	xu	PROPN
chd-210	125	18	w	w	PROPN
chd-210	125	19	,	,	PUNCT
chd-210	125	20	luo	luo	PROPN
chd-210	125	21	f	f	PROPN
chd-210	125	22	,	,	PUNCT
chd-210	125	23	wang	wang	PROPN
chd-210	125	24	b	b	PROPN
chd-210	125	25	,	,	PUNCT
chd-210	125	26	et	et	PROPN
chd-210	125	27	al	al	PROPN
chd-210	125	28	.	.	PROPN
chd-210	125	29	nf	nf	PROPN
chd-210	125	30	-	-	PUNCT
chd-210	125	31	κbmediated	κbmediate	VERB
chd-210	125	32	inflammation	inflammation	NOUN
chd-210	125	33	leading	lead	VERB
chd-210	125	34	to	to	ADP
chd-210	125	35	emt	emt	PROPN
chd-210	125	36	via	via	ADP
chd-210	125	37	mir-200c	mir-200c	NOUN
chd-210	125	38	is	be	AUX
chd-210	125	39	involved	involve	VERB
chd-210	125	40	in	in	ADP
chd-210	125	41	cell	cell	NOUN
chd-210	125	42	transformation	transformation	NOUN
chd-210	125	43	induced	induce	VERB
chd-210	125	44	by	by	ADP
chd-210	125	45	cigarette	cigarette	NOUN
chd-210	125	46	smoke	smoke	NOUN
chd-210	125	47	extract	extract	NOUN
chd-210	125	48	.	.	PUNCT
chd-210	126	1	toxicol	toxicol	PROPN
chd-210	126	2	sci	sci	PROPN
chd-210	126	3	.	.	PROPN
chd-210	126	4	2013	2013	NUM
chd-210	126	5	doi	doi	NOUN
chd-210	126	6	:	:	PUNCT
chd-210	126	7	10.1093	10.1093	NUM
chd-210	126	8	/	/	SYM
chd-210	126	9	toxsci	toxsci	PROPN
chd-210	126	10	/	/	SYM
chd-210	127	1	kft150	kft150	PROPN
chd-210	127	2	7	7	NUM
chd-210	127	3	takahashi	takahashi	PROPN
chd-210	127	4	h	h	PROPN
chd-210	127	5	,	,	PUNCT
chd-210	127	6	ogata	ogata	PROPN
chd-210	127	7	h	h	PROPN
chd-210	127	8	,	,	PUNCT
chd-210	127	9	nishigaki	nishigaki	NOUN
chd-210	127	10	r	r	NOUN
chd-210	127	11	,	,	PUNCT
chd-210	127	12	broide	broide	ADJ
chd-210	127	13	dh	dh	PROPN
chd-210	127	14	,	,	PUNCT
chd-210	127	15	karin	karin	PROPN
chd-210	127	16	m.	m.	PROPN
chd-210	127	17	tobacco	tobacco	NOUN
chd-210	127	18	smoke	smoke	NOUN
chd-210	127	19	promotes	promote	VERB
chd-210	127	20	lung	lung	NOUN
chd-210	127	21	tumorigenesis	tumorigenesis	NOUN
chd-210	127	22	by	by	ADP
chd-210	127	23	triggering	trigger	VERB
chd-210	127	24	ikkβand	ikkβand	PROPN
chd-210	127	25	jnk1	jnk1	NOUN
chd-210	127	26	-	-	PUNCT
chd-210	127	27	dependent	dependent	ADJ
chd-210	127	28	inflammation	inflammation	NOUN
chd-210	127	29	.	.	PUNCT
chd-210	128	1	cancer	cancer	NOUN
chd-210	128	2	cell	cell	NOUN
chd-210	128	3	.	.	PUNCT
chd-210	129	1	2010	2010	NUM
chd-210	129	2	doi	doi	NOUN
chd-210	129	3	:	:	PUNCT
chd-210	129	4	10.1016	10.1016	NUM
chd-210	129	5	/	/	SYM
chd-210	129	6	j.ccr.2009.12.008	j.ccr.2009.12.008	VERB
chd-210	129	7	8	8	NUM
chd-210	129	8	ho	ho	PROPN
chd-210	129	9	mk	mk	PROPN
chd-210	129	10	,	,	PUNCT
chd-210	129	11	mwenifumbo	mwenifumbo	PROPN
chd-210	129	12	jc	jc	PROPN
chd-210	129	13	,	,	PUNCT
chd-210	129	14	al	al	PROPN
chd-210	129	15	koudsi	koudsi	PROPN
chd-210	129	16	n	n	CCONJ
chd-210	129	17	,	,	PUNCT
chd-210	129	18	okuyemi	okuyemi	ADV
chd-210	129	19	ks	ks	PROPN
chd-210	129	20	,	,	PUNCT
chd-210	129	21	ahluwalia	ahluwalia	PROPN
chd-210	129	22	js	js	PROPN
chd-210	129	23	,	,	PUNCT
chd-210	129	24	benowitz	benowitz	PROPN
chd-210	129	25	nl	nl	PROPN
chd-210	129	26	,	,	PUNCT
chd-210	129	27	et	et	PROPN
chd-210	129	28	al	al	PROPN
chd-210	129	29	.	.	PROPN
chd-210	129	30	association	association	PROPN
chd-210	129	31	of	of	ADP
chd-210	129	32	nicotine	nicotine	ADJ
chd-210	129	33	metabolite	metabolite	NOUN
chd-210	129	34	ratio	ratio	NOUN
chd-210	129	35	and	and	CCONJ
chd-210	129	36	cyp2a6	cyp2a6	NOUN
chd-210	129	37	genotype	genotype	NOUN
chd-210	129	38	with	with	ADP
chd-210	129	39	smoking	smoking	NOUN
chd-210	129	40	cessation	cessation	NOUN
chd-210	129	41	treatment	treatment	NOUN
chd-210	129	42	in	in	ADP
chd-210	129	43	african	african	ADJ
chd-210	129	44	-	-	PUNCT
chd-210	129	45	american	american	ADJ
chd-210	129	46	light	light	NOUN
chd-210	129	47	smokers	smoker	NOUN
chd-210	129	48	.	.	PUNCT
chd-210	130	1	clin	clin	PROPN
chd-210	130	2	pharmacol	pharmacol	PROPN
chd-210	130	3	ther	ther	ADV
chd-210	130	4	.	.	PUNCT
chd-210	131	1	2009	2009	NUM
chd-210	131	2	doi	doi	NOUN
chd-210	131	3	:	:	PUNCT
chd-210	131	4	10.1038	10.1038	NUM
chd-210	131	5	/	/	SYM
chd-210	131	6	clpt.2009.19	clpt.2009.19	NOUN
chd-210	131	7	9	9	NUM
chd-210	131	8	turner	turner	PROPN
chd-210	131	9	mc	mc	PROPN
chd-210	131	10	,	,	PUNCT
chd-210	131	11	andersen	andersen	PROPN
chd-210	131	12	zj	zj	PROPN
chd-210	131	13	,	,	PUNCT
chd-210	131	14	baccarelli	baccarelli	VERB
chd-210	131	15	a	a	PRON
chd-210	131	16	,	,	PUNCT
chd-210	131	17	diver	diver	NOUN
chd-210	131	18	wr	wr	PROPN
chd-210	131	19	,	,	PUNCT
chd-210	131	20	gapstur	gapstur	VERB
chd-210	131	21	sm	sm	PROPN
chd-210	131	22	,	,	PUNCT
chd-210	131	23	pope	pope	PROPN
chd-210	131	24	ca	can	AUX
chd-210	131	25	,	,	PUNCT
chd-210	131	26	et	et	PROPN
chd-210	131	27	al	al	PROPN
chd-210	131	28	.	.	PROPN
chd-210	131	29	outdoor	outdoor	ADJ
chd-210	131	30	air	air	NOUN
chd-210	131	31	pollution	pollution	NOUN
chd-210	131	32	and	and	CCONJ
chd-210	131	33	cancer	cancer	NOUN
chd-210	131	34	:	:	PUNCT
chd-210	131	35	an	an	DET
chd-210	131	36	overview	overview	NOUN
chd-210	131	37	of	of	ADP
chd-210	131	38	the	the	DET
chd-210	131	39	current	current	ADJ
chd-210	131	40	evidence	evidence	NOUN
chd-210	131	41	and	and	CCONJ
chd-210	131	42	public	public	ADJ
chd-210	131	43	health	health	NOUN
chd-210	131	44	recommendations	recommendation	NOUN
chd-210	131	45	.	.	PUNCT
chd-210	132	1	ca	can	AUX
chd-210	132	2	cancer	cancer	PROPN
chd-210	132	3	j	j	PROPN
chd-210	132	4	clin	clin	PROPN
chd-210	132	5	.	.	PUNCT
chd-210	133	1	2020	2020	NUM
chd-210	133	2	doi	doi	NOUN
chd-210	133	3	:	:	PUNCT
chd-210	133	4	10.3322	10.3322	NUM
chd-210	133	5	/	/	SYM
chd-210	133	6	caac.21632	caac.21632	PROPN
chd-210	133	7	10	10	NUM
chd-210	133	8	ryan	ryan	PROPN
chd-210	133	9	bm	bm	PROPN
chd-210	133	10	.	.	PUNCT
chd-210	134	1	lung	lung	PROPN
chd-210	134	2	cancer	cancer	NOUN
chd-210	134	3	health	health	NOUN
chd-210	134	4	disparities	disparity	NOUN
chd-210	134	5	.	.	PUNCT
chd-210	135	1	carcinogenesis	carcinogenesis	NOUN
chd-210	135	2	.	.	PUNCT
chd-210	136	1	2018	2018	NUM
chd-210	136	2	doi	doi	NOUN
chd-210	136	3	:	:	PUNCT
chd-210	136	4	10.1093	10.1093	NUM
chd-210	136	5	/	/	SYM
chd-210	136	6	carcin	carcin	PROPN
chd-210	136	7	/	/	SYM
chd-210	136	8	bgy047	bgy047	PROPN
chd-210	136	9	11	11	NUM
chd-210	136	10	dogan	dogan	PROPN
chd-210	136	11	s	s	PROPN
chd-210	136	12	,	,	PUNCT
chd-210	136	13	shen	shen	PROPN
chd-210	136	14	r	r	NOUN
chd-210	136	15	,	,	PUNCT
chd-210	136	16	ang	ang	PROPN
chd-210	136	17	dc	dc	PROPN
chd-210	136	18	,	,	PUNCT
chd-210	136	19	johnson	johnson	PROPN
chd-210	136	20	ml	ml	PROPN
chd-210	136	21	,	,	PUNCT
chd-210	136	22	d’angelo	d’angelo	PROPN
chd-210	136	23	sp	sp	NOUN
chd-210	136	24	,	,	PUNCT
chd-210	136	25	paik	paik	NOUN
chd-210	136	26	pk	pk	PROPN
chd-210	136	27	,	,	PUNCT
chd-210	136	28	et	et	PROPN
chd-210	136	29	al	al	PROPN
chd-210	136	30	.	.	PROPN
chd-210	137	1	molecular	molecular	ADJ
chd-210	137	2	epidemiology	epidemiology	NOUN
chd-210	137	3	of	of	ADP
chd-210	137	4	egfr	egfr	NOUN
chd-210	137	5	and	and	CCONJ
chd-210	137	6	kras	kras	PROPN
chd-210	137	7	mutations	mutation	NOUN
chd-210	137	8	in	in	ADP
chd-210	137	9	3,026	3,026	NUM
chd-210	137	10	lung	lung	NOUN
chd-210	137	11	adenocarcinomas	adenocarcinoma	NOUN
chd-210	137	12	:	:	PUNCT
chd-210	137	13	higher	high	ADJ
chd-210	137	14	susceptibility	susceptibility	NOUN
chd-210	137	15	of	of	ADP
chd-210	137	16	women	woman	NOUN
chd-210	137	17	to	to	ADP
chd-210	137	18	smoking	smoking	NOUN
chd-210	137	19	-	-	PUNCT
chd-210	137	20	related	relate	VERB
chd-210	137	21	kras	kra	NOUN
chd-210	137	22	-	-	PUNCT
chd-210	137	23	mutant	mutant	ADJ
chd-210	137	24	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PART
chd-210	137	25	e8	e8	PROPN
chd-210	137	26	cancer	cancer	NOUN
chd-210	137	27	health	health	NOUN
chd-210	137	28	disparities	disparity	NOUN
chd-210	137	29	research	research	NOUN
chd-210	137	30	cancers	cancer	NOUN
chd-210	137	31	.	.	PUNCT
chd-210	138	1	clin	clin	PROPN
chd-210	138	2	cancer	cancer	NOUN
chd-210	138	3	res	re	NOUN
chd-210	138	4	.	.	PROPN
chd-210	138	5	2012	2012	NUM
chd-210	138	6	doi	doi	NOUN
chd-210	138	7	:	:	PUNCT
chd-210	138	8	10.1158/10780432.ccr-11	10.1158/10780432.ccr-11	NUM
chd-210	138	9	-	-	SYM
chd-210	138	10	3265	3265	NUM
chd-210	138	11	12	12	NUM
chd-210	138	12	leidner	leidner	NOUN
chd-210	138	13	rs	rs	NOUN
chd-210	138	14	,	,	PUNCT
chd-210	138	15	fu	fu	NOUN
chd-210	138	16	p	p	NOUN
chd-210	138	17	,	,	PUNCT
chd-210	138	18	clifford	clifford	PROPN
chd-210	138	19	b	b	PROPN
chd-210	138	20	,	,	PUNCT
chd-210	138	21	hamdan	hamdan	PROPN
chd-210	138	22	a	a	PROPN
chd-210	138	23	,	,	PUNCT
chd-210	138	24	jin	jin	NOUN
chd-210	138	25	c	c	NOUN
chd-210	138	26	,	,	PUNCT
chd-210	138	27	eisenberg	eisenberg	PROPN
chd-210	138	28	r	r	PROPN
chd-210	138	29	,	,	PUNCT
chd-210	138	30	et	et	PROPN
chd-210	138	31	al	al	PROPN
chd-210	138	32	.	.	PUNCT
chd-210	139	1	genetic	genetic	ADJ
chd-210	139	2	abnormalities	abnormality	NOUN
chd-210	139	3	of	of	ADP
chd-210	139	4	the	the	DET
chd-210	139	5	egfr	egfr	ADJ
chd-210	139	6	pathway	pathway	NOUN
chd-210	139	7	in	in	ADP
chd-210	139	8	african	african	ADJ
chd-210	139	9	american	american	ADJ
chd-210	139	10	patients	patient	NOUN
chd-210	139	11	with	with	ADP
chd-210	139	12	non	non	ADJ
chd-210	139	13	-	-	ADJ
chd-210	139	14	small	small	ADJ
chd-210	139	15	-	-	PUNCT
chd-210	139	16	cell	cell	NOUN
chd-210	139	17	lung	lung	NOUN
chd-210	139	18	cancer	cancer	NOUN
chd-210	139	19	.	.	PUNCT
chd-210	140	1	j	j	PROPN
chd-210	140	2	clin	clin	PROPN
chd-210	140	3	oncol	oncol	PROPN
chd-210	140	4	.	.	PUNCT
chd-210	141	1	2009	2009	NUM
chd-210	141	2	doi	doi	NOUN
chd-210	141	3	:	:	PUNCT
chd-210	141	4	10.1200	10.1200	NUM
chd-210	141	5	/	/	SYM
chd-210	141	6	jco.2009.23.1431	jco.2009.23.1431	PROPN
chd-210	141	7	13	13	NUM
chd-210	141	8	harada	harada	PROPN
chd-210	141	9	t	t	PROPN
chd-210	141	10	,	,	PUNCT
chd-210	141	11	lopez	lopez	PROPN
chd-210	141	12	-	-	PUNCT
chd-210	141	13	chavez	chavez	PROPN
chd-210	141	14	a	a	PRON
chd-210	141	15	,	,	PUNCT
chd-210	141	16	xi	xi	PROPN
chd-210	141	17	l	l	NOUN
chd-210	141	18	,	,	PUNCT
chd-210	141	19	raffeld	raffeld	PROPN
chd-210	141	20	m	m	PROPN
chd-210	141	21	,	,	PUNCT
chd-210	141	22	wang	wang	PROPN
chd-210	141	23	y	y	PROPN
chd-210	141	24	,	,	PUNCT
chd-210	141	25	giaccone	giaccone	PROPN
chd-210	141	26	g.	g.	PROPN
chd-210	141	27	characterization	characterization	NOUN
chd-210	141	28	of	of	ADP
chd-210	141	29	epidermal	epidermal	ADJ
chd-210	141	30	growth	growth	NOUN
chd-210	141	31	factor	factor	NOUN
chd-210	141	32	receptor	receptor	NOUN
chd-210	141	33	mutations	mutation	NOUN
chd-210	141	34	in	in	ADP
chd-210	141	35	non	non	ADJ
chd-210	141	36	-	-	ADJ
chd-210	141	37	small	small	ADJ
chd-210	141	38	-	-	PUNCT
chd-210	141	39	cell	cell	NOUN
chd-210	141	40	lung	lung	NOUN
chd-210	141	41	cancer	cancer	NOUN
chd-210	141	42	patients	patient	NOUN
chd-210	141	43	of	of	ADP
chd-210	141	44	african	african	ADJ
chd-210	141	45	-	-	PUNCT
chd-210	141	46	american	american	ADJ
chd-210	141	47	ancestry	ancestry	NOUN
chd-210	141	48	.	.	PUNCT
chd-210	142	1	oncogene	oncogene	NOUN
chd-210	142	2	.	.	PUNCT
chd-210	143	1	2011	2011	NUM
chd-210	143	2	doi	doi	NOUN
chd-210	143	3	:	:	PUNCT
chd-210	143	4	10.1038	10.1038	NUM
chd-210	143	5	/	/	SYM
chd-210	143	6	onc.2010.545	onc.2010.545	NUM
chd-210	143	7	14	14	NUM
chd-210	143	8	el	el	PROPN
chd-210	143	9	-	-	PROPN
chd-210	143	10	telbany	telbany	PROPN
chd-210	143	11	a	a	PROPN
chd-210	143	12	,	,	PUNCT
chd-210	143	13	ma	ma	PROPN
chd-210	143	14	pc	pc	PROPN
chd-210	143	15	.	.	PUNCT
chd-210	144	1	cancer	cancer	NOUN
chd-210	144	2	genes	gene	NOUN
chd-210	144	3	in	in	ADP
chd-210	144	4	lung	lung	NOUN
chd-210	144	5	cancer	cancer	NOUN
chd-210	144	6	:	:	PUNCT
chd-210	144	7	racial	racial	ADJ
chd-210	144	8	disparities	disparity	NOUN
chd-210	144	9	:	:	PUNCT
chd-210	144	10	are	be	AUX
chd-210	144	11	there	there	PRON
chd-210	144	12	any	any	PRON
chd-210	144	13	?	?	PUNCT
chd-210	145	1	genes	gene	NOUN
chd-210	145	2	and	and	CCONJ
chd-210	145	3	cancer	cancer	NOUN
chd-210	145	4	.	.	PUNCT
chd-210	146	1	2012	2012	NUM
chd-210	146	2	doi	doi	NOUN
chd-210	146	3	:	:	PUNCT
chd-210	146	4	10.1177/1947601912465177	10.1177/1947601912465177	NUM
chd-210	146	5	15	15	NUM
chd-210	146	6	koivunen	koivunen	PROPN
chd-210	146	7	jp	jp	PROPN
chd-210	146	8	,	,	PUNCT
chd-210	146	9	kim	kim	PROPN
chd-210	146	10	j	j	PROPN
chd-210	146	11	,	,	PUNCT
chd-210	146	12	lee	lee	PROPN
chd-210	146	13	j	j	PROPN
chd-210	146	14	,	,	PUNCT
chd-210	146	15	rogers	rogers	PROPN
chd-210	146	16	am	be	AUX
chd-210	146	17	,	,	PUNCT
chd-210	146	18	park	park	NOUN
chd-210	146	19	jo	jo	PROPN
chd-210	146	20	,	,	PUNCT
chd-210	146	21	zhao	zhao	PROPN
chd-210	146	22	x	x	PROPN
chd-210	146	23	,	,	PUNCT
chd-210	146	24	et	et	PROPN
chd-210	146	25	al	al	PROPN
chd-210	146	26	.	.	PUNCT
chd-210	146	27	mutations	mutation	NOUN
chd-210	146	28	in	in	ADP
chd-210	146	29	the	the	DET
chd-210	146	30	lkb1	lkb1	PROPN
chd-210	146	31	tumour	tumour	NOUN
chd-210	146	32	suppressor	suppressor	NOUN
chd-210	146	33	are	be	AUX
chd-210	146	34	frequently	frequently	ADV
chd-210	146	35	detected	detect	VERB
chd-210	146	36	in	in	ADP
chd-210	146	37	tumours	tumour	NOUN
chd-210	146	38	from	from	ADP
chd-210	146	39	caucasian	caucasian	PROPN
chd-210	146	40	but	but	CCONJ
chd-210	146	41	not	not	PART
chd-210	146	42	asian	asian	ADJ
chd-210	146	43	lung	lung	NOUN
chd-210	146	44	cancer	cancer	NOUN
chd-210	146	45	patients	patient	NOUN
chd-210	146	46	.	.	PUNCT
chd-210	147	1	br	br	PROPN
chd-210	147	2	j	j	PROPN
chd-210	147	3	cancer	cancer	NOUN
chd-210	147	4	.	.	PUNCT
chd-210	148	1	2008	2008	NUM
chd-210	148	2	doi	doi	NOUN
chd-210	148	3	:	:	PUNCT
chd-210	148	4	10.1038	10.1038	NUM
chd-210	148	5	/	/	SYM
chd-210	148	6	sj.bjc.6604469	sj.bjc.6604469	PROPN
chd-210	148	7	16	16	NUM
chd-210	148	8	gill	gill	NOUN
chd-210	148	9	rk	rk	NOUN
chd-210	148	10	,	,	PUNCT
chd-210	148	11	yang	yang	PROPN
chd-210	148	12	sh	sh	PROPN
chd-210	148	13	,	,	PUNCT
chd-210	148	14	meerzaman	meerzaman	NOUN
chd-210	148	15	d	d	NOUN
chd-210	148	16	,	,	PUNCT
chd-210	148	17	mechanic	mechanic	ADJ
chd-210	148	18	le	le	X
chd-210	148	19	,	,	PUNCT
chd-210	148	20	bowman	bowman	PROPN
chd-210	148	21	ed	ed	PROPN
chd-210	148	22	,	,	PUNCT
chd-210	148	23	jeon	jeon	PROPN
chd-210	148	24	hs	hs	PROPN
chd-210	148	25	,	,	PUNCT
chd-210	148	26	et	et	PROPN
chd-210	148	27	al	al	PROPN
chd-210	148	28	.	.	PUNCT
chd-210	149	1	frequent	frequent	ADJ
chd-210	149	2	homozygous	homozygous	ADJ
chd-210	149	3	deletion	deletion	NOUN
chd-210	149	4	of	of	ADP
chd-210	149	5	the	the	DET
chd-210	149	6	lkb1	lkb1	PROPN
chd-210	149	7	/	/	SYM
chd-210	149	8	stk11	stk11	ADJ
chd-210	149	9	gene	gene	NOUN
chd-210	149	10	in	in	ADP
chd-210	149	11	non	non	ADJ
chd-210	149	12	-	-	ADJ
chd-210	149	13	small	small	ADJ
chd-210	149	14	cell	cell	NOUN
chd-210	149	15	lung	lung	NOUN
chd-210	149	16	cancer	cancer	NOUN
chd-210	149	17	.	.	PUNCT
chd-210	150	1	oncogene	oncogene	NOUN
chd-210	150	2	.	.	PUNCT
chd-210	151	1	2011	2011	NUM
chd-210	151	2	doi	doi	NOUN
chd-210	151	3	:	:	PUNCT
chd-210	151	4	10.1038	10.1038	NUM
chd-210	151	5	/	/	SYM
chd-210	151	6	onc.2011.98	onc.2011.98	NUM
chd-210	151	7	17	17	NUM
chd-210	151	8	lusk	lusk	NOUN
chd-210	151	9	cm	cm	PROPN
chd-210	151	10	,	,	PUNCT
chd-210	151	11	watza	watza	NOUN
chd-210	151	12	d	d	NOUN
chd-210	151	13	,	,	PUNCT
chd-210	151	14	dyson	dyson	PROPN
chd-210	151	15	g	g	PROPN
chd-210	151	16	,	,	PUNCT
chd-210	151	17	craig	craig	PROPN
chd-210	151	18	d	d	PROPN
chd-210	151	19	,	,	PUNCT
chd-210	151	20	ratliff	ratliff	PROPN
chd-210	151	21	v	v	NOUN
chd-210	151	22	,	,	PUNCT
chd-210	151	23	wenzlaff	wenzlaff	NOUN
chd-210	151	24	as	as	ADP
chd-210	151	25	,	,	PUNCT
chd-210	151	26	et	et	PROPN
chd-210	151	27	al	al	PROPN
chd-210	151	28	.	.	PROPN
chd-210	152	1	profiling	profile	VERB
chd-210	152	2	the	the	DET
chd-210	152	3	mutational	mutational	ADJ
chd-210	152	4	landscape	landscape	NOUN
chd-210	152	5	in	in	ADP
chd-210	152	6	known	know	VERB
chd-210	152	7	driver	driver	NOUN
chd-210	152	8	genes	gene	NOUN
chd-210	152	9	and	and	CCONJ
chd-210	152	10	novel	novel	ADJ
chd-210	152	11	genes	gene	NOUN
chd-210	152	12	in	in	ADP
chd-210	152	13	african	african	ADJ
chd-210	152	14	american	american	ADJ
chd-210	152	15	non	non	ADJ
chd-210	152	16	–	–	PUNCT
chd-210	152	17	small	small	ADJ
chd-210	152	18	cell	cell	NOUN
chd-210	152	19	lung	lung	NOUN
chd-210	152	20	cancer	cancer	NOUN
chd-210	152	21	patients	patient	NOUN
chd-210	152	22	.	.	PUNCT
chd-210	153	1	clin	clin	PROPN
chd-210	153	2	cancer	cancer	NOUN
chd-210	153	3	res	re	NOUN
chd-210	153	4	.	.	PROPN
chd-210	153	5	2019	2019	NUM
chd-210	153	6	doi	doi	NOUN
chd-210	153	7	:	:	PUNCT
chd-210	153	8	10.1158/1078	10.1158/1078	NUM
chd-210	153	9	-	-	PUNCT
chd-210	153	10	0432.ccr-18	0432.ccr-18	NOUN
chd-210	153	11	-	-	PUNCT
chd-210	153	12	2439	2439	NUM
chd-210	153	13	18	18	NUM
chd-210	153	14	costa	costa	PROPN
chd-210	153	15	pa	pa	PROPN
chd-210	153	16	,	,	PUNCT
chd-210	153	17	saul	saul	PROPN
chd-210	153	18	ee	ee	PROPN
chd-210	153	19	,	,	PUNCT
chd-210	153	20	paul	paul	PROPN
chd-210	153	21	y	y	PROPN
chd-210	153	22	,	,	PUNCT
chd-210	153	23	iyer	iyer	PROPN
chd-210	153	24	s	s	PROPN
chd-210	153	25	,	,	PUNCT
chd-210	153	26	da	da	PROPN
chd-210	153	27	silva	silva	PROPN
chd-210	153	28	ll	ll	PROPN
chd-210	153	29	,	,	PUNCT
chd-210	153	30	tamariz	tamariz	NOUN
chd-210	153	31	l	l	NOUN
chd-210	153	32	,	,	PUNCT
chd-210	153	33	et	et	PROPN
chd-210	153	34	al	al	PROPN
chd-210	153	35	.	.	PUNCT
chd-210	154	1	prevalence	prevalence	NOUN
chd-210	154	2	of	of	ADP
chd-210	154	3	targetable	targetable	ADJ
chd-210	154	4	mutations	mutation	NOUN
chd-210	154	5	in	in	ADP
chd-210	154	6	black	black	ADJ
chd-210	154	7	patients	patient	NOUN
chd-210	154	8	with	with	ADP
chd-210	154	9	lung	lung	NOUN
chd-210	154	10	cancer	cancer	NOUN
chd-210	154	11	:	:	PUNCT
chd-210	154	12	a	a	DET
chd-210	154	13	systematic	systematic	ADJ
chd-210	154	14	review	review	NOUN
chd-210	154	15	and	and	CCONJ
chd-210	154	16	metaanalysis	metaanalysis	NOUN
chd-210	154	17	.	.	PUNCT
chd-210	155	1	jco	jco	PROPN
chd-210	155	2	oncol	oncol	PROPN
chd-210	155	3	pract	pract	PROPN
chd-210	155	4	.	.	PUNCT
chd-210	156	1	2021	2021	NUM
chd-210	156	2	doi	doi	NOUN
chd-210	156	3	:	:	PUNCT
chd-210	156	4	10.1200	10.1200	NUM
chd-210	156	5	/	/	SYM
chd-210	156	6	op.20.00961	op.20.00961	ADJ
chd-210	156	7	19	19	NUM
chd-210	156	8	hunt	hunt	NOUN
chd-210	156	9	jd	jd	PROPN
chd-210	156	10	,	,	PUNCT
chd-210	156	11	strimas	strima	VERB
chd-210	156	12	a	a	PRON
chd-210	156	13	,	,	PUNCT
chd-210	156	14	martin	martin	PROPN
chd-210	156	15	je	je	PROPN
chd-210	156	16	,	,	PUNCT
chd-210	156	17	eyer	eyer	PROPN
chd-210	156	18	m	m	PROPN
chd-210	156	19	,	,	PUNCT
chd-210	156	20	haddican	haddican	PROPN
chd-210	156	21	m	m	PROPN
chd-210	156	22	,	,	PUNCT
chd-210	156	23	luckett	luckett	PROPN
chd-210	156	24	bg	bg	PROPN
chd-210	156	25	,	,	PUNCT
chd-210	156	26	et	et	PROPN
chd-210	156	27	al	al	PROPN
chd-210	156	28	.	.	PROPN
chd-210	156	29	differences	difference	NOUN
chd-210	156	30	in	in	ADP
chd-210	156	31	kras	kras	PROPN
chd-210	156	32	mutation	mutation	NOUN
chd-210	156	33	spectrum	spectrum	NOUN
chd-210	156	34	in	in	ADP
chd-210	156	35	lung	lung	NOUN
chd-210	156	36	cancer	cancer	NOUN
chd-210	156	37	cases	case	NOUN
chd-210	156	38	between	between	ADP
chd-210	156	39	african	african	ADJ
chd-210	156	40	americans	americans	PROPN
chd-210	156	41	and	and	CCONJ
chd-210	156	42	caucasians	caucasian	NOUN
chd-210	156	43	after	after	ADP
chd-210	156	44	occupational	occupational	ADJ
chd-210	156	45	or	or	CCONJ
chd-210	156	46	environmental	environmental	ADJ
chd-210	156	47	exposure	exposure	NOUN
chd-210	156	48	to	to	ADP
chd-210	156	49	known	know	VERB
chd-210	156	50	carcinogens	carcinogen	NOUN
chd-210	156	51	.	.	PUNCT
chd-210	157	1	cancer	cancer	NOUN
chd-210	157	2	epidemiol	epidemiol	PROPN
chd-210	157	3	biomarkers	biomarker	NOUN
chd-210	157	4	prev	prev	X
chd-210	157	5	.	.	PUNCT
chd-210	158	1	2002	2002	NUM
chd-210	158	2	20	20	NUM
chd-210	158	3	reinersman	reinersman	PROPN
chd-210	158	4	jm	jm	PROPN
chd-210	158	5	,	,	PUNCT
chd-210	158	6	johnson	johnson	PROPN
chd-210	158	7	ml	ml	PROPN
chd-210	158	8	,	,	PUNCT
chd-210	158	9	riely	riely	ADJ
chd-210	158	10	gj	gj	NOUN
chd-210	158	11	,	,	PUNCT
chd-210	158	12	chitale	chitale	NOUN
chd-210	158	13	da	da	PROPN
chd-210	158	14	,	,	PUNCT
chd-210	158	15	nicastri	nicastri	ADJ
chd-210	158	16	ad	ad	NOUN
chd-210	158	17	,	,	PUNCT
chd-210	158	18	soff	soff	PROPN
chd-210	158	19	ga	ga	PROPN
chd-210	158	20	,	,	PUNCT
chd-210	158	21	et	et	PROPN
chd-210	158	22	al	al	PROPN
chd-210	158	23	.	.	PROPN
chd-210	158	24	frequency	frequency	PROPN
chd-210	158	25	of	of	ADP
chd-210	158	26	egfr	egfr	NOUN
chd-210	158	27	and	and	CCONJ
chd-210	158	28	kras	kras	PROPN
chd-210	158	29	mutations	mutation	NOUN
chd-210	158	30	in	in	ADP
chd-210	158	31	lung	lung	NOUN
chd-210	158	32	adenocarcinomas	adenocarcinoma	NOUN
chd-210	158	33	in	in	ADP
chd-210	158	34	african	african	ADJ
chd-210	158	35	americans	americans	PROPN
chd-210	158	36	.	.	PUNCT
chd-210	159	1	j	j	PROPN
chd-210	159	2	thorac	thorac	PROPN
chd-210	159	3	oncol	oncol	ADJ
chd-210	159	4	.	.	PUNCT
chd-210	160	1	2011	2011	NUM
chd-210	160	2	doi	doi	NOUN
chd-210	160	3	:	:	PUNCT
chd-210	160	4	10.1097	10.1097	NUM
chd-210	160	5	/	/	SYM
chd-210	160	6	jto.0b013e3181fb4fe2	jto.0b013e3181fb4fe2	NOUN
chd-210	160	7	21	21	NUM
chd-210	160	8	rivlin	rivlin	PROPN
chd-210	160	9	n	n	CCONJ
chd-210	160	10	,	,	PUNCT
chd-210	160	11	brosh	brosh	PROPN
chd-210	160	12	r	r	PROPN
chd-210	160	13	,	,	PUNCT
chd-210	160	14	oren	oren	NOUN
chd-210	160	15	m	m	PROPN
chd-210	160	16	,	,	PUNCT
chd-210	160	17	rotter	rotter	NOUN
chd-210	160	18	v.	v.	ADP
chd-210	160	19	mutations	mutation	NOUN
chd-210	160	20	in	in	ADP
chd-210	160	21	the	the	DET
chd-210	160	22	p53	p53	NOUN
chd-210	160	23	tumor	tumor	NOUN
chd-210	160	24	suppressor	suppressor	NOUN
chd-210	160	25	gene	gene	NOUN
chd-210	160	26	:	:	PUNCT
chd-210	160	27	important	important	ADJ
chd-210	160	28	milestones	milestone	NOUN
chd-210	160	29	at	at	ADP
chd-210	160	30	the	the	DET
chd-210	160	31	various	various	ADJ
chd-210	160	32	steps	step	NOUN
chd-210	160	33	of	of	ADP
chd-210	160	34	tumorigenesis	tumorigenesis	NOUN
chd-210	160	35	.	.	PUNCT
chd-210	161	1	genes	gene	NOUN
chd-210	161	2	and	and	CCONJ
chd-210	161	3	cancer	cancer	NOUN
chd-210	161	4	.	.	PUNCT
chd-210	162	1	2011	2011	NUM
chd-210	162	2	doi	doi	NOUN
chd-210	162	3	:	:	PUNCT
chd-210	162	4	10.1177/1947601911408889	10.1177/1947601911408889	NUM
chd-210	162	5	22	22	NUM
chd-210	162	6	kytola	kytola	PROPN
chd-210	162	7	v	v	PROPN
chd-210	162	8	,	,	PUNCT
chd-210	162	9	topaloglu	topaloglu	PROPN
chd-210	162	10	u	u	PROPN
chd-210	162	11	,	,	PUNCT
chd-210	162	12	miller	miller	PROPN
chd-210	162	13	ld	ld	PROPN
chd-210	162	14	,	,	PUNCT
chd-210	162	15	bitting	bit	VERB
chd-210	162	16	rl	rl	ADP
chd-210	162	17	,	,	PUNCT
chd-210	162	18	goodman	goodman	PROPN
chd-210	162	19	mm	mm	PROPN
chd-210	162	20	,	,	PUNCT
chd-210	162	21	d’agostino	d’agostino	NOUN
chd-210	162	22	rb	rb	PROPN
chd-210	162	23	,	,	PUNCT
chd-210	162	24	et	et	PROPN
chd-210	162	25	al	al	PROPN
chd-210	162	26	.	.	PROPN
chd-210	162	27	mutational	mutational	ADJ
chd-210	162	28	landscapes	landscape	NOUN
chd-210	162	29	of	of	ADP
chd-210	162	30	smokingrelated	smokingrelate	VERB
chd-210	162	31	cancers	cancer	NOUN
chd-210	162	32	in	in	ADP
chd-210	162	33	caucasians	caucasian	NOUN
chd-210	162	34	and	and	CCONJ
chd-210	162	35	african	african	ADJ
chd-210	162	36	americans	americans	PROPN
chd-210	162	37	:	:	PUNCT
chd-210	162	38	precision	precision	NOUN
chd-210	162	39	oncology	oncology	NOUN
chd-210	162	40	perspectives	perspective	NOUN
chd-210	162	41	at	at	ADP
chd-210	162	42	wake	wake	VERB
chd-210	162	43	forest	forest	NOUN
chd-210	162	44	baptist	baptist	PROPN
chd-210	162	45	comprehensive	comprehensive	ADJ
chd-210	162	46	cancer	cancer	NOUN
chd-210	162	47	center	center	NOUN
chd-210	162	48	.	.	PUNCT
chd-210	163	1	theranostics	theranostic	NOUN
chd-210	163	2	.	.	PUNCT
chd-210	164	1	2017	2017	NUM
chd-210	164	2	doi	doi	NOUN
chd-210	164	3	:	:	PUNCT
chd-210	164	4	10.7150	10.7150	NUM
chd-210	164	5	/	/	SYM
chd-210	164	6	thno.20355	thno.20355	PROPN
chd-210	164	7	23	23	NUM
chd-210	164	8	mitchell	mitchell	PROPN
chd-210	164	9	ka	ka	PROPN
chd-210	164	10	,	,	PUNCT
chd-210	164	11	nichols	nichols	PROPN
chd-210	164	12	n	n	CCONJ
chd-210	164	13	,	,	PUNCT
chd-210	164	14	tang	tang	PROPN
chd-210	164	15	w	w	PROPN
chd-210	164	16	,	,	PUNCT
chd-210	164	17	walling	wall	VERB
chd-210	164	18	j	j	PROPN
chd-210	164	19	,	,	PUNCT
chd-210	164	20	stevenson	stevenson	PROPN
chd-210	164	21	h	h	PROPN
chd-210	164	22	,	,	PUNCT
chd-210	164	23	pineda	pineda	PROPN
chd-210	164	24	m	m	PROPN
chd-210	164	25	,	,	PUNCT
chd-210	164	26	et	et	PROPN
chd-210	164	27	al	al	PROPN
chd-210	164	28	.	.	PROPN
chd-210	164	29	recurrent	recurrent	PROPN
chd-210	164	30	ptprt	ptprt	PROPN
chd-210	164	31	/	/	SYM
chd-210	164	32	jak2	jak2	PROPN
chd-210	164	33	mutations	mutation	NOUN
chd-210	164	34	in	in	ADP
chd-210	164	35	lung	lung	NOUN
chd-210	164	36	adenocarcinoma	adenocarcinoma	NOUN
chd-210	164	37	among	among	ADP
chd-210	164	38	african	african	ADJ
chd-210	164	39	americans	americans	PROPN
chd-210	164	40	.	.	PUNCT
chd-210	165	1	nat	nat	PROPN
chd-210	165	2	commun	commun	PROPN
chd-210	165	3	.	.	PUNCT
chd-210	166	1	2019	2019	NUM
chd-210	166	2	doi	doi	NOUN
chd-210	166	3	:	:	PUNCT
chd-210	166	4	10.1038	10.1038	NUM
chd-210	166	5	/	/	SYM
chd-210	166	6	s41467	s41467	NOUN
chd-210	166	7	-	-	PUNCT
chd-210	166	8	019	019	NUM
chd-210	166	9	-	-	PUNCT
chd-210	166	10	13732	13732	NUM
chd-210	166	11	-	-	PUNCT
chd-210	166	12	y	y	PROPN
chd-210	166	13	24	24	NUM
chd-210	166	14	özdemir	özdemir	PROPN
chd-210	166	15	bc	bc	PROPN
chd-210	166	16	,	,	PUNCT
chd-210	166	17	dotto	dotto	PROPN
chd-210	166	18	gp	gp	NOUN
chd-210	166	19	.	.	PUNCT
chd-210	167	1	racial	racial	ADJ
chd-210	167	2	differences	difference	NOUN
chd-210	167	3	in	in	ADP
chd-210	167	4	cancer	cancer	NOUN
chd-210	167	5	susceptibility	susceptibility	NOUN
chd-210	167	6	and	and	CCONJ
chd-210	167	7	survival	survival	NOUN
chd-210	167	8	:	:	PUNCT
chd-210	167	9	more	more	ADJ
chd-210	167	10	than	than	ADP
chd-210	167	11	the	the	DET
chd-210	167	12	color	color	NOUN
chd-210	167	13	of	of	ADP
chd-210	167	14	the	the	DET
chd-210	167	15	skin	skin	NOUN
chd-210	167	16	?	?	PUNCT
chd-210	168	1	trends	trend	NOUN
chd-210	168	2	in	in	ADP
chd-210	168	3	cancer	cancer	NOUN
chd-210	168	4	.	.	PUNCT
chd-210	169	1	2017	2017	NUM
chd-210	169	2	doi	doi	NOUN
chd-210	169	3	:	:	PUNCT
chd-210	169	4	10.1016	10.1016	NUM
chd-210	169	5	/	/	SYM
chd-210	169	6	j.trecan.2017.02.002	j.trecan.2017.02.002	PROPN
chd-210	169	7	25	25	NUM
chd-210	169	8	campbell	campbell	PROPN
chd-210	169	9	jd	jd	PROPN
chd-210	169	10	,	,	PUNCT
chd-210	169	11	lathan	lathan	PROPN
chd-210	169	12	c	c	PROPN
chd-210	169	13	,	,	PUNCT
chd-210	169	14	sholl	sholl	PROPN
chd-210	169	15	l	l	PROPN
chd-210	169	16	,	,	PUNCT
chd-210	169	17	ducar	ducar	ADJ
chd-210	169	18	m	m	PROPN
chd-210	169	19	,	,	PUNCT
chd-210	169	20	vega	vega	PROPN
chd-210	169	21	m	m	PROPN
chd-210	169	22	,	,	PUNCT
chd-210	169	23	sunkavalli	sunkavalli	PROPN
chd-210	169	24	a	a	PROPN
chd-210	169	25	,	,	PUNCT
chd-210	169	26	et	et	PROPN
chd-210	169	27	al	al	PROPN
chd-210	169	28	.	.	PROPN
chd-210	169	29	comparison	comparison	NOUN
chd-210	169	30	of	of	ADP
chd-210	169	31	prevalence	prevalence	NOUN
chd-210	169	32	and	and	CCONJ
chd-210	169	33	types	type	NOUN
chd-210	169	34	of	of	ADP
chd-210	169	35	mutations	mutation	NOUN
chd-210	169	36	in	in	ADP
chd-210	169	37	lung	lung	NOUN
chd-210	169	38	cancers	cancer	NOUN
chd-210	169	39	among	among	ADP
chd-210	169	40	black	black	ADJ
chd-210	169	41	and	and	CCONJ
chd-210	169	42	white	white	ADJ
chd-210	169	43	populations	population	NOUN
chd-210	169	44	.	.	PUNCT
chd-210	170	1	jama	jama	PROPN
chd-210	170	2	oncol	oncol	PROPN
chd-210	170	3	.	.	PUNCT
chd-210	171	1	2017	2017	NUM
chd-210	171	2	doi	doi	NOUN
chd-210	171	3	:	:	PUNCT
chd-210	171	4	10.1001	10.1001	NUM
chd-210	171	5	/	/	SYM
chd-210	171	6	jamaoncol.2016.6108	jamaoncol.2016.6108	PROPN
chd-210	171	7	26	26	NUM
chd-210	171	8	bauml	bauml	PROPN
chd-210	171	9	j	j	PROPN
chd-210	171	10	,	,	PUNCT
chd-210	171	11	mick	mick	PROPN
chd-210	171	12	r	r	PROPN
chd-210	171	13	,	,	PUNCT
chd-210	171	14	zhang	zhang	PROPN
chd-210	171	15	y	y	PROPN
chd-210	171	16	,	,	PUNCT
chd-210	171	17	watt	watt	PROPN
chd-210	171	18	cd	cd	PROPN
chd-210	171	19	,	,	PUNCT
chd-210	171	20	vachani	vachani	NOUN
chd-210	171	21	a	a	PRON
chd-210	171	22	,	,	PUNCT
chd-210	171	23	aggarwal	aggarwal	NOUN
chd-210	171	24	c	c	PROPN
chd-210	171	25	,	,	PUNCT
chd-210	171	26	et	et	PROPN
chd-210	171	27	al	al	PROPN
chd-210	171	28	.	.	PROPN
chd-210	171	29	frequency	frequency	PROPN
chd-210	171	30	of	of	ADP
chd-210	171	31	egfr	egfr	NOUN
chd-210	171	32	and	and	CCONJ
chd-210	171	33	kras	kras	PROPN
chd-210	171	34	mutations	mutation	NOUN
chd-210	171	35	in	in	ADP
chd-210	171	36	patients	patient	NOUN
chd-210	171	37	with	with	ADP
chd-210	171	38	non	non	PRON
chd-210	171	39	small	small	ADJ
chd-210	171	40	cell	cell	NOUN
chd-210	171	41	lung	lung	NOUN
chd-210	171	42	cancer	cancer	NOUN
chd-210	171	43	by	by	ADP
chd-210	171	44	racial	racial	ADJ
chd-210	171	45	background	background	NOUN
chd-210	171	46	:	:	PUNCT
chd-210	171	47	do	do	AUX
chd-210	171	48	disparities	disparity	NOUN
chd-210	171	49	exist	exist	VERB
chd-210	171	50	?	?	PUNCT
chd-210	172	1	lung	lung	NOUN
chd-210	172	2	cancer	cancer	NOUN
chd-210	172	3	.	.	PUNCT
chd-210	173	1	2013	2013	NUM
chd-210	173	2	doi	doi	NOUN
chd-210	173	3	:	:	PUNCT
chd-210	173	4	10.1016	10.1016	NUM
chd-210	173	5	/	/	SYM
chd-210	173	6	j.lungcan.2013.05.011	j.lungcan.2013.05.011	PROPN
chd-210	173	7	27	27	NUM
chd-210	173	8	bollig	bollig	NOUN
chd-210	173	9	-	-	PUNCT
chd-210	173	10	fischer	fischer	PROPN
chd-210	173	11	a	a	PROPN
chd-210	173	12	,	,	PUNCT
chd-210	173	13	chen	chen	PROPN
chd-210	173	14	w	w	PROPN
chd-210	173	15	,	,	PUNCT
chd-210	173	16	gadgeel	gadgeel	PROPN
chd-210	173	17	sm	sm	PROPN
chd-210	173	18	,	,	PUNCT
chd-210	173	19	wenzlaff	wenzlaff	NOUN
chd-210	173	20	as	as	ADP
chd-210	173	21	,	,	PUNCT
chd-210	173	22	cote	cote	PROPN
chd-210	173	23	ml	ml	PROPN
chd-210	173	24	,	,	PUNCT
chd-210	173	25	schwartz	schwartz	PROPN
chd-210	173	26	ag	ag	PROPN
chd-210	173	27	,	,	PUNCT
chd-210	173	28	et	et	PROPN
chd-210	173	29	al	al	PROPN
chd-210	173	30	.	.	PUNCT
chd-210	174	1	racial	racial	ADJ
chd-210	174	2	diversity	diversity	NOUN
chd-210	174	3	of	of	ADP
chd-210	174	4	actionable	actionable	ADJ
chd-210	174	5	mutations	mutation	NOUN
chd-210	174	6	in	in	ADP
chd-210	174	7	non	non	ADJ
chd-210	174	8	-	-	ADJ
chd-210	174	9	small	small	ADJ
chd-210	174	10	cell	cell	NOUN
chd-210	174	11	lung	lung	NOUN
chd-210	174	12	cancer	cancer	NOUN
chd-210	174	13	.	.	PUNCT
chd-210	175	1	j	j	PROPN
chd-210	175	2	thorac	thorac	PROPN
chd-210	175	3	oncol	oncol	ADJ
chd-210	175	4	.	.	PUNCT
chd-210	176	1	2015	2015	NUM
chd-210	176	2	doi	doi	NOUN
chd-210	176	3	:	:	PUNCT
chd-210	176	4	10.1097	10.1097	NUM
chd-210	176	5	/	/	SYM
chd-210	176	6	jto.0000000000000420	jto.0000000000000420	NUM
chd-210	176	7	28	28	NUM
chd-210	176	8	heath	heath	PROPN
chd-210	176	9	ei	ei	PROPN
chd-210	176	10	,	,	PUNCT
chd-210	176	11	lynce	lynce	NOUN
chd-210	176	12	f	f	PROPN
chd-210	176	13	,	,	PUNCT
chd-210	176	14	xiu	xiu	PROPN
chd-210	176	15	j	j	PROPN
chd-210	176	16	,	,	PUNCT
chd-210	176	17	ellerbrock	ellerbrock	VERB
chd-210	176	18	a	a	PRON
chd-210	176	19	,	,	PUNCT
chd-210	176	20	reddy	reddy	PROPN
chd-210	176	21	sk	sk	PROPN
chd-210	176	22	,	,	PUNCT
chd-210	176	23	obeid	obeid	PROPN
chd-210	176	24	e	e	NOUN
chd-210	176	25	,	,	PUNCT
chd-210	176	26	et	et	PROPN
chd-210	176	27	al	al	PROPN
chd-210	176	28	.	.	PUNCT
chd-210	177	1	racial	racial	ADJ
chd-210	177	2	disparities	disparity	NOUN
chd-210	177	3	in	in	ADP
chd-210	177	4	the	the	DET
chd-210	177	5	molecular	molecular	ADJ
chd-210	177	6	landscape	landscape	NOUN
chd-210	177	7	of	of	ADP
chd-210	177	8	cancer	cancer	NOUN
chd-210	177	9	.	.	PUNCT
chd-210	178	1	anticancer	anticancer	NOUN
chd-210	178	2	res	re	NOUN
chd-210	178	3	.	.	PUNCT
chd-210	179	1	2018	2018	NUM
chd-210	179	2	doi	doi	NOUN
chd-210	179	3	:	:	PUNCT
chd-210	179	4	10.21873	10.21873	NUM
chd-210	179	5	/	/	SYM
chd-210	179	6	anticanres.12466	anticanres.12466	PROPN
chd-210	179	7	29	29	NUM
chd-210	179	8	dasgupta	dasgupta	PROPN
chd-210	179	9	s.	s.	PROPN
chd-210	179	10	mitochondrion	mitochondrion	PROPN
chd-210	179	11	:	:	PUNCT
chd-210	179	12	i	i	PRON
chd-210	179	13	am	be	AUX
chd-210	179	14	more	more	ADJ
chd-210	179	15	than	than	ADP
chd-210	179	16	a	a	DET
chd-210	179	17	fuel	fuel	NOUN
chd-210	179	18	server	server	NOUN
chd-210	179	19	.	.	PUNCT
chd-210	180	1	ann	ann	PROPN
chd-210	180	2	transl	transl	PROPN
chd-210	180	3	med	med	PROPN
chd-210	180	4	.	.	PROPN
chd-210	181	1	2019	2019	NUM
chd-210	181	2	doi	doi	NOUN
chd-210	181	3	:	:	PUNCT
chd-210	181	4	10.21037	10.21037	NUM
chd-210	181	5	/	/	SYM
chd-210	181	6	atm.2019.08.22	atm.2019.08.22	PROPN
chd-210	181	7	30	30	NUM
chd-210	181	8	yuan	yuan	NOUN
chd-210	181	9	y	y	PROPN
chd-210	181	10	,	,	PUNCT
chd-210	181	11	ju	ju	PROPN
chd-210	181	12	ys	ys	PROPN
chd-210	181	13	,	,	PUNCT
chd-210	181	14	kim	kim	PROPN
chd-210	181	15	y	y	PROPN
chd-210	181	16	,	,	PUNCT
chd-210	181	17	li	li	PROPN
chd-210	181	18	j	j	PROPN
chd-210	181	19	,	,	PUNCT
chd-210	181	20	wang	wang	PROPN
chd-210	181	21	y	y	PROPN
chd-210	181	22	,	,	PUNCT
chd-210	181	23	yoon	yoon	PROPN
chd-210	181	24	cj	cj	PROPN
chd-210	181	25	,	,	PUNCT
chd-210	181	26	et	et	PROPN
chd-210	181	27	al	al	PROPN
chd-210	181	28	.	.	PROPN
chd-210	182	1	comprehensive	comprehensive	ADJ
chd-210	182	2	molecular	molecular	ADJ
chd-210	182	3	characterization	characterization	NOUN
chd-210	182	4	of	of	ADP
chd-210	182	5	mitochondrial	mitochondrial	ADJ
chd-210	182	6	genomes	genome	NOUN
chd-210	182	7	in	in	ADP
chd-210	182	8	human	human	ADJ
chd-210	182	9	cancers	cancer	NOUN
chd-210	182	10	.	.	PUNCT
chd-210	183	1	nat	nat	PROPN
chd-210	183	2	genet	genet	PROPN
chd-210	183	3	.	.	PUNCT
chd-210	184	1	2020	2020	NUM
chd-210	184	2	doi	doi	NOUN
chd-210	184	3	:	:	PUNCT
chd-210	184	4	10.1038	10.1038	NUM
chd-210	184	5	/	/	SYM
chd-210	184	6	s41588	s41588	VERB
chd-210	184	7	-	-	PUNCT
chd-210	184	8	019	019	NUM
chd-210	184	9	-	-	PUNCT
chd-210	184	10	0557	0557	NUM
chd-210	184	11	-	-	PUNCT
chd-210	184	12	x	x	SYM
chd-210	184	13	31	31	NUM
chd-210	184	14	hertweck	hertweck	PROPN
chd-210	184	15	kl	kl	PROPN
chd-210	184	16	,	,	PUNCT
chd-210	184	17	dasgupta	dasgupta	PROPN
chd-210	184	18	s.	s.	PROPN
chd-210	184	19	the	the	DET
chd-210	184	20	landscape	landscape	NOUN
chd-210	184	21	of	of	ADP
chd-210	184	22	mtdna	mtdna	NOUN
chd-210	184	23	modifications	modification	NOUN
chd-210	184	24	in	in	ADP
chd-210	184	25	cancer	cancer	NOUN
chd-210	184	26	:	:	PUNCT
chd-210	184	27	a	a	DET
chd-210	184	28	tale	tale	NOUN
chd-210	184	29	of	of	ADP
chd-210	184	30	two	two	NUM
chd-210	184	31	cities	city	NOUN
chd-210	184	32	.	.	PUNCT
chd-210	185	1	front	front	ADJ
chd-210	185	2	oncol	oncol	ADJ
chd-210	185	3	.	.	PUNCT
chd-210	186	1	2017	2017	NUM
chd-210	186	2	doi	doi	NOUN
chd-210	186	3	:	:	PUNCT
chd-210	186	4	10.3389	10.3389	NUM
chd-210	186	5	/	/	SYM
chd-210	186	6	fonc.2017.00262	fonc.2017.00262	PROPN
chd-210	186	7	32	32	NUM
chd-210	186	8	lu	lu	PROPN
chd-210	186	9	j	j	PROPN
chd-210	186	10	,	,	PUNCT
chd-210	186	11	sharma	sharma	PROPN
chd-210	186	12	lk	lk	PROPN
chd-210	186	13	,	,	PUNCT
chd-210	186	14	bai	bai	PROPN
chd-210	186	15	y.	y.	PROPN
chd-210	186	16	implications	implication	NOUN
chd-210	186	17	of	of	ADP
chd-210	186	18	mitochondrial	mitochondrial	ADJ
chd-210	186	19	dna	dna	NOUN
chd-210	186	20	mutations	mutation	NOUN
chd-210	186	21	and	and	CCONJ
chd-210	186	22	mitochondrial	mitochondrial	ADJ
chd-210	186	23	dysfunction	dysfunction	NOUN
chd-210	186	24	in	in	ADP
chd-210	186	25	tumorigenesis	tumorigenesis	NOUN
chd-210	186	26	.	.	PUNCT
chd-210	187	1	cell	cell	NOUN
chd-210	187	2	res	re	NOUN
chd-210	187	3	.	.	PUNCT
chd-210	187	4	2009	2009	NUM
chd-210	187	5	doi	doi	NOUN
chd-210	187	6	:	:	PUNCT
chd-210	187	7	10.1038	10.1038	NUM
chd-210	187	8	/	/	SYM
chd-210	187	9	cr.2009.69	cr.2009.69	NOUN
chd-210	187	10	33	33	NUM
chd-210	187	11	osellame	osellame	NOUN
chd-210	187	12	ld	ld	PROPN
chd-210	187	13	,	,	PUNCT
chd-210	187	14	blacker	black	ADJ
chd-210	187	15	ts	ts	VERB
chd-210	187	16	,	,	PUNCT
chd-210	187	17	duchen	duchen	PROPN
chd-210	187	18	mr	mr	PROPN
chd-210	187	19	.	.	PROPN
chd-210	187	20	cellular	cellular	ADJ
chd-210	187	21	and	and	CCONJ
chd-210	187	22	molecular	molecular	ADJ
chd-210	187	23	mechanisms	mechanism	NOUN
chd-210	187	24	of	of	ADP
chd-210	187	25	mitochondrial	mitochondrial	ADJ
chd-210	187	26	function	function	NOUN
chd-210	187	27	.	.	PUNCT
chd-210	188	1	best	good	ADJ
chd-210	188	2	pract	pract	PROPN
chd-210	188	3	res	re	NOUN
chd-210	188	4	clin	clin	PROPN
chd-210	188	5	endocrinol	endocrinol	NOUN
chd-210	188	6	metab	metab	NOUN
chd-210	188	7	.	.	PUNCT
chd-210	189	1	2012	2012	NUM
chd-210	189	2	doi	doi	NOUN
chd-210	189	3	:	:	PUNCT
chd-210	189	4	10.1016	10.1016	NUM
chd-210	189	5	/	/	SYM
chd-210	189	6	j.beem.2012.05.003	j.beem.2012.05.003	ADJ
chd-210	189	7	34	34	NUM
chd-210	189	8	friedman	friedman	PROPN
chd-210	189	9	jr	jr	PROPN
chd-210	189	10	,	,	PUNCT
chd-210	189	11	nunnari	nunnari	PROPN
chd-210	189	12	j.	j.	PROPN
chd-210	189	13	mitochondrial	mitochondrial	ADJ
chd-210	189	14	form	form	NOUN
chd-210	189	15	and	and	CCONJ
chd-210	189	16	function	function	NOUN
chd-210	189	17	.	.	PUNCT
chd-210	190	1	nature	nature	NOUN
chd-210	190	2	.	.	PUNCT
chd-210	191	1	2014	2014	NUM
chd-210	191	2	doi	doi	NOUN
chd-210	191	3	:	:	PUNCT
chd-210	191	4	10.1038	10.1038	NUM
chd-210	191	5	/	/	SYM
chd-210	191	6	nature12985	nature12985	PROPN
chd-210	191	7	35	35	NUM
chd-210	191	8	taanman	taanman	NOUN
chd-210	191	9	jw	jw	PROPN
chd-210	191	10	.	.	PUNCT
chd-210	192	1	the	the	DET
chd-210	192	2	mitochondrial	mitochondrial	ADJ
chd-210	192	3	genome	genome	NOUN
chd-210	192	4	:	:	PUNCT
chd-210	192	5	structure	structure	NOUN
chd-210	192	6	,	,	PUNCT
chd-210	192	7	transcription	transcription	NOUN
chd-210	192	8	,	,	PUNCT
chd-210	192	9	translation	translation	NOUN
chd-210	192	10	and	and	CCONJ
chd-210	192	11	replication	replication	NOUN
chd-210	192	12	.	.	PUNCT
chd-210	193	1	biochim	biochim	PROPN
chd-210	193	2	biophys	biophy	NOUN
chd-210	193	3	acta	acta	PROPN
chd-210	193	4	bioenerg	bioenerg	PROPN
chd-210	193	5	.	.	PUNCT
chd-210	194	1	1999	1999	NUM
chd-210	194	2	doi	doi	NOUN
chd-210	194	3	:	:	PUNCT
chd-210	194	4	10.1016	10.1016	NUM
chd-210	194	5	/	/	SYM
chd-210	194	6	s0005	s0005	NOUN
chd-210	194	7	-	-	VERB
chd-210	194	8	2728(98)001613	2728(98)001613	NUM
chd-210	194	9	36	36	NUM
chd-210	194	10	chaban	chaban	ADJ
chd-210	194	11	y	y	PROPN
chd-210	194	12	,	,	PUNCT
chd-210	194	13	boekema	boekema	PROPN
chd-210	194	14	ej	ej	PROPN
chd-210	194	15	,	,	PUNCT
chd-210	194	16	dudkina	dudkina	PROPN
chd-210	194	17	n	n	PROPN
chd-210	194	18	v.	v.	VERB
chd-210	194	19	structures	structure	NOUN
chd-210	194	20	of	of	ADP
chd-210	194	21	mitochondrial	mitochondrial	ADJ
chd-210	194	22	oxidative	oxidative	ADJ
chd-210	194	23	phosphorylation	phosphorylation	NOUN
chd-210	194	24	supercomplexes	supercomplexe	NOUN
chd-210	194	25	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	ADP
chd-210	194	26	e9	e9	PROPN
chd-210	194	27	cancer	cancer	NOUN
chd-210	194	28	health	health	NOUN
chd-210	194	29	disparities	disparity	NOUN
chd-210	194	30	research	research	NOUN
chd-210	194	31	and	and	CCONJ
chd-210	194	32	mechanisms	mechanism	NOUN
chd-210	194	33	for	for	ADP
chd-210	194	34	their	their	PRON
chd-210	194	35	stabilisation	stabilisation	NOUN
chd-210	194	36	.	.	PUNCT
chd-210	195	1	biochim	biochim	PROPN
chd-210	195	2	biophys	biophy	NOUN
chd-210	195	3	acta	acta	PROPN
chd-210	195	4	bioenerg	bioenerg	PROPN
chd-210	195	5	.	.	PUNCT
chd-210	196	1	2014	2014	NUM
chd-210	196	2	doi	doi	NOUN
chd-210	196	3	:	:	PUNCT
chd-210	196	4	10.1016	10.1016	NUM
chd-210	196	5	/	/	SYM
chd-210	196	6	j.bbabio.2013.10.004	j.bbabio.2013.10.004	PROPN
chd-210	196	7	37	37	NUM
chd-210	196	8	dasgupta	dasgupta	PROPN
chd-210	196	9	s	s	PROPN
chd-210	196	10	,	,	PUNCT
chd-210	196	11	yung	yung	PROPN
chd-210	196	12	rc	rc	PROPN
chd-210	196	13	,	,	PUNCT
chd-210	196	14	westra	westra	PROPN
chd-210	196	15	wh	wh	PROPN
chd-210	196	16	,	,	PUNCT
chd-210	196	17	rini	rini	PROPN
chd-210	196	18	da	da	PROPN
chd-210	196	19	,	,	PUNCT
chd-210	196	20	brandes	brandes	PROPN
chd-210	196	21	j	j	PROPN
chd-210	196	22	,	,	PUNCT
chd-210	196	23	sidransky	sidransky	PROPN
chd-210	196	24	d.	d.	PROPN
chd-210	196	25	following	follow	VERB
chd-210	196	26	mitochondrial	mitochondrial	ADJ
chd-210	196	27	footprints	footprint	NOUN
chd-210	196	28	through	through	ADP
chd-210	196	29	a	a	DET
chd-210	196	30	long	long	ADJ
chd-210	196	31	mucosal	mucosal	NOUN
chd-210	196	32	path	path	NOUN
chd-210	196	33	to	to	ADP
chd-210	196	34	lung	lung	NOUN
chd-210	196	35	cancer	cancer	NOUN
chd-210	196	36	.	.	PUNCT
chd-210	197	1	plos	plos	PROPN
chd-210	197	2	one	one	NUM
chd-210	197	3	.	.	PUNCT
chd-210	198	1	2009	2009	NUM
chd-210	198	2	doi	doi	NOUN
chd-210	198	3	:	:	PUNCT
chd-210	198	4	10.1371	10.1371	NUM
chd-210	198	5	/	/	SYM
chd-210	198	6	journal.pone.0006533	journal.pone.0006533	PROPN
chd-210	198	7	38	38	NUM
chd-210	198	8	dasgupta	dasgupta	PROPN
chd-210	198	9	s	s	PROPN
chd-210	198	10	,	,	PUNCT
chd-210	198	11	soudry	soudry	ADJ
chd-210	198	12	e	e	NOUN
chd-210	198	13	,	,	PUNCT
chd-210	198	14	mukhopadhyay	mukhopadhyay	NOUN
chd-210	198	15	n	n	CCONJ
chd-210	198	16	,	,	PUNCT
chd-210	198	17	shao	shao	PROPN
chd-210	198	18	c	c	PROPN
chd-210	198	19	,	,	PUNCT
chd-210	198	20	yee	yee	PROPN
chd-210	198	21	j	j	PROPN
chd-210	198	22	,	,	PUNCT
chd-210	198	23	lam	lam	PROPN
chd-210	198	24	s	s	PROPN
chd-210	198	25	,	,	PUNCT
chd-210	198	26	et	et	PROPN
chd-210	198	27	al	al	PROPN
chd-210	198	28	.	.	PROPN
chd-210	199	1	mitochondrial	mitochondrial	ADJ
chd-210	199	2	dna	dna	NOUN
chd-210	199	3	mutations	mutation	NOUN
chd-210	199	4	in	in	ADP
chd-210	199	5	respiratory	respiratory	ADJ
chd-210	199	6	complex	complex	NOUN
chd-210	199	7	-	-	PUNCT
chd-210	199	8	i	i	PRON
chd-210	199	9	in	in	ADP
chd-210	199	10	never	never	ADV
chd-210	199	11	-	-	PUNCT
chd-210	199	12	smoker	smoker	NOUN
chd-210	199	13	lung	lung	NOUN
chd-210	199	14	cancer	cancer	NOUN
chd-210	199	15	patients	patient	NOUN
chd-210	199	16	contribute	contribute	VERB
chd-210	199	17	to	to	ADP
chd-210	199	18	lung	lung	NOUN
chd-210	199	19	cancer	cancer	NOUN
chd-210	199	20	progression	progression	NOUN
chd-210	199	21	and	and	CCONJ
chd-210	199	22	associated	associate	VERB
chd-210	199	23	with	with	ADP
chd-210	199	24	egfr	egfr	ADJ
chd-210	199	25	gene	gene	NOUN
chd-210	199	26	mutation	mutation	NOUN
chd-210	199	27	.	.	PUNCT
chd-210	200	1	j	j	PROPN
chd-210	200	2	cell	cell	NOUN
chd-210	200	3	physiol	physiol	PROPN
chd-210	200	4	.	.	PUNCT
chd-210	201	1	2012	2012	NUM
chd-210	201	2	doi	doi	NOUN
chd-210	201	3	:	:	PUNCT
chd-210	201	4	10.1002	10.1002	NUM
chd-210	201	5	/	/	SYM
chd-210	201	6	jcp.22980	jcp.22980	PROPN
chd-210	201	7	39	39	NUM
chd-210	201	8	choudhury	choudhury	PROPN
chd-210	201	9	ar	ar	PROPN
chd-210	201	10	,	,	PUNCT
chd-210	201	11	singh	singh	PROPN
chd-210	201	12	kk	kk	PROPN
chd-210	201	13	.	.	PUNCT
chd-210	201	14	mitochondrial	mitochondrial	ADJ
chd-210	201	15	determinants	determinant	NOUN
chd-210	201	16	of	of	ADP
chd-210	201	17	cancer	cancer	NOUN
chd-210	201	18	health	health	NOUN
chd-210	201	19	disparities	disparity	NOUN
chd-210	201	20	.	.	PUNCT
chd-210	202	1	semin	semin	PROPN
chd-210	202	2	cancer	cancer	PROPN
chd-210	202	3	biol	biol	PROPN
chd-210	202	4	.	.	PUNCT
chd-210	203	1	2017	2017	NUM
chd-210	203	2	doi	doi	NOUN
chd-210	203	3	:	:	PUNCT
chd-210	203	4	10.1016	10.1016	NUM
chd-210	203	5	/	/	SYM
chd-210	203	6	j.semcancer.2017.05.001	j.semcancer.2017.05.001	NOUN
chd-210	203	7	40	40	NUM
chd-210	203	8	piyarathna	piyarathna	PROPN
chd-210	203	9	dwb	dwb	PROPN
chd-210	203	10	,	,	PUNCT
chd-210	203	11	balasubramanian	balasubramanian	PROPN
chd-210	203	12	a	a	X
chd-210	203	13	,	,	PUNCT
chd-210	203	14	arnold	arnold	PROPN
chd-210	203	15	jm	jm	PROPN
chd-210	203	16	,	,	PUNCT
chd-210	203	17	lloyd	lloyd	PROPN
chd-210	203	18	sm	sm	PROPN
chd-210	203	19	,	,	PUNCT
chd-210	203	20	karanam	karanam	PROPN
chd-210	203	21	b	b	NUM
chd-210	203	22	,	,	PUNCT
chd-210	203	23	castro	castro	NOUN
chd-210	203	24	p	p	PRON
chd-210	203	25	,	,	PUNCT
chd-210	203	26	et	et	PROPN
chd-210	203	27	al	al	PROPN
chd-210	203	28	.	.	PROPN
chd-210	204	1	err1and	err1and	VERB
chd-210	204	2	pgc1αassociated	pgc1αassociate	VERB
chd-210	204	3	mitochondrial	mitochondrial	ADJ
chd-210	204	4	alterations	alteration	NOUN
chd-210	204	5	correlate	correlate	VERB
chd-210	204	6	with	with	ADP
chd-210	204	7	pancancer	pancancer	NOUN
chd-210	204	8	disparity	disparity	NOUN
chd-210	204	9	in	in	ADP
chd-210	204	10	african	african	ADJ
chd-210	204	11	americans	americans	PROPN
chd-210	204	12	.	.	PUNCT
chd-210	205	1	j	j	PROPN
chd-210	205	2	clin	clin	PROPN
chd-210	205	3	invest	invest	PROPN
chd-210	205	4	.	.	PUNCT
chd-210	206	1	2019	2019	NUM
chd-210	206	2	doi	doi	NOUN
chd-210	206	3	:	:	PUNCT
chd-210	206	4	10.1172	10.1172	NUM
chd-210	206	5	/	/	SYM
chd-210	206	6	jci127579	jci127579	NOUN
chd-210	206	7	introduction	introduction	NOUN
chd-210	206	8	potential	potential	ADJ
chd-210	206	9	contributing	contributing	NOUN
chd-210	206	10	factors	factor	NOUN
chd-210	206	11	associated	associate	VERB
chd-210	206	12	with	with	ADP
chd-210	206	13	lung	lung	NOUN
chd-210	206	14	cancer	cancer	NOUN
chd-210	206	15	disparity	disparity	NOUN
chd-210	206	16	genetic	genetic	ADJ
chd-210	206	17	heterogeneity	heterogeneity	NOUN
chd-210	206	18	in	in	ADP
chd-210	206	19	lung	lung	NOUN
chd-210	206	20	cancer	cancer	NOUN
chd-210	206	21	and	and	CCONJ
chd-210	206	22	its	its	PRON
chd-210	206	23	association	association	NOUN
chd-210	206	24	with	with	ADP
chd-210	206	25	racial	racial	ADJ
chd-210	206	26	health	health	NOUN
chd-210	206	27	disparity	disparity	NOUN
chd-210	206	28	conclusion	conclusion	NOUN
chd-210	206	29	and	and	CCONJ
chd-210	206	30	future	future	ADJ
chd-210	206	31	perspective	perspective	NOUN
chd-210	206	32	acknowledgements	acknowledgement	NOUN
chd-210	206	33	conflict	conflict	NOUN
chd-210	206	34	of	of	ADP
chd-210	206	35	interest	interest	NOUN
chd-210	206	36	authors	author	NOUN
chd-210	206	37	’	'	PUNCT
chd-210	206	38	contribution	contribution	NOUN